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Summary
Summary
„ Recent literature indicates that between 40-53% of AIDS patients 
are infected with disseminated M. avium-intracellulare (MAI) complex.
In order to determine how TB and MAI have evolved at St. 
Vincent's Hospital during the current AIDS epidemic in which differing 
populations have entered into the scenario, a retrospective analysis 
was made between 1979-1989. The study demonstrated that the MAI:TB 
ratio which expresses changes in MAI and TB exposure patterns, can 
serve as a useful indicator of change in the composition of the AIDS 
population pool.
The paraffin wax slide culture baiting technique or Para SL/C 
for viewing in situ mycobacterial cording provided a useful means for 
making the distinction between the serpentine cording of non- 
tuberculous and tuberculous cording. Twenty percent of the St. 
Vincent's blood isolates displayed cording.
An adaptation of the Para SL/C method was developed for 
antimicrobial sensitivity testing. Clinical isolates of MAI were 
tested against ciprofloxacin, amikacin and azithromycin by Para SL/C. 
The procedure was reproducible with all agents tested.
The plasmid profile of St. Vincent's blood derived MAI isolates 
showed that pLR-7 type plasmids were found in 85% of the MAI isolates 
obtained from St. Vincent's Hospital and Memorial Sloan-Kettering 
Cancer Center. By contrast, only 20% of the aforementioned isolates 
showed the presence of pLR-20 type plasmids.
This investigation has observed that the A1 R.F.L.P. pattern 
occurred in 50% of the MAI isolates analyzed. R.F.L.P. patterns A/1, 
A2 and A3 occurred, respectively, at 12.5%, 25%, 12.5%.
HeLa Cells have epithelial cell characteristics and were used 
to indicate MAI invasiveness. The loss of MAI cording, presence or 
absence of pLR-7 or the presence of both the pLR-7 and pLR-20 types 
plasmids appeared not to be indicative of a heightened invasiveness. 
The sampling of R.F.L.P. types analyzed did not permit a direct 
correlation between specific R.F.L.P. type and a heightened index of 
invasiveness.
Section I 
General Introduction
INTRODUCTION
1.0 Mycobacterium Avium-intracellulare Complex MAI
Rivolta was credited by Strauss and Gamaleia as being the first 
to express the idea that human and avian tuberculosis were the result 
of two different species (Strauss and Gameleia, 1891). Robert Koch 
also stated that the bacilli responsible for the human and avian forms 
of tuberculosis were two different organisms. In 1891, Strauss and 
Gameleia were the first to isolate the avian bacilli from birds. The 
organism was named Mycobacterium avium by F.D. Chester in 1901 
(Chester, 1901).
M. avium can cause tuberculosis in domestic fowls and other 
forms of bird life (Runyon et al.,1974). M^ . avium has been seen less 
frequently in lesions or lymph nodes of cattle and swine and other 
animals. It has also been found to produce a localized disease in 
pigs. In experimental rabbits and mice, it is able to proliferate 
but, it did not produce macroscopic tubercles. M^ avium serotypes 
have infrequently been implicated in human pulmonary disease. It has 
been found on rare occasions in soil or as an etiologic agent of human 
disease.
The avian bacillus is readily distinguishable from M. 
tuberculosis and Mj_ bo vis (Wolinsky, 1980). The individual cells are 
smaller; the colonies are smooth; it grows optimally at 41° C; it is 
resistant to most of the antituberculosis drugs; and it is pathogenic 
for chickens and rabbits but not for guinea pigs.
In 1949, Cuttino and McCabe isolated from both biopsy and 
necropsy a mycobacterial agent which grew in the cytoplasm of cells
but, did not produce necrosis (Cuttino and McCabe, 1949; Smith et al., 
1968). Their organisms were strongly acid-fast and could grow on a 
variety of routine lab media (Smith, et al., 1968). This isolate was 
found to be non-pathogenic for mice, guinea pigs, rabbits or fowl. 
Because the organism displayed extreme branching in hanging drop 
slides, it was named Nocardia intracellularis.
A peculiar mycobacterial isolate accounted for 1% of all hospital 
admissions at Battey State Hospital for Tuberculosis during the 5 year 
interval from 1950-1955 (Smith et al., 1968) . This organism was found 
to branch in the same manner as that described by Cuttino and McCabe. 
When Magnusson prepara ted sens it in derived from Nocardia intracellularis 
and from the Battey Hospital strain, he found that both strains caused 
identical allergic reactions ( Smith et al.,1968). In 1967, Runyon 
named the organism Mycobacterium intracellulare (Runyon, 1967).
M. intracellulare has been isolated from a fatal system disease in 
a child (Runyon et al., 1974) . It is seen most often in the pulmonary 
secretions and surgical specimens of patients with a tuberculosis-like 
disease. When M_j_ intracellulare is isolated from human secretions, it 
is considered as an etiologic agent of pulmonary disease. However, it 
should be noted that this organism has been occasionally isolated as an 
apparent casual resident. The organism has been isolated in cattle and 
pigs. It has been occasionally found in soil.
M. intracellulare is generally less thermophilic than ML. avium and 
the classical distinction between M^ . avium and M^ . intracel lulare had 
been based upon pathogenicity tests in chickens (Barksdale and Kim, 
1977; Wolinsky, 1980). M^ _ avium was virulent for chickens but, M.
intracellulare was not (Barksdale and Kim, 1977) . However, virulence in 
chickens due to ML. avium can easily be lost (Cross and Goodfellow, 
1973) . There are forms that are intermediate between Mi avium and M. 
intracellulare in terms of colonial morphology, cultural behavior and
chicken pathogenicity thus making the two strains indistinguishable 
(Runyon et al., 1974). Therefore, because both Mj_ avium and M. 
intracellulare share many properties, it was proposed they should be 
placed under the common heading of IL avium complex (Cross and 
Goodfellow, 1973; Wolinsky, 1980; Sommers and Good, 1985).
1.1 Pre-AIDS-ERA M. avium-intracellulare Infection
Before the AIDS era, clinically important infection caused by M. 
avium-intracellulare were generally confined to older patients who 
suffered from chronic lung disease that was slowly progressive and 
often resembled those due to tuberculosis. (Ellner et al., 1991).
It was also an uncommon cause of pneumonia in persons with chronic 
pneumonia (Horsburgh, 1991). In this pre-AIDS period, disseminated 
M. avium-intracellulare infection involving the blood and multiple 
organs was extremely rare with only 24 cases cited in the literature.
1.2 AIDS-ERA M. avium-intracellulare Infection
The MAI complex infection in AIDS patients has been shown to be 
widely disseminated in the host with involvement of the blood, bone, 
lungs, spleen, liver, spinal fluid, and intestinal tract (Reichert, 
et al., 1985). An infection of the gastrointestinal tract with 
M.avium-intracellulare usually in the presence of the disseminated 
form of the disease, is associated with diarrhea, abdominal pain, 
malabsorption,weight loss, and fever with or without night sweats 
(Smith et al, 1992). Recent literature indicates that between 40-53% 
of AIDS patients are infected with disseminated MAI complex (Guthertz 
et al., 1989; Yakrus and Good, 1990 ; Nassos, et al., 1991). 
Disseminated avium complex infection is the most common cause of
bacillemia in patients with AIDS (Brown et al., 1991). It has been
called the most common systemic bacterial infection in patients 
suffering from AIDS (Nassos et al., 1991).
Genetic analysis of AIDS-related MAI strains indicated that 97%- 
98% of the isolates were MU. avium (Guthertz et al., 1989/ Hellyer, et 
al., 1991; Ellner, et al., 1991). The remaining 3% of MAI isolates in 
AIDS patients were JL. intracellulare. In the case of MAI isolates 
derived from non-AIDS patients, only 60% were M^ . avium (Hellyer, 
Brown, Dale and Easmon, 1991).
Jacobson et al. (1991) found that of 137 consecutive patients 
who had a sterile body site cultured for mycobacteria within 3 months 
of their first Pneumocystis carinii infection, those with disseminated 
M.avium displayed significantly shorter (107 days) median survival 
when compared to those with negative cultures (275 days). In 
addition, these investigators found that among 34 patients with AIDS 
and respiratory MAI, 22 later developed the disseminated form of MAI. 
This investigation concluded that disseminated MAI infection was 
linked with a shorter survival in AIDS patients. They also found that 
when MAI was isolated from AIDS patient respiratory specimens, it 
carried a 65% predicative value for subsequent disseminated MAI 
infection.
When M. avium-intracellulare is definitively identified and it has 
been decided to offer therapy, the following drugs are among those 
that have been tried in combination: ansamycin, clofazimine,
ethambutol, isoniazid, amikacin, ciprofloxacin, and imipenem (Powell, 
1991). The optimal duration of therapy is undetermined. None of the 
aforementioned chemotherapeutic agents has thus far proved effective 
in eradicating the infection.
Thus, Mycobacterium avium-intracellulare complex once a 
rare causative mycobacterial agent of disseminated infection, is now
5a devastating and frequent secondary infectious agent of disseminated 
infection in the AIDS patient population.
1.3 Serotype Analysis of M. avium-intracellulare
J. Firth in 1926 first studied the serological properties 
of Avian tubercle bacilli by agglutination and complement fixation 
with bacillary suspensions as the antigen (Schaefer, 1965). Schaefer 
was able to serologically identify strains of nonphotochromogenic and 
scotochromogenic atypical mycobacteria which were derived from a 
variety of human and veterinary sources by their specific 
agglutination. These specific agglutinations were classified into 20 
serotypes (Schaefer, 1965; Schaefer, 1968) . The Mj. avium strains 
studied by Schaefer were found to belong in serotypes 1 and 2 
(Schaefer, 1968) . Barksdale and Kim (1977) noted that M_j_ avium types 
1 and 2 were found to be the cause of human disease. Type 2 occurred 
more frequently as the causative infectious agent in chickens, other 
birds, cattle, pigs and man (Barksdale and Kim, 1977).
The seroagglutination protocol as described by Schaefer for 
serotyping, however, suffers from inherent weaknesses such as a high 
frequency of cross-reactivity and the occasional presence of false- 
positive results or multiple reactions (Denner et al., 1992). In 
addition, agglutinating antibodies cannot distinguish between serovars 
with similar glycopeptidolipid compositions such as serovars 8 and 21. 
There is also the issue of semirough variant strains which 
autoagglutinate.
When the conventional Schaefer seroagglutination protocol was 
combined with the results of animal virulence studies, the recognition 
of serovars 1 to 3 of L  avium and 17 serovars (serovars 12-28) of M. 
intracellulare. as well as, 8 intermediate serovars (serovars 4-11) 
were realized. This classification was again altered on the basis of
genomic analysis and there is currently an ongoing debate as to which 
serovars are of the M_j_ avium or the M^ . intracellulare species. The 
28 well-documented serovars are termed the M^ _ avium complex (Denner 
et al., 1992).
The serovar specific typing antigens of the M_j_ avium complex have 
now been identified as glycolipids, or more specifically 
glycopeptidolipids (GPLs) which are composed of an invariant 
monoglyocosylated lipopeptide core to which a variable oligosaccharide 
hapten is glycosidically linked (Denner et al., 1992). These have 
been called polar GPLs to distinguish them from the singly 
glycosylated, apolar GPLs which are nonspecific, being present in all 
serovars. This fundamental knowledge has allowed the development of 
simple chemical tools for the identification of IL avium complex 
isolates, notably thin-layer chromatography (TLC) of the alkali- 
stable, serovar-specific polar GPLs. The easy resolution by gas 
chromatography (GC) of the characteristic sugars that make up the 
haptenic oligosaccharide of the specific GPLs has provided yet another 
powerful tool for the identification and classification of 
mycobacteria. Enzyme-linked immunosorbent assay (ELISA) based on the 
GPL antigens and the original type-specific rabbit antisera has proved 
beneficial in this respect, and more recently, the generation of 
murine monoclonal antibodies (Mab) to specific epitopes within the 
GPLs of individual serovars has increased the ease and specificity of 
identifications. All of these methods have been applied by Tsang et 
al. in a recent investigation to distinguish IL avium serovars with 
great accuracy, and to help answer clinical and epidemiological 
questions such as the relevance of nontuberculous bacterial isolates 
from nonsterile body sites, the distribution patterns of individual 
serovars in the environment and within patient populations, and the 
conseguent epidemiological implications (Tsang et al., 1992).
Saito et al.(1990) have applied DNA probes specific for either 
M. avium complex or intracellulare for the identification of a 
variety of serovar strains of Mj_ avium complex (MAC) . When reference 
strains of Mj_ avium complex organisms belonging to serovars 1 to 28 
were examined with DNA probes specific for either avium or M^ .
intracellulare. the investigation found that earlier designations of 
MAC serovars, in which serovars 1 to 3 and 4 to 28 were regarded as 
M. avium and M^ intracellulare respectively, should be revised. The 
study stated that JL avium should include serovars 1 to 6, 8 to 11, 
and 21. In addition, the investigation stated that NL. intracellulare 
should include serovars 7, 12 to 20 and 25. These investigators also 
stated that other serovars, such as serovars 22 to 24 and 26 to 28, 
involve M^ intracellulare. M. scrofulaceum. and MAC that were lacking 
the reactivity with either the M^ avium or M^ . intracellulare probe. 
The absence of reactivity of serovars 22 to 24 and 26 to 28 to either 
the M_s_ avium or M^ intracellulare probe precluded a description 
related to taxonomic position in the M_j_ avium complex. Tsang et al. 
(1992) have stated that the DNA probes to date have not been able to 
identify different serovars within one species and that only the 
immunogenic markers involved in serotyping are able to discern 
differences and similarities among strains of the same species.
1.4 Serotype of M. avium-intracellulare in AIDS Patients
Serotyping of the Mj. avium complex provided important 
epidemiological information, especially in tracing the origins of 
infections (Denner et al., 1992). The seroagglutionation protocol of 
Schaefer has been instrumental in the assembly of reference strains 
in the study of the geographic distribution of serovars in humans with 
underlying AIDS and in animals and in tracking sources of such 
isolates.
An analysis of the M_j_ avium serovars from AIDS patients indicated 
that approximately 70% were either serovar 1, 4 or 8 (Morris et al., 
1990) . When a sample collection of AIDS-related Mj_ avium isolates 
(50% of which came from medical centers in California and New York 
State) was serotyped using a modification of the basic Schaefer 
serotype protocol, regional variation in serotype was observed (Yakrus 
and Good, 1990) . In the state of California, serotype 8 was found 
slightly more freguently than serotype 4. In western states other 
than California and New York, serotype 4 was found in slightly greater 
abundance than serotype 8. The serotypes other than 4 and 8 ,namely,
1,9 and 10 had even distribution throughout the western and eastern 
United States (Yakrus and Good, 1990).
The frequency of isolation of specific serotypes for avium 
were determined for the cities of New York, Los Angeles and San 
Francisco (Yakrus and Good, 1990) . In the city of Los Angeles, 
serotype 8 accounted for 36% of AIDS-related fL avium isolates. 
Serotype 8 was found in only 8% of New York City isolates and only in 
16% of San Francisco isolates.
In Europe, a Swedish study of 25 AIDS-derived strains of Mj_ avium 
found serotype 6 to be dominant followed by 4 and 9 (Hoffner et al , 
1989; Tsang et al., 1992). A German study found that 90% of patient 
isolates were serotype 8/21 followed by serotype 8 and serotypes
6,9,12 and 4/8 (Ruf et al., 1989).
All of these investigations share two basic points: a)
individuals acquire whatever serotype predominates in the immediate 
region, b) certain serotypes are found more frequently in one 
geographic location than another.
1.5 Gen Probe
The basic problem encountered with the conventional biochemical 
identification plans or schemes is that these protocols rely on 
metabolic processes that occur during the growth of the organisms 
under consideration (Tenover, 1989). There can occur random
mutations in the genome of the organism that can alter the biochemical 
profiles and therefore make identification difficult. Assays which 
employ rapid monoclonal antibody-based tests rely on the production 
of specific antigens that may be produced only late in the life cycle 
of the specific organism. A DNA based probe protocol does not require 
the expression of a gene but, utilizes the unique sequence of the 
nucleic acids in an organism as a "fingerprint" for identification 
(Tenover, 1989).
In 1987, the Gen Probe Company of San Diego, U.S.A. introduced 
nucleic acid probes for the identification of M^ . tuberculosis complex 
(M. tuberculosis. M. bpyis, africanum and Mj. microti) , M_j_ avium, 
and Mj_ intracellulare (Roberts et al., 1991) . The Gen Probe procedure 
utilized nucleic acid hybridization assays based upon the ability of 
complementary nucleic acid strands to bond and yield stable, double 
stranded complexes under appropriate assay conditions. The original 
Gen Probe employed an 125 I-labeled single stranded DNA probe which was 
complementary to the rRNA from the target organism. The actual rRNA 
of the target organism was released from the test organism via the 
action of a lysing reagent, heat and sonication. The resulting 
hybridization of the 125 I-labeled DNA probe and the rRNA of the target 
organism formed a stable DNA-RNA hybrid. A separation suspension 
separated the labeled complex (DNA-RNA hybrid) from the unhybridized 
DNA. The resulting radiolabelled DNA-RNA hybrids were counted and the 
assay results were expressed as a percentage of input probe
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hybridized. The cutoff value for positive hybridization with the 
probe is set at 10% hybridization (Gonzalez and Hanna, 1987).
Gonzalez and Hanna evaluated the efficacy of the Gen-Probe 
diagnostic protocol for M.avium-intracellulare complex (MAIC) and 
found that it correctly identified 63 of 64 MAIC clinical isolates and 
controls but, yielded 1 false negative value for a sensitivity of 
98.43% (Gonzalez and Hanna, 1987). These investigators stated that 
whereas conventional techniques required subculture and are growth- 
dependent, the DNA probes can be utilized directly on the primary 
isolate as long as there is sufficient growth (3-6 x 108 org/ml) . The 
false negative result obtained by Gonzalez and Hanna was explained by 
the fact that there is a contaminant in their specimen. These 
investigators recommended Gen Probe not be utilized on heavily 
contaminated clinical specimens.
The Gen Probe system was able to demonstrate the presence of M. 
avium directly from BACTEC 12B hemoculture vials by centrifuging 3ml 
of the Bactec broth culture at 3,000 x g for 10 min if the Bactec 
radiometric system had a growth index of greater or equal to 999 
(Kiehn and Edwards, 1987). Ellner et al. (1988) utilized Gen Probe 
DNA probes specific for Mj_ tuberculosis. M. avium and M. 
intracellulare on Bactec 12B radiometric hemocultures (specifically 
utilized for the isolation of mycobacteria) for the purpose of 
speeding up the time to final report and elimination of the need for 
biochemical testing. When the Gen Probe system and the radiometric 
system (BACTEC 12B) were utilized in combination, there was a marked 
reduction in the time to final report (two-thirds of these isolates 
were detected and identified within 2 weeks of inoculation and the 
rest were detected by 4 weeks-a reduction of 5-7 weeks to final 
report) with the total elimination of biochemical testing. The 
utilization of the Gen Probe system for Mj_ avium and M^ _ intracellulare
permitted Conville et al. (1989) to identify for the first time in the 
clinical literature, the presence of a mixed Mj_ avium and M.
intracellulare from blood samples derived from an AIDS patient.
Sherman et al. (1989) found that the results of their investigations
utilizing the Gen Probe DNA probes for IL tuberculosis. M. avium and 
M. intracellulare were greatly improved by expressing percentage 
hybridization values of >15% as positive results, percentage
hybridization values of <5% as negative values and values of 5%-15% 
as indeterminant values. These investigators noted that if they had 
utilized the manufacturers recommended cutoff value of 10%, they would 
have resulted in 27 misidentified cultures, 16 false-negative cultures 
and 11 false positive cultures.
Recent developments in Gen-Probe technology has made possible the 
use of non-radioactive nucleic acid probes. These probes utilize an 
acridinium ester-labeled single stranded DNA probe complementary to 
the rRNA of the target organism (Roberts et al., 1991). In this non­
isotopic protocol, rRNA released from the target organism combines 
with labeled nucleic acid probe to form a stable DNA-RNA hybrid. The 
differentiation of hybridized and nonhybridized probe is achieved by 
the use of a differential hydrolysis reagent. Only the acridinium 
ester label that is bound to the probe in the hybrids is 
chemiluminescent and is detected by a luminometer. These nonisotopic 
nucleic acid probes have an extended shelf life of at least 6 months 
and are cheaper than the current isotopic probes. This latter feature 
makes these DNA probes very useful in the routine clinical 
microbiology lab.
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1.6 Restriction Fragment Length Polymorphism (RFLP) Analysis 
The restriction fragment length polymorphism (RFLP) analysis 
procedure was developed as a method of detecting small differences 
(i.e. single basepair changes) in the chromosomal DNA of closely 
related organisms as seen via conventional genomic analysis such as 
total chromosomal DNA-DNA hybridizations or in sequence determinations 
of highly conserved genes (Clark-Curtiss, 1990). In the RFLP 
protocol, restriction endonucleases are utilized to generate numerous 
fragments from the genomic DNA and these fragments are then separated 
via electrophoresis on the basis of their size. RFLP typing is useful 
as either a method of species identification, or as a method for 
subdividing species into a number of RFLP types (McFadden et al.,
1990). Thus, among the closely related DNA's, the differences in the 
length of a specific restriction fragment could be due to genotypic 
variations that resulted in differences of one or more individual 
bases such that the resulting cleavage sites for a specified 
endonuclease could be lost or gained; alternatively, these differences 
could be the result of insertions or deletions of blocks of DNA within 
the fragment (Clark-Curtiss, 1990) . RFLP studies have been used to 
estimate base-substitution between closely related strains and species 
(McFadden et al., 1990). The use of labelled restriction fragments 
as a DNA probe permits variation among restriction fragments in total 
genomic DNA to be detected by using Southern hybridization (Clark- 
Curtiss, 1990).
1.7 Application of RFLP Analysis to M. Paratuberculosis 
and M. avium Complex Organisms
Crohn's disease (CD) is a chronic granulomatous inflammation 
found chiefly in the large and small intestine and also found in other 
parts of the alimentary canal as well as in the skin, liver and joints
(McFadden et al., 1987). This disease, however, resembled intestinal 
tuberculosis and therefore, was initially suggestive of a 
mycobacterial infection. The idea of a mycobacterial causative agent 
was revived because of the isolation of slow growing, mycobactin 
dependent Mvcobacterium species from the intestinal mucosa of patients 
(McFadden et al., 1987; Butcher et al., 1988: Hampson et al., 1989; 
Kunze et al., 1991). It was found that the biochemical and cultural 
characteristics of this Mvcobacter ium species were similar to those 
of Mj_ paratuberculosis. the causative agent of an intestinal disease 
in ruminants called Johne's Disease (McFadden et al., 1987). Mj_ 
paratuberculosis is similar to mycobacteria of the M^ . avium- 
intracellulare complex (McFadden, et al., 1987) . It was thus decided 
to utilize RFLP methodology in order to clearly be able to distinguish 
between these closely related mycobacterial species.
DNA was extracted and cloned from an unclassified Mycobacterium 
species that was isolated from CD (McFadden et al.,1987). McFadden 
et al., conducted RFLP analysis to distinguish between these 
mycobacteria. Upon RFLP analysis it was discovered that no RFLP's 
were detected between the DNA derived from the unclassified CD 
isolated Mycobacterium species and IL paratuberculosis but, there were 
several RFLP's detected and distinguished between Mj_ paratuberculosis 
and both M^ . avium complex serovars 2 and 5 (McFadden et al., 1987). 
In addition, it was found that the frequency of DNA base substitution 
between M^ _ paratuberculosis and M^ avium complex serovar 2 was 
measured as 0.87. Of the probes examined by McFadden et al., one 
probe pMB22 (this probe contains the insertion sequence IS900) 
hybridized to give multiple banding patterns with IL paratuberculosis 
and the CD Mycobacterium species (Clark-Curtiss, 1990). However, 
pMB22 hybridized to far fewer bands when applied to M_j_ avium and 
weakly to M^ _ kansasii and Mj_ phlei. Thus, from these RFLP studies,
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it was determined that the degree of relationship of JL 
paratuberculosis to the other mycobacteria studied was therefore: M. 
par a tuber cu 1 o s i s > M^ . avium > M^ . kansasii > ML. phlei. The findings 
thus indicated that although M^ . paratuberculosis and ML. avium were 
very closely related, M paratubercu1osis appeared to be a genetically 
distinct, highly conserved pathogen (Clark-Curtiss, 1990).
1.8 Application of RFLP to Ma. avium Complex Organisms
DNA probes were utilized to identify RFLP's in DNA samples of the 
M. avium complex and thus were able to divide it into Mj_ avium and M. 
intracellulare strains (McFadden et al., 1987). There was less than 
2% base substitution between ML. avium strains but, the Ma. 
intracellulare strains had greater than 15% base substitution.
Hampson et al. (1989) looked at the RFLPs in strains of M^ avium- 
intracellulare complex organisms derived from 45 AIDS patients, 18 
Non-AIDS patients and 8 mycobacteria isolated from the stools of 
healthy patients. These investigators utilized DNA probes pMB16, 
pMB17, pMB20 and pMB22 (plasmid clones isolated from a genomic 
library of ML paratuberculosis) for RFLP analysis on the target
mycobacterial genomic DNA that was previously digested with the PvuII 
restriction enzyme. The majority of the AIDS derived strains (33 
isolates (73%)) exhibited Type A RFLP banding pattern and 2 AIDS 
strains from Africa exhibited a Type C banding pattern and the 
remainder showed heterogeneity.
The type A banding pattern included organisms classified as both 
serovars 4 and 8. Thirty one of the 33 AIDS derived isolates had been 
serotyped and of these, one each were serovars 3 and 9, 6 each were 
serovars 1 and 28, 10 were serovar 8 and 7 were serovar 4 (Hampson et 
al., 1989). All of the organisms serotyped as serovar 28 
(theoretically an intracellulare type) had displayed a type A banding
pattern. Of the non-AIDS derived M^ . avium-intracellulare complex 
organisms, 39% (7 isolates) belonged to the Type A RFLP banding
pattern, with 4 isolates exhibiting RFLP banding pattern B, 1 
exhibiting RFLP banding pattern C and the rest showing heterogeneity. 
The 8 isolates that were derived from healthy patients displayed an 
RFLP banding pattern that was distinct from that seen in any of the 
AIDS-related strains of avium-intracellulare complex. The probe 
pMB22 was found to differentiate as many strains as the other four 
probes and thus their subsequent study utilized only pMB22. This 
investigation has supported the finding that the AIDS-derived 
mycobacterial serovars differ from those found in non-AIDS patients. 
However, serotyping correlated poorly with the genetic identity of 
these mycobacteria (Hampson et al., 1989).
McFadden et al.(1990) have reviewed the early work of Hampson et 
al. in an effort to better characterize the RFLP banding pattern. The 
banding pattern given to the MAI serovar 4, strain 1241 was originally 
designated type A (6 bands) by Hampson et al. but, it was changed to 
M. avium complex RFLP type A6 (McFadden et al., 1990). The related 
banding patterns have been designated JL avium complex RFLP type A4.2 
(4 bands in common with A6, two unique). The more distantly related 
mycobacteria (greater than 13% base substitution) such as M. 
intracellulare isolates that have been considered part of the MAI 
complex give completely dissimilar patterns and have been designated 
as M^ avium complex RFLP type Cl. Some of the closely related M. 
avium strains and M^ paratuberculosis strains give a group of 
additional bands and the presence of these additional bands are due 
to the presence of repetitive elements related to IS900 present in 
these strains. These strains have been designated as M^ _ avium RFLP 
type A5.1/I6 (McFadden et al., 1990). Extensive studies by McFadden 
and co-workers have found that after an examination of hundreds of M^ _
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avium complex strains from a variety of sources most strains fall into 
a very limited number of highly conserved RFLP types.
Section II
Retrospective Analysis of IL tuberculosis 
and Mi avium-intracellulare at St.Vincent' 
Hospital During the Decade of 1979-1989
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INTRODUCTION
2.0 AIDS-Related Tuberculosis
In October of 1984, the Centers for Disease Control reported 
that six groups of adults were known to be at risk for AIDS 
(Goedert and Blattner, 1985). Homosexually active males made up 
the vast majority of cases (72.9%) followed by Nonhomosexual 
parenteral drug users (17.2%), non-homosexual non-drug-using 
immigrants from Haiti (3.6%), hemophiliacs (0.7%), heterosexual 
contacts of persons with or at risk for AIDS (0.7%), and recipients 
of blood transfusions (1.2%). Studies done on Haitian immigrants 
to the United States demonstrated that up to 10% of AIDS cases 
develop tuberculosis and over 45% of cases of active TB were HIV 
seropositive (Maayan et al., 1991). The children who have a parent 
who either has or is at risk for AIDS make up 64.8% of the 
pediatric cases (Goedert and Blattner, 1985). Nearly 4% of the 
cases cannot be attributed to the aforementioned risk groups. In 
1989, Ma and Armstrong stated that 62% of the AIDS population was 
made up of homosexual and bisexual men (Ma and Armstrong, 1989) .
In the period from 1963-1985, the incidence rate of 
Mycobacterium tuberculosis (TB) had declined in the United States 
on an annual percentage rate of 5.9% ( McCray et al., 1990). 
However, the incidence of TB stabilized in 1984 and increased in 
1986 (Fife et al., 1991). In 1986, the United States had its first 
increase in indigenous TB morbidity in 33 years ( Onorato et al., 
1992) . The Centers for Disease Control (CDC) estimates that there 
were greater than 14,000 more tuberculosis cases than expected 
during 1984-1988. It was found that this increase occurred mainly 
in areas such as California and New York. The New York City 
Department of Health identified a high rate of TB cases in AIDS
patients in the period of 1981-1985 (Lin and Goodhart, 1991). 
Reported tuberculosis in New York City has been increasing since 
1979 after decades of steady decline (Brudney and Dobkin, 1991).
The growth of homelessness among urban drug abusers in the 1980's 
paralleled the spread of HIV infection , greatly complicating 
tuberculosis treatment and probably promoting further spread of 
this infection. There has occurred an increase in the incidence of 
TB in the total New York City metropolitan population since 1985 
compared to 1981 (Lin and Goodhart, 1991). Many of these cases of 
TB have occurred in the disadvantaged areas of New York City which 
are known to have a high number of individuals who use intravenous 
drugs, are non-white and homeless. These regions of the city also 
have a high incidence of AIDS. Cote et al. (1990) have stated that 
in the most recent AIDS population surveys, patients who are 
intravenous drug users or Haitians appear to be at higher risk for 
TB than other AIDS patients. In the preceding year (1990), 3520 
cases of tuberculosis were reported in the New York City area, a 
rise of 38% over the 2545 cases cited in 1989 (Charatan, 1991).
The incidence in New York City rose from 1980-1990 by 132%. The 
incidence of tuberculosis was 46 cases per 100,000 which is 5 times 
the national U.S. average and accounting for 15% of the nation's 
reported cases. When the incidence of tuberculosis is defined by 
race and ethnic group with sexes combined, tuberculosis reveals 
itself to be the scourge of minorities. The incidence for white 
New Yorkers is just below 10 per 100,000 whereas the incidence for 
black, hispanic and Asian people are respectively 129, 72 and 62 
per 100,000. The classification of cases in 1990 by area of birth 
showed that one in five occurred among immigrants, mainly those 
from the Caribbean and from Central and South America. The largest 
increases of tuberculosis occurred among blacks and Hispanics 25-44
years old (Onorato et al, 1992). The Centers for Disease Control 
data state that 13-46% of patients with tuberculosis are also 
infected with HIV and the highest rates of coinfection occur in New 
York City and are on par with those in parts of Central Africa 
(Charatan, 1991). tuberculosis has been seen as an important
complication of AIDS in those countries where it is usually endemic 
( Gold and Armstrong, 1989).
In equatorial Africa, about half the adult population is 
infected with Mj. tuberculosis and 5 million new cases of 
tuberculosis are diagnosed each year (Maayan et al., 1991). In 
this population in which endemic tuberculosis is present, HIV 
infection was diagnosed in 17-55% of Tuberculosis cases. The World 
Health Organization data indicated that 30% of the AIDS cases in 
Zimbabwe and Ethiopia showed an initial presentation of 
tuberculosis.
The most striking clinical feature of tuberculosis in patients 
with AIDS infection is the extremely high frequency of 
extrapulmonary involvement, usually with concomitant pulmonary 
tuberculosis (Barnes et al., 1991). The most frequent forms of 
extrapulmonary involvement in persons with HIV infection are 
lymphadenitis and miliary disease. In addition, there is 
involvement of the bone marrow, genitourinary tract and central 
nervous system.
The number of cases of extrapulmonary tuberculosis increased 
by 20% from 1984-1989 as compared with 3% for pulmonary 
tuberculosis (Barnes et al., 1991). Extrapulmonary disease occurs 
in more than 70% of patients with tuberculosis and preexisting AIDS 
or AIDS diagnosed soon after the diagnosis of tuberculosis.
However, the extrapulmonary disease is found in only 24-45% of 
patients with tuberculosis and less advanced HIV infection.
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Proof of hematogenous dissemination of M^ tuberculosis was 
initially reported in the 1900*s and was found to be most frequent 
in patients with miliary TB (Clark et al., 1991). When Clough 
reviewed the literature in 1917, bacteremia was found in up to 
66.6% of the patients with miliary tuberculosis but in only 6.7% of 
patients with other forms of M^ . tuberculosis disease. Later 
reports cited cases of patients with disseminated TB but, M. 
tuberculosis bacteremia was rare during the pre-AIDS Era. In the 
AIDS-Era, however, LL tuberculosis bacteremia has become a more 
frequent occurence in HIV infected patients.
Because tuberculosis often appears before other 
opportunistic infections in persons infected with HIV, a large 
number of persons who have otherwise latent HIV infection may seek 
care at TB Clinics (Onorato et al., 1992).
2.1 AIDS-Related Disseminated MAI
In the Pre-AIDS era, disseminated 1L avium-intracellulare 
infection was very rare; in 1980 only 24 cases had been cited in 
the literature (Horsburgh, 1991). However, in 1982, when the 
disseminated form of MAI infection was recognized in patients with 
AIDS, the number of cases increased dramatically. Disseminated MAI 
infection is concurrent with the current AIDS epidemic. In 
December of 1990, the CDC reported that there were 12,202 cases of 
disseminated nontuberculous disease out of an AIDS patient 
population of 161,073. The cumulative incidence was cited as 7.6%.
The studies from clinics have stated that 15-24% of AIDS 
patients have concomitant disseminated MAI infection (Horsburgh, 
1991). The number of disseminated MAI cases in AIDS patients is 
most certainly underestimated because MAI infection occurs after 
the initial AIDS indicating diagnosis. The disseminated M.avium-
intracellulare infection is now the most common systemic bacterial 
infection of AIDS patients in the United States and has been found 
in as many as 50% of AIDS patients upon autopsy (Nassos et al.,
1991).
In Europe and Australia, the percentages are similar to those 
in the United States (Horsburgh, 1991). In addition, MAI has been 
reported in Africa but, dissemination was not identified 
(Horsburgh, 1991; Okello et al., 1990).
2.2 AIDS-Related TB and MAI at St. Vincent1s Hospital
The first AIDS-related TB case reported at St. Vincent*s 
occurred in 1983, and the first MAI case was cited in 1984. In 
order to determine how TB and MAI have evolved at St. Vincentfs 
Hospital during the current AIDS epidemic in which differing 
populations have entered into the scenario, a retrospective 
analysis was made over the decade between 1979-1989.
METHODS AND MATERIALS
2.3 Statistical Analysis
All statistical analysis of the data was determined with the 
aid of a STATISTIX II statistical software package (NH Analytical 
Software, Roseville, Minnesota U.S.A.).
A Chi-Square analysis was made for the purpose of determining 
if there occurred statistically significant changes in the annual 
distribution of mycobacterial disease caused by 
M. avium-intracellulare and M^ . tuberculosis during the 1979-1989 
decade.
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RESULTS AND DISCUSSION
2.4 AIDS-Related MAI and TB 1979-1989
Data from the years 1979-1989 came from the files of the 
Mycobacterial Lab and the Department of Infection control of 
St. Vincent's Hospital and Medical Center of New York. This data 
can be seen in Table 1.
Table 1 reveals that prior to the AIDS Era, the incidence of 
M. avium-intracellulare complex at St. Vincent*s Hospital (first 
AIDS-related TB case at St. Vincent's Hospital seen in 1983; first 
AIDS-related disseminated MAI case seen in 1984) was very rare (3 
cases in 1979; 6 cases in 1980). The distribution of mycobacterial 
infection between MAI and TB (as reflected by the MAI: TB ratio) 
was 0.07 (See Table 1). In 1981 onward there occurred increases in 
the number of MAI infection as reflected by changes in the annual 
incidence of MAI and its distribution. This 1981 increase in the 
numerical value of the MAI:TB ratio could actually represent the 
true starting point of AIDS-related MAI at St. Vincent's hospital 
which represented undiagnosed cases of AIDS infection. By 1984, the 
number of MAI cases seen in St. Vincent's Mycobacteriology unit 
actually exceeded the TB cases (See Table 1). The highest MAI:TB 
ratio of 2.07 was reached in 1984 (See Table 1). In the subsequent 
years following 1984, however, the number of cases of TB again 
exceeded those with MAI (See Table 1). By 1989, the annual 
incidence of TB was two times that of MAI. A Chi-Square analysis 
of heterogeneity of the MAI/TB distribution per annum for the 
decade of 1979-1989 revealed that there did occur a statistically 
significant variation (P<0.0001).
In the early period of the AIDS Era (up to 1985), the vast 
majority of AIDS patients in the U.S. (72.9%) were homosexual males 
(Goedert and Blattner, 1985). The early AIDS patient population
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seen at St. Vincent's Hospital (located in the Greenwich Village 
Section) in New York City was confined to a predominantly middle 
class male homosexual population in which M^ . tuberculosis was not 
endemic. The increases in the MAI:TB ratio in the years from 1981 
through 1984 reflect an AIDS population consisting primarily of 
individuals who were not normally exposed to M^ . tuberculosis.
From 1983 onward, a change in the composition of the AIDS 
population occurred in the United States and Europe with an 
increase in the number of heterosexual individuals infected with 
the HIV virus (Holmes et al., 1989). The 1985 St. Vincent's 
Mycobacterial lab data also reflected the citywide increase in the 
annual incidence of TB. Thus, despite the fact that there occurred 
increases in the per annum incidence of MAI in 1985 and thereafter, 
there also occurred an even greater corresponding increase in the 
annual incidence of TB. These increases in the annual incidence of 
TB surpassed those of MAI by the end of the decade (See Table 1) .
In 1986, the United States experienced its first increase in 
indigenous tuberculosis morbidity ( Onorato, McCray et al., 1992). 
The change in the composition of the AIDS patient population 
reflected a decline in the number of homosexual and bisexual males 
to 62% (Ma and Armstrong, 1989). This new patient population 
consisted of intravenous drug users, minorities (blacks and 
Hispanics), homeless, Carribean immigrants (Haitians and Cubans) 
and immigrants from Central and South America (Onorato et al.
1992). This new patient pool consisted of individuals normally 
exposed to high levels of endemic TB (Brudney and Dobkin, 1991; 
Onorato et al., 1992, Lin and Goodhart, 1991). The literature has 
stated that 1985 marked the first increase in TB cases in many 
years for the City of New York (Lin and Goodhart, 1991). The 
decreases in the MAI:TB ratio in the years from 1985
through 1989 reflect a differing AIDS patient population consisting 
primarily of individuals who had a high exposure to M. 
tuberculosis. The study did not go beyond 1989 because the new 
stricter patient confidentiality regulations introduced in 1990 
allowed only physicians and health care professionals directly 
involved with the patients to have access to file data.
The study demonstrated that the MAI:TB ratio which expresses 
changes in MAI and TB exposure patterns, can serve as a useful 
indicator of change in the composition of the AIDS patient 
population pool.
Table is Annual Incidence of MAI and TB at St.
1979-1989
Year MAI TB
1979 3 41
1980 6 71
1981 17 30
1982 25 65
1983 32 71
1984 54 26
1985 52 54
1986 69 53
1987 67 91
1988 70 106
1989 90 188
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Vincent1s Hospital 
MAI:TB Ratio
0.07
0.08
0.57
0.38
0.45
2.07
0.96
1.30
0.74
0.66
0.48
Section III
Paraffin Wax Slide Culture for Isolation and Speciation 
of Mycobacterium avium-intracellulare
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INTRODUCTION
3.0 Conventional Mvcobacteriology
The isolation of mycobacterial agents has been achieved 
conventionally on egg medium (Lowenstein Jensen) and clear agar 
medium (7H11) (Runyon et al., 1974). In addition, prior to 
isolation, highly contaminated and viscous samples such as sputum 
were treated to a variety of homogenization and decontamination 
procedures prior to cultivation. To decrease the possibility of 
cross-contamination of the mycobacterial culture, the media 
included a variety of agents ( penicillin, nalidixic acid and 
polymixin ). The conventional system worked but, required from 7- 
67 days for M;_ avium detection and additional time for 
identification (a minimum of two weeks) ( Roberts et al.,1987). In 
1975, a new system of detection for mycobacteria was developed 
called Radiometric (Ellner et al., 1988). An automated BACTEC 
Radiometric apparatus for detecting the presence of mycobacteria in 
sputa was developed in 1977. The BACTEC system used broth with Re­
labelled palmitic acid. The apparatus measured the release of 14C02 
from the metabolism of the [14C]-labelled palmitic acid to detect 
the presence of mycobacteria. A growth index or GI of 10 or more 
showed the release of 14C02. The assay was measured until a GI of 
10 was reached. With the onset of the AIDS era, disseminated 
infection due to MAI and its associated mycobacteremia have become 
common (Motyl et al., 1989). The automated radiometric system was 
then easily adapted for the analysis of blood culture specimens 
using 7H12 broth containing 14C-labelled palmitic acid to analyze 
blood for the presence of mycobacteria in AIDS patients. The 
automated Radiometric BACTEC (Johnston Laboratories, Inc., Towson, 
Maryland, U.S.A.) provided a more rapid MAI detection time of from 
3-23 days but, it did not provide a more rapid identification of
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any of the Mycobacteria Other Than Tuberculosis (MOTT) (Roberts et 
al., 1987).
Most recently, it has been reported by several investigators 
(Ellner et al., 1988; Gonzalez and Hanna, 1987) that a DNA probe 
called the "Gen-Probe Rapid Diagnostic System” was able to rapidly 
speciate (within 2 hours) Mj. avium organisms from a variety of 
noncontaminated mycobacterial isolates. Ellner et al. stated that 
with the use of the DNA probe all their isolates were identified 
within 4 days of their detection by BACTEC or on conventional media 
(Ellner et al., 1988). The DNA probe assay, however, costs about 
$12.00 per assay (Gonzalez and Hanna, 1987).
A limitation of the radiometric assays and DNA probe is that 
they are dependent upon skilled personnel and the support of a well 
equipped clinical laboratory including expensive detecting devices 
(Ollar et al., 1991). A simpler and cheaper method for the 
detection, isolation and speciation of MAI complex organisms would 
be quite beneficial in those circumstances where expensive 
radiometric systems, highly skilled personnel and or financial 
resources are limited.
3.1 Paraffin Wax Baiting
Sohngen in 1913 first developed the use of the paraffin wax 
baiting technique as a means of isolating certain bacteria 
including the Mycobacteria and Nocardia species solely on their 
ability to utilize paraffin wax as a carbon source (Sohngen, 1913). 
Gordon and Hagan isolated acid-fast saprophytic mycobacteria from 
soil solely based upon the ability of the latter group of organisms 
to utilize paraffin wax as a source of carbon (Gordon and Hagan, 
1936). This was accomplished by introducing paraffin wax coated 
rods into media that lacked all other sources of carbon. This
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technique has been called Paraffin Baiting. Waksman has often 
refered to this technique in the isolation of nocardias from soil 
(Waksman, 1967).
In the realm of clinical microbiology, Mishra and Randhawa, 
for the first time applied the paraffin baiting technique for the 
isolation of Nocardia asteroides from sputum, bronchial aspirates 
and gastric lavage (Mishra and Randhawa, 1969). Kurup, Randhawa 
and Mishra further studied the use of this procedure for the 
isolation of Nocardia asteroides from sputum (Kurup et al., 1970). 
Later, Mishra, et al. (1973) conducted a more detailed study on the 
paraffin baiting procedure and its application as a laboratory 
diagnostic procedure in Nocardial infection.
Mishra et al. found that the property of paraffin wax 
metabolism was very useful since it is a property not commonly 
found among human pathogens and permitted heavily contaminated 
sites to be examined for the presence of nocardioform organisms 
without the need to incorporate antibiotics into the media. The 
inoculated media that contained these paraffin utilizing organisms 
showed colonial growth on the paraffin coated rods (Ollar, 1976). 
Palmer et al. further cited reasons for the utilization of the 
paraffin baiting procedure, "Finally paraffin techniques using the 
ability of Nocardia to utilize paraffin as a sole source of carbon 
has proven to be helpful as a simple method in detection of low 
concentrations of the organisms in respiratory secretions." (Ollar, 
1976).
3.2 Slide Culture
Traditionally mycologists and microbiologists studying the 
filamentous bacteria (actinomycetes) have been very interested in 
observing the nondisturbed or "in situ" microscopic growth of their
respective fungal and filamentous bacterial elements in order to 
identify morphologic cultural changes (Moss and McQuown, 1969).
The method utilized to study this "in situ" growth is known as 
Slide culture. The technique of slide culture has conventionally 
utilized either agar coated glass slides or agar blocks mounted 
upon glass slides (Vanbreuseghem, 1966 ; Riddell, 1950). The 
resulting "in situ" growth was then subsequently stained and 
mounted with a combination of lactophenol and cotton blue within a 
saturated aqueous solution of potassium acetate (Emmons et al., 
1970).
3.3 Paraffin Wax Slide Culture
The Nocardial mycelium fragments easily, and therefore the 
growth taken from solid media often reveals only the bacillary or 
coccoid forms. Thus, in order to see the undisturbed or "in situ" 
growth, slide culture of Nocardia must be used. Ollar has shown 
that paraffin wax coated slides could be utilized for baiting 
(Ollar, 1976). The application of paraffin wax coated slides for 
baiting was a great advance over the conventional baiting achieved 
with rods because it united the factors of "in situ" growth on 
paraffin wax, nocardial microscopic morphology and acid-fastness 
(via Kinyoun cold acid-fastness) in presumptive identification of 
nocardioform organisms.
3.4 Paraffin Slide Culture and MAI
Blood has become the most common source of isolation in 
AIDS related MAI (Horn et al., 1989). The basic procedure 
currently used for the detection of MAI in blood relies on the 
Bactec Radiometric system (Kirihara et al., 1985). For sites other 
than the blood, Lowenstein-Jensen, Middlebrook 7H9 and related
Middlebrook media are currently used (Ollar et al., 1990). The 
speciation of MAI is based upon several important conventional 
criteria; namely, tellurite reduction after 3 days, negative urease 
reaction, negative niacin production and negative Tween 80 
hydrolysis assay.
Fuhs in 1961 noted that many, mycobacteria including M. 
avium and M^ intracellulare but not Mycobacterium tuberculosis were 
able to make use of paraffin wax as a sole source of carbon in 
basal salt media devoid of all other carbon sources (Fuhs, 1961).
Therefore, because the MAI complex is also able to make 
use of paraffin wax, a slide culture protocol could be adapted for 
use with conventional biochemical assays such as tellurite 
reduction, nitrate reduction, urease utilization and Tween 80 assay 
in simplified and economical systems for isolation and speciation 
of MAI complex organisms.
METHODS AND MATERIALS
3.5 Paraffin Wax Slide Culture Slides
Standard microscope slides were cut longitudinally so 
that they could fit within test tubes and could be easily withdrawn 
(Ollar, 1976; Ollar et al., 1990). The test tubes were plugged and 
sterilised by autoclaving. Hollow glass tubing was bent into U- 
shaped or V-shaped rods (to act as slide supports) and added to 
standard size glass petri dishes which were then wrapped and 
autoclaved.
For preparation of paraffin wax coated slides, several 
tubes of histological grade paraffin embedding wax (previously 
sterilised by autoclaving) were melted in a boiling water bath, 
while a glass petri dish containing a slide support was heated on 
an electric hot plate to a temperature sufficient to keep the 
paraffin wax molten. Molten paraffin wax was then poured into the 
heated petri dish to a level sufficient to cover a slide on the 
support.
Ethanol-flame sterilised forceps were used to transfer a 
previously autoclaved microscope slide onto the supporting glass 
rod in the petri dish which contained molten paraffin wax. The 
slide was kept there for only a few seconds so that it was covered 
by a thin coat of paraffin wax. The coated slide was quickly 
returned to the tube from which it was initially withdrawn. A tube 
of molten paraffin wax was added to the petri dish after 6-10 
slides had been processed to ensure that there was always 
sufficient wax to cover the supported slides.
3.6 Czapek Broth for Slide Culture Isolation
Czapek broth (See Appendix IV; Media) to 1.0 litre in 
distilled water, and adjusted to pH 7.5 (Ollar, 1976). The broth 
was dispensed in 4.5 ml amounts and sterilized by autoclaving for 
15 min at l.0kg/cm2.
3.7 Blood Culture Isolates
Aliquots of 3-5 ml of blood from AIDS patients were first 
added to Bactec 13A Blood Culture Medium (30 ml Bactec 13A (Becton 
Dickenson) per vial). Aliquots of 0.5 ml. subcultured from the 
inoculated Bactec 13A vial were added initially to six tubes 
containing 4.5 ml Czapek broth. Paraffin wax coated slides were 
then added to each of the six tubes. At intervals of 7 days 
additional tubes were inoculated as cited above. A total of 3-4 
seven day samples were usually taken. These paraffin slide 
cultures were then incubated at 37° C for a period of 30 days before 
declaring the subculture to be negative (Ollar et al., 1990). When 
growth was observed on a series of paraffin slide cultures, it was 
scraped off the surface of a paraffin slide culture with a flame- 
sterilized inoculating needle and subcultured aseptically onto two 
Lowenstein-Jensen slopes. The five remaining paraffin slide 
cultures of the series were utilized for the speciation assays 
previously described (see Speciation Assays cited below).
3.8 Stool Culture Isolates
Fresh fecal suspensions were prepared from stools of AIDS 
patients by inoculating a 4mm loop of sample into 5.0 ml of sterile 
saline. Aliquots of 500 fil were added to 4.5 ml of sterile Czapek 
broth. Paraffin wax coated slides were then added. Cultures were 
incubated and periodically checked. In addition, when broth level
became low or growth on paraffin slide was observed, slides were 
transferred to new tubes containing sterile Czapek broth. The 
growth from paraffin slide culture surface was subcultured and 
speciated in the same manner as cited above for Blood Culture 
Isolates.
A modification of the standard fecal isolation protocol 
as cited above was also used. In the modification, the Czapek 
broth which was to be inoculated with fecal suspension contained a 
1:100 final dilution of antibiotic cocktail called Bactec Panta 
Plus (manufactured by Becton and Dickenson: stock solution 
contained: Polymyxin B 10,000 units/ml; Amphotericin B 1,000 /xg/ml; 
Nalidixic Acid 4,000 /Ltg/ml; Trimethoprim 1,000 ijlg/ml; Azlocillin
2,000 fig/ml) . The paraffin wax coated slides were transferred as 
cited above but, in this protocol the new tubes also contained 
antibiotic cocktail. The subculturing and speciation procedures 
the same as those cited below.
3.9 Sputum Culture Isolates
Suspensions of sputum were prepared from sputum derived 
from AIDS patients by inoculating 500 /il of sputum into 4.5 ml of 
sterile Czapek broth which also contained 1:100 final dilution of 
Bactec Panta Plus antibiotic cocktail. The subculturing speciation 
procedures were the same as previously cited.
3.10 Speciated MAI Isolates
The strains speciated as MAI complex organisms were: 953, 
1516, 1762, 4861, 5097, 6475, 8515, 8997, 15113, 10,000, 10,001, 
10,002, 10,008, 10,010, 10,011, 10,012, 10,013, 10,014, 10,015 and 
10,016. The aforementioned strains were initially isolated from 
the blood of the AIDS-patient population of St. Vincent's Hospital
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and Medical Center of New York via the Paraffin Wax Slide culture 
protocol. These were speciated by the following conventional 
biochemical criteria: reduction of tellurite in 3 days, absence of 
nitrate reduction, negative urea hydrolysis and absence of Tween 80 
hydrolysis reaction. A parallel species conformation of the MAI 
complex organisms was performed via the GEN-PROBE hybridization 
protocol.
3.11 Stock Cultures
The stock cultures of Mvcobacterium fortuitum NI and 
Mycobacterium kansasii Nil were kindly supplied to us by Mr.
William Millett, Assistant Director, Department of Microbiology,
St. Vincent's Hospital and Medical Center of New York.
3.12 Stock Culture Media
The stock cultures were grown in Trypton broth (See 
Appendix IV; Media), made up to 1.0 litre in distilled water, and 
adjusted to pH 7.5 (Ollar, 1976). The trypton broth was dispensed 
in 4.5 ml amounts and sterilized by autoclaving for 15 mins at 1.0 
kg/cm2.
3.13 Speciation Media
The media utilized for speciation were dispensed in 4.5 
ml amounts and sterilized by autoclaving for 15 min at 1.0kg/cm2. 
Urea broth and nitrate broths were prepared according to the method 
cited in the Ninth Edition of the Difco Manual (Difco Laboratories 
Inc., 1974). Tween 80 broth and tellurite reduction indicator were 
prepared according to the method cited in the Second Edition of the 
Manual of Clinical Microbiology (Runyon et al., 1974).
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3.14 Preparation of Stock Culture for Speciation Assays
A loopful (10 nl) of stock culture was added to 4.5ml 
amounts of trypton broth and incubated at 37° C. The cultures were 
grown for 6-14 days. Thereafter, 0.5ml of stock culture broth 
culture were pipetted into 6 tubes containing sterile Czapek broth, 
and the paraffin wax coated slides were added (Ollar, 1976), 
incubated at 37° C and checked daily for growth on the slide 
(paraffin slide culture).
3.15 Speciation Assays
3.15a Paraffin utilization and 11 in situ11 acid alcohol fastness 
assay
When visible growth was observed on the paraffin wax- 
coated culture slides, one of the slides was removed and stained 
for acid-alcohol fastness by placing it into a tube containing 
Kinyoun carbolfuchsin (See Appendix V; Stains) for 15 min, 
immersing it several times in distilled water, placing it in a tube 
containing acid-alcohol (See Appendix V; Stains) for 5 min, 
immersing it in a tube containing distilled water and then 
immersing it in a tube containing 1.0% (v/v) aqueous solution of 
methylene blue (See Appendix V; Stains) counterstain for 1 minute. 
The slide cultures were given a final rinse in a tube containing 
distilled water, removed and gently blotted (with care not to 
remove the stained growth from the paraffin wax surface) with a 
clean absorbent paper tissue. It is important to note that during 
each step of the staining the entire slide should be totally 
submerged. The slides were then viewed at 25Ox, 45Ox and lOOOx oil 
immersion (Ollar et al. 1990).
3.15b Tellurite reduction assay
Slide cultures showing heavy growth were tested for the 
ability to reduce tellurite in 72 hours by transferring them to 
sterile tubes containing sterile Czapek broth to which 200 /zl of 
potassium tellurite reagent had been previously added (Runyon et 
al., 1974; Ollar et al., 1990). The slide cultures were then 
incubated at 37° C and checked daily for tellurite reduction for a 
period of 72 hours. A blank sterile paraffin wax coated slide was 
added to sterile media containing tellurite as a reagent control. 
The strains of M«_ avium-intracellulare and Mj. fortuitum cited above 
were used as positive controls and the known strain of kansasii 
cited above was utilised as a negative control.
3.15c Nitrate reduction assay
Slide cultures showing heavy growth were assayed for the 
ability to reduce nitrates by adding them to tubes containing 
sterile nitrate broth (Runyon et al., 1974; Ollar et al., 1990). 
After a period of 12-24 hours incubation at 37° C, the slides were 
removed from the broth and 5 drops of sulfanilic acid reagent 
solution followed by 5 drops of alpha naphthylamine reagent 
solution were added to the tubes. The same procedure was carried 
out with sterile media exposed to sterile paraffin slides as 
reagent controls. The strains of M. fortuitum and M_s_ kansasii 
cited above were used as positive controls and the strains of M. 
avium-intracellulare cited above served as negative controls.
3.15d Urea Hydrolysis Assay
Slide cultures were added to tubes containing 4.5ml 
amounts of sterile urea broth (Runyon et al., 1974; Ollar et al., 
1990) . The cultures were incubated at 37° C and checked for a
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period of 3 days. Sterile paraffin slides, added to sterile urea 
broth, served as reagent controls. The strains of M^ . fortuitum and 
M. kansasii served as positive controls and the strains of M;_ 
avium-intracellulare served as negative controls. A positive 
reaction involved a colour change to pink or red after a period of 
3 days.
3.15e Tween 80 Hvdrolvsis Assay
Slide cultures were added to sterile tubes containing 
Tween 80 media and incubated at 37° C (Runyon et al., 1974; Ollar et 
al., 1990). The reagent controls were sterile Tween 80 media and 
sterile paraffin slides. A slide culture of the strain M. 
kansasii. added to sterile Tween 80 media, served as a positive 
control. Positive reaction involved the appearance of pink colour 
within 5 days. A slide culture of the strain M^ . avium- 
intracellulare served as a negative control.
3.15f Gen Probe Hybridization
The GEN-PROBE hybridization analysis of the Paraffin 
slide culture isolates was performed by the Dept of Clinical 
Microbiology of St. Vincent's Hospital.
RESULTS AND DISCUSSION
3.16 Paraffin Wax Slide Culture isolation of MAI
The use of slide culture for the mycobacteria has largely 
been overlooked, namely, because of the fact that in some species 
of the genus Mycobacterium hyphae are never seen, whereas other 
species have incipient hyphae only in young cultures (Gottlieb, 
1973).
Prior to this investigation, the concepts of Paraffin 
Slide Culture "in situ" growth isolation linked with a slide 
culture based biochemical assay of "in situ" growth were unknown 
concepts in the realm of Mycobacteriology. At the onset of this 
investigation, the Paraffin Slide Culture was a device which I had 
developed 17 years earlier for isolation of Nocardia asteroides 
and therefore did not have any Mycobacterial focus (Ollar, 1976).
In its original form, the Paraffin Wax Slide Culture merely 
examined "in situ" morphology and the acid-fastness of the latter.
The literature at the beginning of this project, however, 
noted that several early investigations had determined there were 
species of mycobacteria capable of utilizing paraffin wax as a sole 
source of carbon in basal media devoid of all other carbon sources 
(Sohngen, 1913; Gordon and Hagen, 1936: Fuhs, 1961). In addition, 
one investigator had found that IL tuberculosis was incapable of 
utilizing paraffin wax (Fuhs, 1961). However, these citings were 
related to growth upon paraffin wax coated rods so that Paraffin 
Wax Slide Culture or its application to the examination of "in 
situ" mycobacterial growth was ignored.
In the scenario of AIDS-related mycobacterial infection, 
M. avium complex organisms are often found growing concomitantly 
with IL tuberculosis. A Paraffin Slide therefore could serve as a 
means of distinguishing between "atypical" mycobacteria and IL
tuberculosis because the latter cannot utilize paraffin wax as a 
sole source of carbon. The Paraffin Wax Slide Culture System has 
the advantage of being a highly selective milieu, and would reduce 
the risk of contamination because very few human pathogens and 
commensals are able to grow on paraffin wax. In addition, the acid- 
alcohol fast staining procedure allows for additional screening to 
determine whether the organisms are nocardioforms or atypical 
mycobacteria. The nocardioforms such as Nocardia asteroides are 
able to utilize paraffin but are not acid-alcohol fast (by the 
staining method used) and are filamentous upon slide culture. Thus 
they would be ruled out by the Paraffin utilization and "in situ" 
acid-alcohol fastness assay (cited below) in the paraffin-wax based 
system.
The role of the Paraffin Wax Slide Culture was further 
enhanced by the inclusion of a series of key conventional 
biochemical assays performed upon the "in situ" growth (Tellurite 
reduction, Nitrate reduction, Urea hydrolysis and Tween 80 
hydrolysis) which are indicative of MAI complex organisms. The 
concept of performing biochemical speciation upon "in situ" slide 
culture growth especially Paraffin Wax Slide Culture is a 
completely new approach. These "in situ" biochemical assays will 
be discussed in greater detail below.
3.17 Blood
The median time needed to isolate acid-alcohol fast 
organisms from blood culture via the Paraffin Wax Slide Culture 
system (Para SL/C) was 22 days (See Tables 2&3) . The range of time 
needed for detection of MAI via the Para SL/C was 13 to 41 days.
The literature has revealed that the range of time needed 
for detection with the Bactec Radiometric system was 3 to 23 days
43
(Roberts et al., 1987). A Chi-square analysis of the two time 
distributions revealed that there did not occur a statistically 
significant (P=0.1892) difference in the time intervals needed for 
MAI detection by these two diverse systems.
This is the first time that a paraffin-wax system has 
been successfully used in AIDS patients to isolate paraffinophilic 
acid-alcohol fast organisms (953, 1516, 1762, 4861, 5097, 6475,
8515, 8997, 15113, 10,000, 10,001, 10,002, 10,003, 10,004, 10,008, 
10,009 10,010, 10,011, 10,012, 10,013, 10,014, 10,015 and 10,016 ) 
from blood. Unfortunately, due to incubator malfunction, 3 blood 
isolates (10,003, 10,004, 10,009) were destroyed before speciation 
could be carried out.
3.18 Stool
The experiments with stool culture marked the first time 
that Paraffin Wax Slide Culture had been applied to isolate 
paraffinophilic acid-alcohol fast organisms in stool specimens of 
AIDS-patients. Stool isolates are quite important since the 
gastrointestinal tract has been cited as a focus of MAI infection 
(Hellyer et al., 1991) and as a possible causative agent of 
diarrhea (Smith et al., 1992). The initial experimental work in 
this highly contaminated environment proved that the Para SL/C 
linked with acid-alcohol fast staining could discern the presence 
of acid-alcohol fast elements and non-acid-alcohol fast but 
paraffinophilic elements as seen in figure 1.
The isolation of uniquely acid-alcohol fast elements by 
the Paraffin Wax Slide Culture System, however, was only achieved 
by the addition of 1:100 dilution of an Anti-bacterial and Anti- 
fungal antibiotic Cocktail called Panta Plus (Becton and Dickenson) 
as seen in figure 2. This Panta Plus additive killed all possible
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paraffinophilic non-acid alcohol fast growth as is demonstrated in 
figure 2. Stool sample analysis was possible without the need for 
vigorous pre-inoculation decontamination procedures as are required 
for conventional Lowenstein & Jensen preps.
The time needed to isolate acid-alcohol fast organisms 
from a stool culture via the Paraffin Slide Culture system varied 
from 7 to 24 days. The mean isolation time was 15.5 days.
When the Paraffin Slide Culture incorporated 1:100 
dilution of the Bactec Panta Plus antibacterial and antifungal 
antibiotic cocktail in specimen 10,006, the time needed for 
isolation was 7 days. By contrast, in specimen SK7B where the 
Bactec Panta Plus antibacterial and antifungal was not utilized, it 
required 24 days for the isolation of acid-alcohol fast organisms.
Despite the encouraging initial experiments involving 
AIDS-related stool specimens, these experiments with stool culture 
were incomplete due to the destruction of these stool isolates 
(10,005, 10,006, SK7B) in an incubator thermostat malfunction. 
Further experimentation with fecal isolation proved difficult due 
to the official reluctance on the part of Medical Staff to permit 
the taking of fecal samplings. It should be noted that the 
official line among the Hospital Staff at St. Vincent's Hospital is 
that blood is the only relevant MAI specimen.
3.19 Sputum
During the course of this investigation one sputum sample 
was obtained from an AIDS patient. The time needed to isolate 
acid-alcohol fast organisms from a sputum culture was 7 days. 
Tragically, this specimen was among those lost due to incubator 
malfunction.
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Figure Is Stool isolate from AIDS patient. Atypical Mycobacteria 
SK7B (acid-alcohol fast staining) and yeasts (non-acid-alcohol fast 
staining) 24 days in situ growth on Para SL/C at 37° C (lOOOx Oil 
Immersion, Microscopic Magnification).
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Figure 2: Stool isolate from AIDS patient. Atypical Mycobacteria
10,006 (acid-alcohol fast staining) 7 days in situ growth on Para 
SL/C at 37° C. The Czapek broth also contained 1:100 dilution of 
Bactec Panta Plus (antibacterial and antifungal antibiotic) 
cocktail. (lOOOx Oil Immersion, Microscopic Magnification) .
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3.20 Paraffin utilisation assay and 11 in situ” acid-alcohol 
fastness.
A macroscopic view of a Paraffin Wax Slide Culture where 
growth occurred, displayed the presence of a heavy pellicle that 
was either non-pigmented or pigmented at the level of the menicus. 
The macroscopic view of the same Paraffin Wax Slide below the 
menicus revealed small white punctiform colonies. The kinyoun acid 
alcohol fast staining of the slide cultures revealed, under the 
light microscope at 450x and lOOOx, bacillary forms, branching 
filaments, and thick colonial mass (See Figures 3 and 4).
The growth of Ms. fortuitum usually appeared after a 
minimal growth period of 48-72 hours at 37° C and the Ms. kansasii 
growth usually appeared after a minimal growth period of more than 
148 hours at 37° C. In both these organisms there were again 
observed a variety of acid alcohol fast staining forms.
A useful finding obtained from these studies with the 
Paraffin Wax Side Culture was that we were able to observe the 
presence of cording in some of our isolates (10,002, 10,010, 10,011 
and 10,015) without having to perform any additional assays. The 
subject of MAI cording is examined in greater detail in Section IV.
3.21 Tellurite reduction assay
A heavy growth on the paraffin wax slide culture was 
necessary in order to perform this assay. After a period of 24-72 
hours exposure of the tellurite to paraffin slide culture, the 
positive control mycobacterial species (M;. fortuitum NI) displayed 
a heavy black precipitate at the level of the meniscus pellicle 
indicative of the classifical tellurite reduction (See Figure 5).
By contrast, the reagent controls which were processed in the same 
manner failed to show a positive tellurite reduction. The negative
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control mycobacterial species (M^ . kansasii Nil) failed to show any 
reduction of the tellurite (See Figure 5). M^ . avium-intracellulare
complex organisms are able to reduce tellurite (Runyon et al.,
1974; Ollar et al., 1990). The reliability and reproducibility of 
this assay was confirmed by the fact that in 20 isolates where it 
was run (See Table 2) a tellurite reduction was achieved. These 
isolates were also confirmed as being avium by a subsequent 
GEN-PROBE analysis.
The system even permitted us to view microscopically the 
"in situ" microcolonies that had reduced tellurite since they were 
in effect stained by the tellurite reaction.
3.22 Nitrate reduction assay
Nitrate broth that had been exposed to slide cultures 
that contained heavy growth of M^ . fortuitum and Mj_ kansasii for a 
period of 12-24 hours showed a typical red colour when treated with 
the sulfanilic acid and alpha naphthylamine reagents revealing a 
reduction of the nitrate to nitrite. By contrast, the reagent 
controls which were processed in the same manner failed to show a 
positive nitrate reaction. Mj. avium-intracellulare complex fail to 
reduce nitrate (Runyon et al., 1974; Ollar et al., 1990). The 
reliability and reproducibility of this assay was confirmed by the 
fact that in 20 isolates where it was run (See Table 2) a nitrate 
reduction was not achieved. A GEN-PROBE analysis confirmed the 
species as being avium.
This investigation found that because the Czapek broth 
control contained a nitrate source, namely, NaN03, it also could be 
used as an additional medium to assay for nitrate reduction. In 
fact, the nitrate reduction assay worked equally well with either 
Czapek or nitrate broth. This finding added to the utility of the
Paraffin Wax Slide Culture System by reducing the number of special 
speciation media required and thereby cutting down costs incurred 
by the purchase of these additional assay broth media.
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Figure 3: Microcolonial growth of MAI. Paraffin slide culture
stained with Kinyoun acid alcohol fast staining (200x, Microscopic 
Magnification)
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Figure 4: Bacillarv and rudimentary filamentous forms. Paraffin
slide culture stained with Kinyoun acid alcohol fast staining 
(2000X Oil immersion, Microscopic Magnification)
Figure 5: Comparison of paraffin slide cultures. A positive
tellurite (black) assay and a routine paraffin slide culture 
growth.
N.--*
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3.23 Urea hvdrolvsis Assay
When slide cultures that contained heavy growth of M. 
fortuitum were added to sterile urea broth, a pink or rose colour 
developed 3 days at 37° C, indicative of urea hydrolysis. By 
contrast, the reagent controls which were processed in the same 
manner failed to show a positive Urea hydrolysis reaction. M. 
avium-intracellulare complex do not hydrolyze Urea (Runyon et al., 
1974; Ollar et al., 1990). The reliability and reproducibility of 
this assay was confirmed by the fact that in 20 isolates where it 
was run (See Table 2) a Urea hydrolysis was not achieved. These 
isolates were also tested by GEN-PROBE analysis and found to be M. 
avium
3.24 Tween 80 Hydrolysis Assay
Slide cultures containing heavy growth of the strain M. 
kansasii added to sterile tubes containing Tween 80 media produced 
positive reactions within 5 days incubation at 37° C, seen as the 
appearance of red colouration of the colonial growth at the 
meniscus surface of the slide culture. By contrast, the reagent 
controls which were processed in the same manner failed to show a 
positive reaction. M^ . avium-intracellulare complex do not 
hydrolyze Tween 80 (Runyon et al., 1974; Ollar et al., 1990). The
reliability and reproducibility of this assay was confirmed by the
fact that in 20 isolates where it was run (See Table 2) a Tween 80 
hydrolysis was not achieved. These isolates were also speciated by
GEN-PROBE analysis and found to be 1L_ avium.
3.25 Pigmentation of MAI Isolates
The presence of colonial pigmentation was seen to be 
variable. Several MAI speciated isolates (1516, 6475, 10,000, 
10,013 and 10,014) from the total collection of speciated MAI 
isolates were pigmented whereas the remaining MAI speciated 
isolates were not (See Table 2). The presence of pigmentation of 
the paraffin slide culture was correlated by its presence on 
subsequent subcultures made on conventional L&J slopes.
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Table 2: isolates Speciated as g&I
Spec. ParSL/C Tell- Nitrate Urea Tween
number and urite Reduct. Hydro 80
Alcohol Reduct Hydro
-acid
fast.
Gen
Probe
Hybrid
with
IL.
avium
probe
953 +
(MAI)
1516 +
(MAI)
1762 +
(MAI)
4861 +
(MAI)
5097 +
(MAI)
6475 +
(MAI)
8515 +
(MAI)
8997 +
(MAI)
15113 +
(MAI)
10,00 +
(MAI)
10,001 + 
(MAI) 
10,002 + 
(MAI)
10,008 + 
(MAI)
10,010 +
(MAI)
10,011 +
(MAI)
10,012 +
(MAI)
10,013. +
(MAI)
10.014 + 
(MAI)
10.015 + 
(MAI)
10.016 + 
(MAI)
IL. +
kansas
Al Nil
IL. +
fOVXr
NI
*nd=not done
nd*
Pig­
ment
+
+
+
+
+
+
+
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Table 3: 
Strains
Isolate
10,000
10,001
10,002
10,008
10,010
10,011
10,012
10.013
10.014
10.015
10.016
Total Time Needed For Isolation and Speciation of MAI
from Blood by Paraffin Wax Slide Culture System
Time in Time in Total Final
Bactec Para time time
13A SL/C (in (in
vial (in days days)
(in days) for (+) includ­
days) for (+) Par ing
before 
seeding 
in Para 
SL/C
growth SL/C
isolat­
ion
=time
in
Bactec 
+ time 
in Para 
SL/C
spec­
iation
17 5 22 25
0 22 22 25
14 4 18 21
0 18 18 21
21 7 28 31
9 11 20 23
9 11 20 23
14 27 41 44
6 19 25 28
10 3 13 16
25 6 31 34
3.26 The Duration of Speciation
The literature revealed that the range of time needed for 
MAI speciation was 7 to 27 days via the Bactec Radiometric/GENE- 
Probe (Roberts, McMillan and Coyle, 1987; Ellner, Kiehn Cammarata 
and Hosmer, 1988). The range of time needed for speciation with 
the Para SL/C system was 16 to 44 days. The Chi-square analysis of 
the time distributions for speciations also failed to reveal 
statistically significant differences (P=0.5101). The median time 
needed to confirm the presence of MAI organisms on Para SL/C (i.e. 
speciation of MAI complex organisms) was 25 days (See Table 3).
The combination of Bactec 13A media and the Paraffin Wax 
Slide Culture System was successfully able to isolate and speciate 
MAI organisms from AIDS blood without the need to purchase a 
sophisticated radiometric detector. In addition, these experiments 
have also revealed that the Para SL/C system could indeed isolate 
and speciate MAI at time intervals comparable with the more 
sophisticated Bactec Radiometric and GENE-Probe assays.
3.27 General Comment On Paraffin Wax Slide Culture
As the AIDS epidemic spreads through the developed and 
developing areas of the world, this world-wide problem will oblige 
many bacteriologists who have not hitherto worked with mycobacteria 
to focus on the MAI organisms. This investigation has shown that a 
Para SL/C can successfully isolate and speciate MAI complex 
organisms. The simplicity, low cost, and reduced risk of 
contamination make the system especially suitable for small rural 
laboratories and field stations where the small AIDS population 
would not warrant the extra expenditure of expensive equipment and 
extra personnel. The procedure is specially useful for
laboratories in developing countries where manpower and financial 
resources are both in short supply (Ollar et al., 1990).
Section IV
Cording in Mvcobacterium avium-intracellulare 
Complex Organisms
INTRODUCTION
4.0 Serpentine Cording
The mycobacteria are inducers of granuloma formation 
(Youmans et al., 1975). The component of the mycobacterial cell 
that appears to be primarily responsible for inducing the 
granulomatous response is the cord factor. This substance, found 
in the mycobacterial cell wall surface, was thought to be 
responsible for the manner in which virulent mycobacteria adhere to 
one another and grow as intertwining serpentine cords in which the 
bacilli aggregate with the long axes parallel. Virulent strains of 
M. tuberculosis complex organisms have been observed to grow as 
characteristic ropes, bundles or serpentine cords of acid-fast 
organisms, however, most avirulent strains grow in a more 
disordered manner (Yagupsky et al.1990). The correlation between 
cording and virulence has proven to be imperfect because the 
presence of serpentine cords has been shown to be also found in 
saprophytic strains such as phlei (Runyon, 1965).
Lorian found he could achieve enhanced cording of M. 
tuberculosis by culturing it upon 7H10 Agar supplemented by Triton 
WR 1339 and OADC (Lorian, 1969). Non ionic detergents (i.e. Tween 
80) reduce cord formation by coating the cell surface (Wolinsky, 
1980). Therefore, Buttiaux et al. have recommended that all media 
utilized for examining cording should exclude Tween 80 (Buttiaux et 
al. , 1974) . Thus the ability of IL tuberculosis to grow in vitro 
as serpentine cords was indeed influenced by the composition of the 
culture milieu (Yagupsky et al., 1990).
4.1 Cording Factor
The cord factor which may be responsible for both 
virulence and serpentine cording has been identified as being the 
mycoside 6,6'-dimycolate trehalose (Wolinsky, 1980). The toxic 
glycolipids that contain trehalose occur with distinctive 
modifications in members of the genera Corvnebacterium, 
Mycobacterium and Nocardia (Barksdale and Kim, 1977). It was 
theorized that the trehalose esters such as the cord factor behaved 
as detergents and this coupled with the fact that they are 
suggestive of a role in facilitating the inward movement of certain 
molecules important to the growth of the cell (Barksdale and Kim, 
1977).
Mvcobacterium tuberculosis H37Rv elaborates the cord 
factor 6,6' dimycolyl-alpha, alpha prime -D-trehalose which, in 
microgram amounts, kills mice (Barksdale and Kim, 1977). This 
killing is associated with the destruction of mitochondrial 
membranes and phosphorylation. In addition, it has been found that 
a side effect of the cord factor has been the intoxication upon the 
microsomal enzymes pyrazinamide deasamidase and aminopyrine 
demethylase. In contrast to its toxic effect in mice, cord factor 
is relatively nontoxic for the rat.
There are several factors which are thought to link cord 
factor to virulence, namely, a) its extraction renders cells 
phenotypically nonvirulent, b)it inhibits migration of normal 
polymorphonuclear leukocytes in vitro (as in the case of virulent 
tubercle bacilli) , and when 10 /xg of cord factor are given 
subcutaneously to a mouse it will die, c) cord factor is more 
abundant in virulent strains of tuberculosis, d) M*. tuberculosis 
bacilli which have been recovered from animals or from young 
cultures are more virulent, and exhibit a greater content of cord
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factors than do mycobacterial cells of the same strain from older 
cultures, e) mice have been protected against tuberculosis 
infection by being actively immunized with a complex of cord factor 
and methylated bovine serum albumin or via passive transfer of 
rabbit anti-cord-factor serum (Wolinsky, 1980).
Recently, it has been proposed that the trehalose 
glycolipids that have been found on the surface of the mycobacteria 
may be important in the inflammatory response caused by virulent 
mycobacterial strains (Behling et al., 1991). Injections of 
trehalose 6,6*-dimycolate into susceptible mice was found to be 
lethal in much lower amounts than other mycolic acid-disaccharide 
esters. Trehalose 6,6* -dimycolate (TDM) injections also produced 
pulmonary granulomas in mice. In those mice treated with TDM, 
pulmonary granulomas were larger and accompanied by alveolar wall 
thickening and hyperplasia not seen in other treatments. This 
investigation supported earlier investigators that the glycolipid 
structure of TDM is important for its biological activity and 
suggest that TDM contributes to the granulomatous response in 
mycobacterial infections (Behling et al., 1991).
4.2 Corded M. avium-intrace1lulare Colonial Morphology
The essence of mycobacterial roughness is the cohesion of 
the bacteria, usually in cords or strands; these cords or strands 
are commonly serpentine (Sommers and Good, 1985). Moehring and 
Solotorovsky have found that rough isolates of Mj. avium have been 
seen less frequently than smooth isolates (Moehring and 
Solotorovsky, 1965). These rough isolates were hydrophobic and not 
easily suspended in liquid and were found in low proportions (1 to 
10 per cent) in several of the cultures studied. The virulence of 
the different colonial morphological types was performed by chick
virulence assay. The smooth, transparent colony type was present 
in all the virulent M^ . avium strains and comprised 80-100 per cent 
of the total colonies observed. Rough granular variants were 
variable in virulence. Pattyn investigated the colonial morphology 
of Mi. avium correlated with in vitro characteristics and fowl 
virulence (Pattyn, 1967). He found that rough or freshly isolated 
variants were capable of bringing about morbidity in chicks 
(Pattyn, 1967). Rastogi et al. (1989) have also noted that a rough 
mutant of M .avium appeared to be as virulent for rabbits and 
chickens as their parental smooth strain. In addition, Rastogi et 
al. have noted that attempts to correlate the colonial morphology 
of M .avium with virulents has given conflicting data. Rastogi et 
al. have stated that certain reports have given greater virulence 
to the rough strains while other reports have stated the opposite. 
It has been found that a small proportion of JL intracellulare 
colonies may be partially or completely rough and that in the case 
of avium the proportion of rough may be often greater (Sommers 
and Good, 1985). There have been strains of It avium complex 
organisms that have colonies so rough that these isolates have been 
confused with Mj_ tuberculosis.
In a recent study of 126 isolates of M^ avium complex 
from specimens other than blood, only 0.8% (1/126) of these 
isolates was seen to exhibit cording (Yagupsky et al., 1990).
The majority of the strains of AIDS-related It avium 
that have been isolated in my study have been derived from blood. 
Horn and associates have said that most of the isolates of AIDS- 
related It avium complex organisms are derived from blood isolates 
(Horn et al.,1989). The current literature does not mention 
anything about the presence, occurrence and significance of
hypercorded strains of M. avium complex organisms derived from 
blood isolates of AIDS patients .
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METHODS AND RESULTS
4.3 Strains
The 2 0 strains of MAI (953, 1516, 1762, 4861, 5097, 6475, 
8515, 8997, 15113, 10,000, 10,001, 10,002, 10,008, 10,010, 10,011, 
10,012, 10,013, 10,014, 10,015 and 10,016) which had been isolated 
and speciated in Section III were utilized in this section.
4.4 Detection of in situ Cording
The 20 alcohol-acid fast stained paraffin wax slide 
culture slides derived from the strains cited above (originally 
obtained during the process of Speciation in Section III) were all 
further scrutinized via light microscope at 450X for the presence 
of Serpentine Cording.
Of the 20 L  avium complex strains examined, the 4 
isolates previously cited in section III (10,002, 10,010, 10,011 
and 10,015) as being hypercorded were the only isolates that 
displayed Serpentine Cording (See Figures 6,7,8; See Table 4). 
Hypercorded isolates accounted for 20% (4/20) of the speciated St. 
Vincent's M_j_ avium complex strains.
4.5 Stability of Cording
The isolates of M^ _ avium complex originally derived from 
AIDS blood cultures which displayed hypercording (10,002, 10,010, 
10,011, 10,015) had been previously subcultured on Lowenstein- 
Jensen slopes and stored at 4° C (See Section III) .
A 4 mm loopful of original hypercorded isolate was
aseptically removed from the Lowenstein-Jensen slope and added to
2.0 ml of sterile saline. Aliquots of 0.5ml were added to 2 tubes 
of Czapek liquid Para SL/C (Para SL/C was utilized to determine 
non-disturbed in situ colonial morphology) and 2 tubes of 7H9 broth
supplemented with 2% glycerol and 4% OADC ( See Appendix IV;
Media) . The tubes were then incubated at 37° C for 10-13 days. The 
Para SL/C's were stained via the Kinyoun acid-alcohol procedure (as 
cited in Section III) to determine the presence or loss of 
hypercording. The 7H9 tubes were utilized to inoculate a new 
series of cultures consisting of 2 tubes of Czapek Para SL/C and 2 
tubes of 7H9. The .process of subculturing and Para SL/C in situ 
analysis was carried for 4 successive subcultures.
The Para SL/C 1 s of the original patient isolates of all 
four strains examined showed hypercording. In strain 10,002, 
diminished hypercording in the first subculture with a total loss 
of hypercording at the third subculture. In strain 10,010, the 
first subculture showed strong hypercording, however, subcultures 
2-3 showed diminished cording and at subculture four there was a 
complete absence of hypercording. The loss of hypercording was 
seen in strain 10,011 at subculture 2. In strain 10,015, however, 
the loss of hypercording was detected by subculture 3. (See Figures 
9-11 ; Table 5).
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Figure 6: Corded in situ growth on Para SL/C. Para SL/C growth of
MAI isolate 10,010 derived from an AIDS patient blood sample (lOOx,
Microscopic Magnification)
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Figure 7: Serpentine cording of in situ growth on Para SL/C. MAI
isolate 10,010 on Para SL/C derived from an AIDS patient blood 
sample (450x, Microscopic Magnification).
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Figure 8: Corded in situ growth on Para SL/C. Growth on Para SL/C
of MAI isolate 10,011 on Para SL/C derived from an AIDS patient 
blood sample (450x, Microscopic Magnification).
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Figure 9: MAI 10.011-Initial isolate. Initial AIDS patient blood
isolate showing hypercording (lOOx, Microscopic Magnification).
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Figure 10: MAI 10.011-First Subculture. First subculture (10 days)
showing diminished hypercording (lOOx, Microscopic Magnification).
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Figure 11: MAI 10.011-Second Subculture. Second subculture (10
days) showing loss of hypercording ( lOOOx Oil Immersion,
Microscopic Magnification)
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Table 4: St. Vincent1s Hospital AIDS-Related MAI Blood Isolates 
AIDS-Related MAI Isolate Presence of Cording
953 
1516 
1762 
4861 
5097 
6475 
8515 
8997 
15113 
10,000 
10,001
10,002 +
10,008
10,010 +
10,011 +
10,012
10.013
10.014
10.015 +
10.016
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Table 5: Effects of Subculturinq on Hvpercorded MAI Isolates
Original
Corded
Isolate
Subculture
I
Subculture
II
Subculture
III
Subculture
IV
10,002 +/- +/- - -
10,010 + +/-
+ / "
-
10,011 +/- - - -
10,015 +/- +/- - -
+ = presence of cording
+/-= presence of diminished cording 
= complete absence of cording
DISCUSSION
4.6 Significance of Corded MAI
Virulent strains of M tuberculosis have been shown to 
often grow as characteristic ropes, bundles or serpentine cords of 
acid-fast bacilli in liquid culture (Yagupsky et al., 1990). By 
contrast, the avirulent strains of MU. tuberculosis have been found 
to grow in liquid media in a nonoriented, dispersed manner. The 
serpentine cording that occurs in tuberculosis also occurs in 
the saprophyte M;. phlei. and other mycobacterial species such as 
the M js_ avium complex and Mj. triviale (Runyon, 1965; Sommers and 
Good, 1985). In fact when serpentine cording does occur in M. 
avium and Mj_ triviale. these strains have on occasion been confused 
with tubercle bacilli and it was only after subsequent biochemical 
assays that speciation as non-tuberculous mycobacteria was possible 
(Gilkerson et al., 1966, Sommers and Good, 1985). The Para SL/C 
for viewing in situ mycobacterial cording provided a useful means 
for making the distinction between the serpentine cording of non- 
tuberculous and tuberculous cording. The ability to make this 
distinction of cording is based on the fact that only atypical 
corded or non-corded mycobacteria can utilize a paraffin wax 
substrate whereas, IL tuberculosis cannot (Fuhs, 1961; Ollar et 
al., 1990). This in situ protocol fulfills the basic notions for 
the observation of cording cited by Buttiaux and his co-workers, 
namely, 1) that the culture be seeded in liquid milieu, 2) does not 
contain Tween 80. Nonionic detergents such as Tween 80 reduce the 
formation of cording by coating the cell surface (Wolinsky, 1980). 
The third notion for observing cording requires that the 
mycobacterial growth not be agitated during its growth upon the 
surface of the slide (Buttiaux et al., 1974). Buttiaux et al. have 
in reality described a slide culture system. The finding of corded
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in situ growth on slide culture would indeed make slide culture a 
relevant protocol in mycobacteriology.
The relationship of serpentine cording to virulence is 
demonstrable with the species 1L_ tuberculosis and bovis but, 
cording and virulence is not known to be so correlated in other 
mycobacterial species (Runyon, 1965). Pattyn has demonstrated that 
a rough strain of avium was as virulent for chicks as the more 
commonly occurring virulent smooth strains of Mj. avium (Pattyn, 
1967). Runyon has stated that achieving equal inocula of rough and 
smooth strains in terms of numbers and activity is difficult and 
perhaps rarely obtainable and, thus, caution is needed in crediting 
differences in virulence due to smooth and rough colonial 
morphology. Studies with human non-peripheral blood isolates has 
shown that the occurence of corded strains was extremely rare and 
occurred in 0.8% or 1/126 isolates (Yagupsky et al., 1990). The 
studies conducted at St. Vincent's Hospital on AIDS patient 
peripheral blood isolates of MAI found that 20% or 4/20 isolates 
displayed cording. This increased incidence of rough or 
hypercorded strains is all the more curious given the fact that 
rough or hypercorded strains are seldom seen in clinical 
laboratories (Rastogi et al., 1989). These hypercorded isolates 
lost their hypercording after 4 successive subcultures. Thus, the 
significance of more frequent occurrence of the hypercorded or 
serpentine corded colonial morphological forms of MAI complex 
organisms in AIDS-patient peripheral blood isolates and any 
possible differences in virulence when compared with the noncorded 
AIDS-patient peripheral blood isolates still remain unclear. The 
relationship between hypercording and its loss upon MAI virulence 
will be discussed in further detail in Section VIII.
Section V 
Antibiotic Sensitivity Methodology 
for Mvcobacterium avium-intracellulare Complex
Organisms
INTRODUCTION
5.0 A Therapeutic Dilemma
The role of Mvcobacterium avium as a pathogen in the HIV 
infected patients has been confusing and controversial to clinical 
practitioners (Ellner et al., 1991). Laughon et al. (1991) have 
stated, 11 Uncertainty about the extent of the morbidity and 
mortality caused by Mycobacterium avium complex infections in AIDS 
patients and the resistance of Mycobacterium avium complex to most 
therapeutic interventions has created controversy and frustration 
among researchers and clinicians regarding the relative merits of 
specific therapy". Clinical isolates have been often resistant to 
conventional antimycobacterial agents and a lack of correlation 
between in vitro sensitivities, and clinical response in 
uncontrolled series has been observed (Hawkins et al., 1986; Young, 
1988) . At one time in the current AIDS story, it was suggested 
that patients with disseminated MAI complex should not be treated 
because the therapy have proven to be of no value and also was 
potentially toxic ( Bach, 1989). Linked to this early leaning to 
therapeutic nihilism was the debate that was concerned with whether 
disseminated infection caused symptoms and contributed to patient 
mortality (Ellner et al., 1991).
5.1 Antibiotic Sensitivity Testing for MAI
Conventional disk and well diffusion protocols are not 
suitable for antimicrobial sensitivity testing of slowly growing 
mycobacteria (Runyon et al., 1974). Most studies on susceptibility 
testing have traditionally employed agar dilution methods (Hawkins, 
Wallace and Brown, 1991; Ollar et al., 1991). Heifets stated that 
an important drawback in the agar dilution assay was that the drug 
concentrations incorporated in solid media are not always the same
as those actually interacting with the mycobacterial inoculum 
during the period of incubation. For this reason, Heifets 
preferred a mycobacterial sensitivity assay that could be performed 
via a radiometric BACTEC (See Section I) system which used 
radiolabelled 7H12 broth. This radiometric assay was able to be 
completed in 8 days and was able to avoid using excessive inoculum 
which would be necessary to obtain comparable results if a 
conventional tube dilution turbidimetrical protocol had been 
utilized. Heifets and his co-workers noted that broth dilution 
methods for the determination of antibiotic susceptibility are 
preferable to agar dilution methods because they have a shorter 
incubation period which reduces the risk of drug degradation and 
because the concentration of antibiotic dissolved in broth is 
directly responsible for producing the antibacterial effect 
(Heifets, 1988; Heifets, Lindholm-Levy, 1989). The radiometric 
method is now commonly applied in both clinical and research 
settings.
The conventional broth dilution protocol employs 
turbidimetric determination in either microdilution wells or test 
tubes. The microdilution assay works well but must be cautiously 
interpreted with those antimicrobials that produce a "tail without 
a clear borderline between growth and inhibition (Heifets, 1988; 
Heifets and Lindholm-Levy, 1989) . Concern for the production of 
potentially infectious aerosols may restrict the use of microtiter 
testing to special containment facilities. Macrodilution tubes 
assays with MAI are possible but MIC's determined by this method 
may be inaccurate because of the heavy inoculum required to produce 
detectable growth within 8 days (Heifets, 1988; Heifets and 
Lindholm-Levy, 1989; Heifets et al., 1990). A practical limitation 
of the radiometric procedure described by Heifets is its dependence
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upon highly skilled personnel and the support of a well equipped 
clinical laboratory, including an expensive radiometric detector.
All current methods require the use of perishable media 
which must be prepared and maintained under sterile conditions. 
Furthermore, no consensus has been reached as to which of the 
currently employed methods for antibiotic sensitivity testing 
should be accepted as a standard for sensitivity determinations in 
atypical mycobacteria (Ollar et al., 1991).
Paraffin baiting (Ollar et al., 1990) may be particularly 
useful for the isolation of organisms from heavily contaminated 
specimens and where the use of sophisticated microbiological 
techniques are impractical. With the growing appreciation of the 
pathogenicity of MAI in patients with AIDS as well as in the normal 
host, this tool may be of particular importance in locations where 
modern techniques are unavailable. The capacity to determine 
antimycobacterial sensitivities under these circumstances would 
extend the usefulness of this Para SL/C tool.
METHODS AND MATERIALS
5.2 Strains
Strains of MAI used in this study were originally 
isolated from AIDS patients at St. Vincent's Hospital and Medical 
Center of New York and at Memorial Sloan-Kettering Cancer Center. 
The strains from both institutions were identified by routine 
morphologic and microbiological procedures with confirmation by DNA 
hybridization (Gene Probe; Biogen) for M^ _ avium and M. 
intracellulare. Strains isolated at St. Vincent's Hospital were: 
10,000, 1762, 1516, 15113, 8515, 6475, 5097, 8197 and 4861. Those 
strains from Memorial Sloan-Kettering Cancer Center were: SK015, 
SK016, SK095, SK069, SK037, SK060, SK024. All strains were 
isolated from patients with AIDS and identified as Mj_ avium with 
the exception of SK069 which was an M;. intracellulare isolated from 
an immunocompromised patient with cavitary pulmonary disease.
5.3 Sensitivity Testing
Stock solutions of antimicrobial agents were prepared. 
Amikacin (Bristol-Myers) was dissolved in distilled water and 
filter sterilized; azithromycin (Pfizer) was dissolved in 95% 
ethanol and ciprofloxacin-HCl (Miles Laboratories) was dissolved in 
distilled water and filter sterilized.
5.4 Microtiter broth dilution assay
A modification of previously described methods for MIC 
determination for MAI by microtiter broth dilution was employed 
(Fenlon and Cynamon, 1986).
To make working solutions, stock solutions of amikacin 
and ciprofloxacin-HCl were diluted in sterile distilled water. 
Azithromycin was diluted in sterile phosphate buffer adjusted to a
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pH of 6.5 (Retsema et al., 1987). lOOjil amounts of the working 
solutions were distributed in serial 2-fold dilutions in sterile 
96-well round bottomed microtiter trays at 2 times the final 
concentration to be tested. Trays were stored frozen at -70° C 
until used. Trays not used within 1 month of preparation were 
discarded.
Strains previously maintained on Lowenstein-Jensen slants 
were cultured on Middlebrook 7H9 media with OADC (Becton-Dickenson) 
enriched agar. Strains maintained as frozen stocks in 7H9 with 19% 
DMSO were thawed and plated as confluent lawns on enriched 7H11 
agar. Lawns were harvested after 3-5 days and suspended in normal 
saline (NS) containing 0.5% Tween 80. Single cell suspensions were 
obtained by centrifugation 50xg for 3 min. The supernate was then 
spun at lOOOxg for 10 min. The sediment from this was re-suspended 
in double strength 7H9 broth with OADC and the number of organisms 
per ml estimated by optical density. Actual inoculum size was 
determined by plating serial 10-fold dilutions on the initial 
inoculum on OADC enriched 7H11 agar and determining colony counts 
after 7-10 days.
The bacterial suspension was diluted in double strength 
7H9 broth and distributed in 100 /zl amounts to each well of the 
thawed plates to yield a final concentration of 1-5 x 104 organisms 
per well. Final dilutions were amikacin 128-0.125/xg/ml, 
azithromycin 512-0.5/xg/ml, and ciprofloxacin 128-0.125/xg/ml.
Plates were read after 4 and 7 days incubation in a 
humidified chamber at 37° C. The MIC was defined as the lowest 
concentration of drug showing no visible growth. All studies were 
performed in triplicate.
5.5 Paraffin Slide Culture Assay
The paraffin slide culture (Para SL/C) system for 
selective growth of MAI species as previously cited (Ollar et al., 
1990).
Stock solutions of antibiotics which were 11 times the 
final concentration were diluted in sterile distilled water to 
obtain initial working concentrations.
From stock cultures which were maintained on Lowenstein 
and Jensen slants, a 4mm loopful was added to 4.5ml of tryptone 
broth and incubated at 37° C for 6-7 days. Cultures were diluted in 
normal saline to 105 bacilli/ml or 10 bacilli per lOOx oil immersion 
field (Buttiaux et al., 1974).
For each antimicrobial concentration tested, 0.5ml each 
of infectious inoculum and the initial working antimicrobial 
solution, and paraffin wax coated slides (Para SL/C) were added to 
4.5ml of Czapek medium. This resulted in a final concentration of 
organisms to just under 104/ml. The antibiotic concentrations 
tested were amikacin 16, 12.8, 9.6, 6.4, 3.2 /jlg/ml; azithromycin 
13.2, 10.6, 7.9, 5.3, 2.6 fig/ml and ciprofloxacin 18.2, 14.5, 10.9, 
7.3, 3.6 /xg/ml. A control tube for azithromycin containing 0.5ml 
of 95% ethanol in 5.0 ml Czapek broth was included to ensure that 
any inhibition observed in the higher concentrations of antibiotic 
was not the result of ethanol. Stock solutions of azithromycin 
(1.452 mg/ml) were prepared in 95% ethanol. Controls for amikacin 
and ciprofloxacin contained 0.5ml of normal saline added to 5.0 ml 
Czapek broth.
There were three experimental series consisting of two 
experiments each. The first experiment in each experimental series 
consisted of strains 10,000, 1762, 1516, 15113, 8515, 6475, 5097,
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8197 and 4861. The second experiment of each experimental series
consisted of strains SK015, SK016, SK069, SK037, SK060 and SK024.
The paraffin slide cultures were usually read after 5-10 
days incubation at 37° C. The MIC was defined as the lowest 
concentration of drug allowing no visible growth on the paraffin 
slide culture when compared with the control tube which was devoid 
of antibiotic and exhibited confluent growth on the paraffin slide 
culture.
5.6 Statistical Analysis
All statistical analyses were performed on an Amstrad 
Model PC 1512 microcomputer utilizing a Statistix II statistical 
software programme which was produced by the NH Software Company of 
Roseville, Minnesota, U.S.A. A non-parametric Wilcoxon Matched 
Pairs Signed Rank statistical assay was applied to the 
ciprofloxacin studies to determine if statistically significant 
interseries variation occurred in the MIC values between the two 
related or paired experimental series (II and III). The non- 
parametric Friedman statistical assay was applied to the MIC values 
of three related experimental series to determine if statistically 
significant variation had occurred between the two antibiotic 
sensitivity methods. Where absolute MIC values were not available, 
the nearest absolute value was utilized for purposes of statistical 
calculation.
5.7 The Effect of pH On MIC Values for Azithromycin
5.7a Paraffin Slide Culture Assay
There were two batches of Czapek broth utilized in this 
procedure. One batch of Czapek broth was adjusted to an initial pH
of 7.53 and the other batch adjusted to pH 6.52. The pH values of 
both batches of Czapek broth were determined by pH meter. The 
concentrations of azithromycin initially analyzed at pH 7.53 and pH
6.52 were the same as that previously cited for azithromycin. Two 
additional azithromycin concentration series were assayed at pH 
6.52, in order to determine the specific MIC at this pH. One pH
6.52 concentration series was 66, 53, 40, 26 and 13 /ug/ml. The 
other pH 6.52 concentration series was 136, 106, 82, 55 and 
27/ng/ml.
The Para SL/C assay followed the same methodology as 
previously cited for azithromycin but, was read, and MIC values 
determined after 8 days following the criteria set forth by Heifets 
(Heifets, 1988).
5.7b Microtiter Assay
There were two batches of double strength 7H9 broth 
utilized in this procedure. One batch of 7H9 broth was adjusted to 
an initial pH of 7.5 and the other batch adjusted to pH 6.5. The 
pH values of both batches of 7H9 broth were determined by pH meter. 
The preparation of the azithromycin working solution at pH 6.5 was 
the same as that previously cited for azithromycin but, the final 
range concentration range was 128-2/Ltg/ml. The azithromycin working 
solution at pH 7.5 was diluted in phosphate buffer adjusted to pH 
7.5. The final range concentration of azithromycin at pH 7.5 was 
64-2/xg/ml.
RESULTS
5.8 Ciprofloxacin-HCl
The basic methodology for the Para SL/C antibiotic 
sensitivity assay was derived from experimental series I (see Table 
6) with ciprofloxacin-HCl. As expected, the control tube showed 
the greatest amount of growth on the paraffin wax surface. When 
visible confluent growth on the paraffin slide culture in the 
control tube occurred, the Para SL/C tubes containing varying 
dilutions of ciprofloxacin-HCl were examined. The effect of 
increased concentration of ciprofloxacin-HCl (See Figure 12) on MAI 
growth were clearly visible on the Para SL/C. The concentration of 
ciprofloxacin in the tube containing the lowest antimicrobial 
concentration in which there were no visible colonies on the 
paraffin wax coated slide was defined as the minimal inhibitory 
concentration (MIC), for this system. Lack of growth at this 
concentration was confirmed by microscopic examination of slides 
stained by the Kinyoun acid-fast staining method (Ollar et al., 
1990) . This method was used to determine the MIC in all subsequent 
series of Para SL/C antimicrobial sensitivity tests.
In all of the experimental series with ciprof loxacin-HCl, 
the median time to development of confluent growth in control tubes 
was 8 days, range 7-9 days.
There was no statistically significant variation (p=0.68) 
of series II and III for ciprofloxacin-HCl (See Tables 6 and 7) . 
This confirmed the reproducibility of the Para SL/C method between 
experimental series.
The overall sensitivity pattern was found to be similar 
with Para SL/C and microtiter procedures, with the MIC50 and MIC90 
values of 7/xg/ml and 18.2/xg/ml for the Para SL/C and 2/ig and
16/Ltg/ml for the microtiter assays. This comparison is considered 
in the discussion.
Figure 12: Paraffin slide culture system for antibiotic sensitivity 
scanning. A view of a 7 day culture of M.intracellulare SK069(non- 
AIDS) showing: (A) Control tube containing 7-day-old culture in
Czapek broth showing confluent growth on Para SL/C. (B) Assay tube 
containing 7-day-old culture in Czapek broth plus 3.6/ug/ml 
ciprofloxacin-HCl showing heavy growth on Para SL/C. (C) Assay 
tube containing 7-day-old culture in Czapek broth plus 14.5/xg/ml 
ciprofloxacin-HCl showing sparse growth on Para SL/C.
5.9 Amikacin
In the amikacin study, the median time to confluency of 
the control tubes was 6.5 days, range 6-7 days.
The MIC values for the experimental series I-III making 
the Para SL/C assay did not vary to a statistically (p=0.39) 
significant level (See Table 8).
There was close agreement between the MIC50 and MIC90 
values obtained by the Para SL/C and microtiter assays-6.4/ig/ml and 
12/ng/inl for the Para SL/C assay and 8/xg/ml and 16/ng/ml for the 
microtiter assay.
5.10 Azithromycin
In the azithromycin experimental series I-III, the median 
time to confluency of the control tubes was 6.5 days, range 6-7 
days. The MIC values for the experimental series I-III making
the Para SL/C assay did not vary to a statistically (p=0.14) 
signficant level (See Table 9).
By contrast to the overall sensitivity patterns obtained 
for ciprof loxacin-HCl and amikacin, the MIC50 and MIC90 values 
obtained by the two procedures for azithromycin were quite 
different: 2.6/^g/ml and 5.3/xg/ml for the Para SL/C and 64/xg/ml and 
128/xg/ml for the microtiter assay. The Azithromycin effect will be 
considered further in the next paragraph, as well as in the 
discussion section.
5.11 Effect of pH On MIC Values for Azithromycin
5.11a Para SL/C ASSAY
The cumulative MIC50 and MIC90 values for experimental series 
I and II at pH 7.53 were 5.3/ig/ml and 10.6/zg/ml respectively. By 
contrast, the cumulative MIC50 and MIC90 values for experimental series 
III and IV at pH 6.53 were 82/xg/ml and >136/xg/ml. The shift downward 
in pH to 6.5, caused a corresponding upward shift in the cumulative 
MIC50 and MIC90 values such that their respective values were 15.5 and 
>12.8 times that noted at pH 7.53 (See Table 10).
5.11b Microtiter Assay
The MIC50 and MIC90 values for experimental series I pH 7.5 
were 32/xg/ml and >64/xg/ml respectively (See Table 16) . The MIC50 and 
MIC90 values for experimental series II pH 6.5 were 128/xg/ml and 
>128/Lig/ml respectively (See Table 10) . The lower pH brought about a 
corresponding increase in the MIC50 and MIC90 and their respective 
values were 4 and >2 times that noted at pH 7.5.
Table 6: MIC values fug/ml) of ciorofloxacin-HCl in paraffin slide 
culture assay
Strains Paraffin slide Days to confluent
culture Exp. series growth
I
10,000 7.3 7
1762 7.3 7
1516 3.6 7
15113 3.6 7
8515 7.3 7
6475 7.3 7
5097 10.9 7
8197 <3.6 7
4861 <3.6 8
SK015 <3.6 6
SK016 <3.6 7
SK095 <3.6 10
SK069 3.6 6
SK037 3.6 8
SK060 <3.6 8
SK024 <3.6 8
Table 7: MIC values (ua/ml) of ciorofloxacin-HCl in paraffin 
slide culture and microtiter assays
Strain Para SL/C 
Exp.
series II 
MIC
Days to 
conflu 
growth
Exp.
series
III
MIC
Days to 
conflu. 
growth
Micro­
titer 
assay 7 
days 
Exp. 
I-II
10,000 3.6 9 3.6 7 1,1,1
1762 18.2 9 14.5 8 32,16,16
1516 NG* NG 3.6 8 4,2,4
15113 3.6 10 3.6 9 4,2,1
8515 7.3 9 7.3 8 16,4,4
6475 3.6 10 7.3 9 1,2,1
5097 3.6 10 7.3 8 1,1,1
8197 3.6 9 3.6 8 0.3, 
0.5, 1
4861 3.6 10 3.6 8 2,2,2
SK015 14.5 7 14.5 6 16,16,16
SK016 7.3 7 7.3 6 16,8,NG
SK095 10.9 7 7.3 6 16,16,16
SK069 18.2 8 >18.2 7 2, 0.3,
0.5
SK037 18.2 7 14.5 7 8,8,8
SK060 7.3 7 7.3 7 1,1,1
SK024 7.3 7 3.6 6 2,2,1
*NG= No growth
Table 8: MIC values fug/ml) of amikacin in paraffin slide
culture and microtiter assays
Strain Para
SL/C
Exp.
series
I
MIC
Days
to
conflu 
growth
Exp.
series
II
MIC
Days
to
conflu 
growth
Exp.
series
III
MIC
Days
to
conflu 
growth
Micro
titer
assay
7
days
Exp.
I-III
10,000 >16 7 >16 7 3.2 5 8,4,4
1762 >16 7 12 7 3.2 5 16,4,
4
1516 6.4 8 6.4 9 6.4 12 8,8,8
15113 3.2 8 6.4 5 3.2 6 8,2,1
8515 6.4 7 3.2 5 3.2 5 4,2,4
6475 12 7 3.2 5 3.2 5 8,4,4
5097 NG* NG 6.4 5 6.4 5 16,16
8
8197 >16 7 >16 7 3.2 5 4,8,8
4861 12 8 3.2 6 3.2 7 8,4,4
SK015 6.4 6 6.4 6 3.2 5 32,16
16
SK016 7.3 5 9.6 6 6.4 5 32,16
NG
SK095 3.2 5 6.4 6 6.4 5 16,4,
8
SK069 3.2 6 9.6 6 6.4 6 4,1,1
SK037 9.6 5 >16 6 6.4 5 16,32
32
SK060 6.4 5 6.4 6 3.2 5 16,8,
8
SK024 
•NG= No
6.4
growth
5 9.6 6 3.2 5 16,4,
4
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Table 9: MIC values (ua/ml) of azithromycin in paraffin slide
culture and microtiter assays
Strain Para Days Exp. Days Exp. Days Micro
SL/C to series to series to titer
Exp. conflu II conflu III conflu assay
series growth growth growth 7
I days
Exp. 
I-III
10,000 2.6 6 2.6 6 2.6 6 32,16
16
1762 5.3 7 2.6 6 5.3 6 128,
64.64
1516 2.6 8 2.6 8 5.3 8 64,32
64
15113 5.3 8 5.3 10 2.6 6 64,8,
4
8515 5.3 8 2.6 6 2.6 6 16,8,
8
6475 2.6 • 8 2.6 8 2.6 6 32,16
8
5097 7.9 6 2.6 6 5.3 6 256,
128,
128
8197 5.3 7 2.6 6 2.6 6 128,
64.64
4861 5.3 10 2.6 6 2.6 6 128,
32,
128
SK015 7.9 7 5.3 6 5.3 7 256,
64,
128
SK016 7.9 10 10.6 6 5.3 8 256,
128,
NG*
SK095 2.6 7 5.3 6 5.3 7 128,
64.64
SK069 2.6 7 2.6 6 5.3 8 8,1,1
SK037 5.3 7 7.9 6 5.3 8 256,
128,
256
SK060 2.6 7 7.9 6 2.6 6 256,
64,
128
SK024 5.3 7 7.9 6 2.6 7 256,
64,
128
*NG= No growth

Table 10: 
Strain 
SK015
SK016
SK095
SK069
SK037
SK060
SK024
Effect of pH on MIC values fucr/ml) of Azithromycin
MIC Para SL/C MIC Microtiter
pH 7.5 pH 6.5 pH 7.5 pH 6.5
10.6, 5.3 >13.2,
>13.2, 
>66, 82
64 128
5.3, *- >13.2,
>13.2, 16 64
>66,>136
5.3, 5.3 >13.2, >64 >128
>13.2,
>66, 55
5.3, 5.3 >13.2,
>13.2, 16 128
>66, 55
10.6, 7.9 >13.2,
>13.2, 16 128
>66, 82
7.9, - >13.2,
>13.2, >64 >128
>66,>136
5.3, - >13.2,
>« ' 2io >64 >12866, 82
*-= absence of growth in control and assay tubes.
DISCUSSION
5.12 Paraffin Slide Culture in MAI Antibiotic Assay
The overall results obtained from this investigation 
suggested that the determination of the MIC values in the Para SL/C 
assay could be further refined. Confluent growth in the control 
slides is generally achieved in 8 days. A standard reading of the 
MIC on the eighth day of incubation would comply with the time 
limit found by Heifets and his co-investigators to be most reliable 
for accurate MAI sensitivity testing (Heifets, 1988; Heifets and 
Lindholm-Levy, 1989; Heifets et al., 1990). Those assays not 
achieving confluent growth in the control tube by the eighth day 
would be reassayed.
Further modifications of this methodology may make it 
possible for the Para SL/C to be utilized for the determination of 
Minimal Bactericidal Concentration (MBC) level. This could be 
achieved by simply removing slides on which no growth was observed 
at the eighth day post-inoculation and transferring them to 
antibiotic-free Czapek Media for a period of 5-8 days at 37° C. 
Those Para SL/C*s that were at the MBC would remain free of growth 
on the surface of the paraffin coated slide after the additional 5- 
8 days incubation period in antibiotic-free Czapek Media.
It should be feasible to employ simultaneously the basic 
Para SL/C assay for primary MAI isolation with its role as an 
antibiotic sensitivity test. When there is a high suspicion of 
non-tuberculous mycobacterial disease, for example with AFB seen in 
a smear of clinical specimen, simultaneous testing would be rapid 
and economical. During the time when isolation is being attempted, 
additional paraffin slides would be placed into a supplementary 
series containing specimen, Czapek media and antibiotic at
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predetermined "break point" concentrations. This may also have 
application in large scale surveys on environmental isolates.
The MIC50 and MIC90 values obtained via the Para SL/C for 
ciprofloxacin-HCl and amikacin were quite close to those obtained 
by other investigators (Heifets and Lindholm-Levy, 1989; Inderleid 
et al., 1987; Leysen et al., 1989; Saito et al., 1989; Tomoika et 
al., 1989) and to those obtained by us using the microtiter method. 
However, the MIC50 and MIC90 values obtained by the Para SL/C for 
azithromycin were divergent from values obtained by microtiter 
method, and also from values obtained by other investigators 
(Inderleid et al., 1989, Naik and Ruck, 1989).
Azithromycin is an azalide antibiotic that is 
structurally related to the macrolide erythromycin. An azalide is 
a dibasic molecule which contains an N-methylgroup in the lactone 
ring. Experiments with S^ . aureus strains showed that the MIC 
varied from 50/xg at pH 6.0 to 0.025/xg/ml at pH 8.0 (Retsema et al., 
1991) . The effect of pH variation of in vitro potency (MIC values) 
was explained by the fact that the pka values of the basic groups 
on azithromycin and erythromycin are 8.4-8.8. Thus, at pH 8.0 the 
unionized compounds should cross the cytoplasmic membrane more 
readily and bind to the bacterial ribosome. Since the pH inside 
the cell is more neutral (pH 7.2), greater ionization will occur, 
causing the intracellular concentration to become greater than the 
exterior concentration.
When the milieu is at pH 6.0 azithromycin is completely 
ionized and will therefore have difficulty in crossing the 
cytoplasmic membrane. Therefore, the relevant activity of 
azithromycin in the clinical situation is probably its activity at 
approximately pH 7.2. Retsema and co-workers thus advised that 
when evaluating the susceptibility of organisms to azithromycin or
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basic macrolides, attempts should be made to keep the pH within the 
physiological range of pH 7.2-7.4 (Retsema et al., 1991).
When another macrolide Clarithromycin was tested against 
M. avium complex organisms by Heifets and co-workers, it was noted 
that differences in pH were particularly important (Heifets, et 
al., 1992). Clarithromycin was found to be more active at pH 7.4 
and less active at pH 5.0, with intermediate activity at pH 6.8.
The MIC values for 90% (25 strains) were 0.85/xg/ml at pH 7.4, 
6.0jitg/ml at pH 6.8 and >16/xg/ml at pH 5.0.
Thus, when reviewing the MIC50 (5.3/xg/ml) and MIC90 
(10.6/zg/ml) for the Para SL/C originally performed at pH 7.5, and 
the MIC50 (64/xg/ml) and MIC90 (128/zg/ml) of the Microtiter Assay 
originally performed at pH 6.5, it is not surprising that the 
respective MIC values are so divergent given the differences of pH 
of the media in the two assays.
When the pH of Para SL/C was reduced to 6.5 there 
occurred a corresponding increase in MIC (reduced sensitivity) 
comparable to the MIC obtained with the microtiter assay but, when 
the microtiter assay was run at pH 7.5 it did not give a comparable 
change in MIC. Heifets has stated that the composition of the 
medium, specifically the metallic cations, phosphates, and some 
other salts can affect the in vitro activity of some antimicrobial 
agents (Heifets, 1988). Thus, when reviewing the data for the Para 
SL/C and the microtiter assay, the divergent MIC values for 
azithromycin are not surprising when the following points are taken 
into consideration: a) the differences in the composition of the 
respective media and b) the presence of phosphate only in the 
microtiter broth. Other explanations for the divergent results 
obtained with azithromycin are plausible, such as alterations in 
mycobacterial cell wall permeability to drug.
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However, the MIC values obtained by the Para SL/C at pH
7.5 gave results more in tune with in vivo sensitivity levels 
obtained with experimental lab animals than did the microtiter 
assay (Dr. James Retsema, Pfizer Labs, Groton, Connecticut, U.S.A.- 
Personal Communication).
These experiments with the Para SL/C have shown that it 
is possible to perform a modified broth assay utilizing basal salt 
media and paraffin coated slides in a sensitive and reproducible 
antibiotic protocol for susceptibility testing of MAI.
Section VI
The Plasmids of Mycobacterium Avium Complex Organisms
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INTRODUCTION
6.0 General Description of Plasmids
A large number of important bacterial genes are not found 
on the chromosomal DNA but, rather on plasmids. The molecular 
weights of plasmids can range from about 1 x 106 to 200 x 106 
(Hardy, 1981) . Most of the plasmid DNA inside bacteria occurs in 
the form of a covalently-closed circle. If one of the two 
polynucleotide strands in a closed-circle plasmid is broken, or 
nicked an open circle is formed. Some very large plasmids are 
extremely difficult to maintain in the covalently-closed circle 
state during plasmid isolation and purification.
Plasmids can be stably inherited without being linked to 
the chromosome. It should be noted that some bacteriophages can be 
classified as plasmids according to the aforementioned definition. 
Plasmids have great importance in medicine and agriculture due to 
their ability to confer antibiotic resistance on human and 
veterinary pathogens and for their ability to code for such 
virulence factors as toxins and adhesions (Hardy, 1981). Plasmids 
can also confer other properties such as lactose fermentation, 
hydrogen sulphide production, urea breakdown. Plasmids encode 
genes that enable bacteria to degrade unusual substrates such as 
xylene, toluene, 2,4-D(2,4-diphenoxyacetic acid) and several 
components of mineral oils (Hardy, 1981).
6.1 Mvcobacterium Avium-intracellulare Plasmids
The investigation of Crawford and Bates first 
demonstrated the presence of mycobacterial plasmids in 
Mycobacterium avium complex organisms (Crawford and Bates, 1979).
The presence of plasmids has also been demonstrated in strains of 
Mvcobacter ium fortuitum. Mycobacterium intracellulare and
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Mvcobacter ium scrofulaceum (Crawford and Falkinham III, 1990; 
Rauzier et al., 1988; Meissner and Falkinham III, 1984).
Crawford and Bates found that a strain of M. 
intracellulare. namely, LR113 carried a small unique plasmid of 
15.3 kb which they called pLR7 (Crawford and Bates, 1984). This 
plasmid was extensively studied and cloned into EU. coli. The pLR7 
plasmid has been mapped and it possessed unique sites for BamHI, 
Hind III and Xba I. In addition, further digests of the pLR7 
plasmid revealed that there occurred a unique site for Xho I and a 
second site for Xho II (Crawford and Bates 1984). A clone of the 
pLR7, pJC20 consisted of the entire pLR7 sequence joined to an E. 
coli pBR322 plasmid via the unique Hind III site (Crawford and 
Bates, 1984; Crawford and Falkinham III, 1990).
Jucker and Falkinham III have found a 12.9 kb plasmid, 
pVT2, from a clinical isolate of Mj. avium. MD1 (Jucker and 
Falkinham III, 1990). The pVT2 plasmid was found to hybridize to 
both clinical (13 of 13 strains) and environmental (5 of 5 strains) 
plasmids of 13.5 kb or smaller. However, there was no 
hybridization between the pVT2 and pLR7 plasmids. Crawford found 
that the pVT2 plasmid cited by Jucker and Falkinham III was similar 
to his pLR20 plasmid which he found in Mj. avium strain LR541. The 
pLR20 plasmid was cloned into pUC 18 as an Eco RI fragment 
(Crawford and Falkinham III, 1990).
Crawford has stated that the large plasmids (>150kb) have 
to date not been characterized other than by their size (Crawford 
and Falkinham III, 1990). He notes that many strains of MAI 
carried similar-sized large plasmids but, studies have not been 
performed to determine if these are similar or related. The 
problem with the large plasmids has been that work with these
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plasmids has been inhibited by the modest yields that were obtained 
in most of the preparations.
6.2 MAI Plasmids in Clinical and Environmental Isolates
Crawford and Bates examined 26 strains of MAI isolated 
from AIDS patients and examined their plasmid content (Crawford and 
Bates, 1986). It was found that all 26 strains carried small 
plasmids (9-15 megadaltons), 11 of the strains carried one small 
plasmid and 15 strains carried 2 small plasmids. In addition, 10 
strains carried large plasmids (>100 megadaltons). All of these 
AIDS-related strains of MAI were probed with a nick-translated and 
radiolabelled probe derived from pLR7:pBR322. The Southern blot 
analysis revealed that each of the 26 AIDS-related MAI isolates 
carried plasmids related to the pLR7 plasmid. The pLR7 related 
plasmid, however, in the AIDS-related strains of MAI showed 
considerable heterogeneity of size. Bates and Crawford proposed 
that the pLR7 clone could serve as a useful marker for epidemiology 
and might also be useful for the detection of MAI in clinical 
material.
It has been found that 56% of clinical isolates of MAI 
and 75% of aerosol isolates of MAI from endemic areas have plasmids 
but, only 5-6% of soil isolates have plasmids ( Gangadharam et al., 
1988). Gangadharam et al. reported that all of their 26 AIDS- 
related strains of MAI that possessed plasmids were of serotypes 4 
or 8. These strains all carried a small plasmid that was closely 
related to the pLR7 plasmid. In a study performed in Denmark, a 
plasmid profile analysis was performed on isolates of MAI isolates 
derived from AIDS patients, children with cervical lymphadenitis 
and from environmental sources (Jensen et al., 1989). The Danish 
study reported that plasmid presence was found in 31% of AIDS-
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related MAI isolates, 27% of pediatric cervical lymphadenitis- 
related MAI and 7% in environmental isolates of MAI. These 
findings showed that plasmid presence occurs more frequently in 
clinical isolates of MAI than in environmental isolates.
Morris et al. (1990) studied the plasmid profiles of 12 
M. avium strains from 12 different AIDS patients . Nine isolates 
including all those of serotypes 4 and 8 carried multiple plasmids 
of less than 100 kb, while two serotype 3b strains and one 
untypeable strain had no detectable plasmids. The predominant band 
found in six of the serotype 4 and 8 strains was 16kb. In 
addition, in 4 of the aforementioned 6 strains there also occurred 
a high copy 13 kb plasmid band. High concentrations of an 
approximately 40 kb plasmid were observed in extracts from 2 
isolates. An untypeable isolate carried a plasmid profile which 
was unique in that it carried three large plasmids of >20 kb. All 
7 serotype 4 and serotype 8 isolates displayed similar 
hybridization patterns with a pLR7 probe. These aforementioned 
strains showed hybridizing bands of approximately 16, 25 and 40 kb.
Hellyer et al.(1991), studied the plasmid content of 147 
MAI isolates which were derived from 88 British AIDS-related MAI 
isolates, 9 U.S. AIDS-related MAI isolates; 36 British non-AIDS 
related MAI isolates and 14 British veterinary isolates. The pLR7 
and pLR20 type plasmids were detected with the pLR7 and pLR20 
probes of Crawford. The plasmids observed on electrophoretic 
analysis displayed two major groupings, namely, the small variety 
that consisted of principally 14 and 3 0 kb and the large variety 
which were> 150 kb. These investigators noted that there was no 
significant difference in the rate of plasmid presence in MAI 
isolates from AIDS and non-AIDS patients in Great Britain. By
contrast, the American AIDS-related strains displayed a higher rate 
of plasmid carriage. The American strains which were derived from 
blood and isolated at St. Vincent's Hospital in New York, possessed 
at least one plasmid. The British veterinary isolates were found 
not to carry large plasmids. In addition, not one of the 147 
isolates surveyed was found to possess more than three plasmids. 
Hybridization studies in which small-sized plasmids were probed 
with the pLR20 probe revealed that this type of plasmid was less 
common. Both the pLR7 and pLR20 probes did not hybridize to either 
the large sized plasmid or chromosomal DNA. None of the small 
plasmids were found to have homology with both probes. Hellyer and 
co-workers found that the pLR7 related plasmids showed considerable 
variation in size (15-30 kb) and by contrast, the pLR20 related 
plasmids were more consistent in size (14-16 kb). The plasmids 
which showed homology with the pLR20 probe were always seen in the 
presence of another small plasmid and were always the smallest 
plasmid present.
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6.3 Specific Plasmid Associated Functions
6.3a Plasmid Coded Mercury Resistance
Meissner and Falkinham III have isolated an environmental 
strain of Mj_ scrofulaceum (closely related to avium and M. 
intracellulare) from Chesapeake Bay which carried a plasmid (pVTl) 
of 177 kb in size (Meissner and Falkinham III, 1984). This plasmid 
bearing strain was able to grow in the presence of 100 fxM of HgCl2 
and was able to convert 203 Hg2+ to volatile mercury at a rate of 50 
pmol/108 cells per min. The extracts from these Mj_ scrofulaceum 
cells were found to contain a soluble mercuric reductase whose 
activity was not dependant on exogenously supplied thiol compounds. 
A derivative of the parent strain was found to be mercury sensitive 
and lacked both the pVTl plasmid and mercuric reductase activity.
It is this latter finding that linked mercury resistance to a 
plasmid.
6.3b Plasmid Coded Copper Resistance
Subseguent studies with the isolate of M*. scrofulaceum 
described by Meissner and Falkinham III above, found that those 
strains lacking the pVTl plasmid also were more susceptible to 
copper than parental strains (carrying the pVTl plasmid) (Crawford 
and Falkinham III, 1990). The parental copper resistant strains 
formed a black precipitate (copper sulphide) when grown in the 
presence of copper sulphate.
6.3c Plasmid Presence and Colonial Variation
The investigation of Mizuguchi and his co-investigators 
found that a wild type strain (strain 103) of M^ intracellulare 
carried two plasmids of 2 Mdal and 50 Mdal plasmid and displayed a
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transparent colonial morphology (Mizuguchi et al., 1981). When the 
wild type strain was treated with mitomycin C and other 
antibacterial agents, the 2 Mdal plasmid was lost and the colonial 
morphology changed from translucent to opaque. This finding of the 
lost 2 Mdal plasmid and the transformation colonial morphologies 
from translucent to opaque was suggestive of a plasmid role in 
determining colonial morphology.
6.3d Plasmid Role In Catalase Activity
Pethel and Falkinham III observed that the ability of 
Crawford Strain LR25 to grow at 43° C was the result of the strain's 
resistance to elevated levels of oxygenation in broth (Pethel and 
Falkinham III, 1989). These investigators measured the catalase 
activity in these aforementioned strains because of the probable 
role of hydrogen peroxide in oxygen dependent killing (Pethel and 
Falkinham III, 1989; Crawford and Falkinham III, 1990). The LR25 
strain at log phase was observed to have a catalase activity that 
was three times higher than those LR25 strains which had undergone 
a loss of plasmid due to curing. These results have, however, been 
invalidated by the subsequent finding which has shown that the "so- 
called" cured strains derived from LR25 have been shown to be a 
contaminant (Dr. J.W. Dale, Personal Communication).
6.3e Antibiotic Resistance and Plasmids
Franzblau et al. (1986) found that the MIC levels for 16 
plasmid bearing strains (8 strains carried a plasmid >100 Mdal and 
produced translucent colonies) of MAI showed consistent levels of 
sensitivity > 100/zg/ml for kanamycin, streptomycin and rifampin. 
Non-plasmid bearing strains, however, showed considerable variation 
in MIC levels.
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6.3f Plasmid Content and Virulence
Crawford and his co-workers found that all of their 26 
AIDS-related isolates of Mj_ avium possessed pLR7 related plasmids. 
In addition, 56% of clinical isolates of MAI and 75% of aerosol 
isolates of MAI from endemic areas have plasmids but, only 5-6% of 
soil, dust, and environmental isolates possess plasmids 
(Gangadharam et al., 1988). These findings thus were suggestive of 
a possible link between the presence of plasmids and virulence 
(Crawford and Bates, 1986).
Gangadharam and associates demonstrated that a Crawford 
isolate LR25 which carried 3 plasmids exhibited a high degree of 
virulence in the beige mouse model when virulence was displayed by 
high mortality and a progressive increase in MAI organisms in the 
spleen and lungs (number of organisms were expressed as colony 
forming units or c.f.u.). When a cured variant (plasmid lost) of 
LR25 called LR163 was judged by the criteria cited above, the 
virulence was lower (Gangadharam et al., 1988). However, this 
study was invalidated by the finding that "LR163 is a contaminant 
not a cured derivative of LR25" (Dr. J.W. Dale, Personal 
Communication). Morris et al., however, stated that the increased 
virulence noted in plasmid bearing strains could be a consequence 
of the presence of minor amounts of a unique plasmid-encoded 
product within cell (Morris et al., 1990).
The investigation of Hellyer et al. (1991) at St. Mary's 
Hospital in London found increasing evidence to support the notion 
that the portal of entry in MAI infection is the gastrointestinal 
tract. This notion of G.I. tract involvement was based upon the 
finding that individuals without HIV infection do not carry MAI in 
feces. In intestinal infections, it is important for organisms to
penetrate the epithelium and thus survive within the gut associated 
lymphoid tissues; mycobacterial cell-wall agents of adhesion could 
perhaps be involved in this process. Plasmids have been known to 
be linked to code for adhesins in other organisms. Thus, perhaps 
MAI virulence could be the result of heightened G.I. tract adhesion 
which could be plasmid encoded. However, because of the complex 
nature of MAI related plasmids the relationship between plasmids 
and virulence is still unclear.
This section will focus upon the pLR7 and pLR20 plasmid 
content of Mj_ avium complex strains isolated at two New York City 
hospitals, namely, St. Vincent's Hospital and Memorial Sloan- 
Kettering Cancer Center.
METHODS AND MATERIALS
6.4 pJC-20 Plasmid Prep
The pJC-20 recombinant plasmid (pLR7: pBR322) contains an 
MAI pLR7 plasmid which had been inserted into a pBR322 plasmid at 
the Hind III site. A 4mm loopful of EL. coli containing the pJC-20 
recombinant plasmid was inoculated into 4 ml of LB broth (See 
Appendix IV) containing 25 jxg/ml of ampicillin to select for 
plasmid bearing strains and incubated overnight at 37° C. This 
overnight growth served as inocula for a 150 ml (in a 500 ml 
erlenmeyer flask) LB broth batch culture (containing 25 fig/ml 
ampicillin) which was placed into a 37° C shaker bath. The E650nm 
reading was taken at 30 min intervals. When the E650nm reading 
reached 0.9 O.D. units, spectinomycin was added to a final 
concentration of 150/ig/ml, and the culture was returned to the 
shaker bath and incubated overnight at 37° C. The cells were 
harvested and plasmids isolated via the basic Qiagen protocol (see 
Qiagen protocol).
6.5 pJC-70 Plasmid Prep
Recombinant plasmid pJC-70 (pLR20 :pUC18) contains an MAI 
pLR20 plasmid which had been inserted into a pUC18 plasmid at the 
Eco RI site. A 4mm loopful of E^ coli containing the pJC70 
recombinant plasmid was inoculated into 4 ml of LB broth which 
contained 100 /zg/ml ampicillin to select for plasmid containing 
strains and incubated overnight at 37° C. The overnight culture 
served as inocula for a 150 ml broth batch culture (containing 100 
ug/ml of ampicillin) which was placed into a 37° C shaker bath. The 
remainder of the protocol was the same as that cited for pJC-20.
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6.6 Oiaaen Plasmid Isolation Protocol
6.6a Oiaaen Midi (30-150ml) Plasmid Protocol for E. coli pJC-20 
The cells (150 ml.) were pelleted by centrifugation at 
4,320 x g for 15 min at 4° C in a Sorvall Model RC-2B Refrigerated 
High Speed using a Sorvall GSA rotor(Qiagen INC., Chatsworth, 
California, U.S.A.). The bacterial pellet was resuspended in 4.0 
ml of PI buffer (See Appendix III). Four ml of P2 buffer (See 
Appendix III) was added to the bacterial cell suspension, was 
gently mixed and allowed to incubate at room temperature for 5 min. 
An Aliquot of 4.0 ml of P3 buffer (See Appendix III) was added to 
the bacterial cell suspension which was gently mixed and placed in 
a Sorvall RC-2B centrifuge using a Sorvall SS-34 rotor and spun at 
a speed of 23,420 x g for 30 minutes at a temperature of 4° C. The 
supernate was removed to a clean sterile tube and it was 
centrifuged two additional times at 23,420 x g for 15 minutes at a 
temperature of 4° C. After each spin the supernate was transferred 
to a clean sterile tube. The final supernate was then filtered on 
a 0.45 micron pore size Nalge filter unit to remove any remaining 
particulate matter. The resulting filtrate was added to a Qiagen- 
pack 100 syringe pressure operated column which had been 
equilibrated with 2.0 ml of QB buffer (See Appendix III). The 
Qiagen-pack 100 column was washed with 2 x 4.0 ml of QC buffer (See 
Appendix III), and the column was eluted with 2.0 ml of QF buffer 
(See Appendix III). The resulting eluate (plasmid DNA) was 
aliquoted (500 /zl per eppendorf tube) into eppendorf tubes. The 
plasmid DNA per aliquot was precipitated with 450 /il of isopropanol 
(equilibrated to room temperature) and was centrifuged at 23,430 x 
g at 4° C for 30 min to pellet the plasmid DNA. The supernates per 
aliquot were carefully removed and the plasmid DNA therein was
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washed with 70% ethanol and spun for 30 minutes at 23, 420 x g at 4° 
C. The supernate per aliquot was again removed carefully and the 
pellet was dried briefly (5 min) under vacuum. A single volume of 
200 /xl of TE buffer (See Appendix I) was pipetted through all the 
eppendorf tubes that contained the dried pellet. The resulting 
pooled re-suspended plasmid DNA was stored at -20° C.
6.6b Oiaaen Maxi (150 - 500 ml 1 Plasmid Protocol for E. coli pJC- 
70
The cells (150 ml) were pelleted in the same manner as 
that cited for the Midi prep(Qiagen INC. Chatsworth, California, 
U.S.A.). For the Maxi prep the bacterial pellet was resuspended in 
10 ml of PI buffer (See Appendix III). A 10 ml aliquot of P2 
buffer was added to the bacterial suspension, was gently mixed and 
allowed to incubate at room temperature for 5 min. A 10 ml aliquot 
of P3 buffer was added to the suspension, gently mixed and placed 
in a centrifuge (Sorvall RC-2B centrifuge using SS-34 rotor) and 
spun at a speed of 23,420 x g for 30 min at a temperature of 4° C. 
The supernate was removed to a clean sterile tube and was 
centrifuged two additional times (each time the supernate was 
transferred to a clean sterile tube) for 15 minutes at 4° C. The 
supernate was then filtered on a 0.45 micron pore size Nalge filter 
unit to remove any remaining particulate matter. The resulting 
filtrate was added to a Qiagen Gravity operated tip-500 column that 
had been equilibrated with 10 ml of QBT buffer (See Appendix III) . 
The Qiagen tip-500 column was washed with 30 ml of QC buffer (See 
Appendix III) and eluted with 15 ml of QF buffer (See Appendix 
III) . The resulting eluate was aliquoted (1000/xl per eppendorf 
tube) into eppendorf tubes. The plasmid DNA eluate per aliquot was 
precipitated with 500 ill of isopropanol (equilibrated to room
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temperature) and centrifuged at 23,420 x g at 4° C for 30 minutes to 
pellet plasmid DNA. The supernates per aliquot were removed 
carefully and the plasmid DNA therein contained were washed with 
70% ethanol and spun for 30 min at 23,420 x g at 4° C. The 
supernate per aliquot was again removed carefully and the pellet 
was dried briefly (5 min) under vacuum. A single volume of 200 (il 
of TE buffer (See Appendix I) was pipetted through all the 
eppendorf tubes that contained dried plasmid pellet. The 
resuspended pooled plasmid DNA pellet was stored at -20° C.
6.6c Modified Oiaaen Midi and Maxi Preps for MAI
MAI strains were first grown in 10ml of 7H9 broth (BBL) 
which was supplemented with 4% OADC (BBL) and 1% glycerol for a 
period of 7 days at 37° C. The 10 ml 7H9 broth culture served as 
inoculum for a 150 ml batch culture contained within a 500 ml 
dimpled erlenmeyer flask which also contained the aforementioned 
suppliments of OADC and glycerol. These cultures were grown at 37°
C in a shaker bath for a period of 8 weeks. The flasks containing 
the MAI cells were exposed to sterile glycine (stock concentration 
20% ; final concentration per flask 2%) for a period of 48 hours 
prior to harvest (in shaker water bath at 37° C in order to make the 
MAI cell walls leaky thus rendering them more susceptible to the 
action of alkaline lysis. Cultures were spun down at 11,950 x g in 
a Sorvall GSA rotor at 4° C. The protocol then followed the basic 
Qiagen Midi Prep protocol as cited above for EL. coli.
The modifications to the Qiagen protocol did enable the 
visualization of plasmid bearing strains of MAI via ethidium 
bromide staining of the agarose, as well as, the identification of 
specific plasmid types by Southern Blotting. Early in these 
studies, it became quite clear that the Qiagen Midi Column which
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the manufacturer cited as having the capacity to utilize 3 0-150 ml 
aliquots of crude E^ _ coli lysate as the source of plasmid DNA, was 
inadequate for use in 8 week old 150ml MAI culture (this volume 
yielded the necessary biomass needed in order to view the low copy 
MAI plasmid via ethidium bromide staining and carry out successful 
nonradiometric colorimeter detection). The Midi column which had 
to be loaded to its upper capacity (150ml) with crude MAI lysate, 
often became clogged. Therefore, the higher capacity Maxi Qiagen 
Column (150ml-500ml capacity) replaced the Midi Column in MAI 
preps. The Qiagen system, however, failed to totally remove 
chromosomal DNA from the MAI prep as demonstrated on the 
electrophoretic and southern blots.
6.7 Electrophoretic Analysis of MAI Plasmid DNA
The samples analyzed were: a) MAI plasmid preps
consisting of 60^ x1 of plasmid prep and 20/il of loading buffer (See 
Appendix I) and b) BRL Supercoiled DNA ladder consisted of 12/il BRL 
Supercoiled DNA (94ng/ml) , 48/xl of TE buffer (See Appendix I) and 
20/xl of loading buffer. Sixty microliter aliquots of MAI plasmid 
sample and BRL supercoiled DNA were loaded into wells ( 2.0mm x 
7.5mm) in 0.6% agarose. The agarose was 9.68mm thick, contained 
0.5/xg/ml ethidium bromide, and was 11 x 14 cm. The electrophoretic 
run was carried out in a BRL Model H5 Electrophoretic Horizontal 
Submarine Gel Unit tank using IX TAE as the electrophoretic buffer 
(See Appendix I). The electrophoresis was run at 104 Volts 
generated from a BRL Model 250 Power Pack for a period of 2 hours 
and 40 min. The resulting electrophoretic run was viewed on a 
254nm UV transilluminator. A photographic record was made by the 
use of a Polaroid Quick Shooter Camera using Polaroid 667 film.
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6.8 The Preparation of Probe DNA for detecting pLR-7 and 
p LR-20 Type Plasmids in AIDS-related MAI
6.8a PLR7 Plasmid Prep from PJC-20
Fifteen microliters of Qiagen Midi Prep eluate 
PJC-20 plasmid digested with 2 ijlI of Hind III (Boehringer 
Mannheim; 11 units/ml) restriction enzyme in a total volume of 20 
111 for 60 minutes at 37° C. Five microliters of loading buffer were 
added to the 20 ill of digest. A 25;xl aliquot of the PJC-20 digest 
and several additional samples were subsequently analyzed 
electrophoretically. The additional samples analyzed were: a) PJC- 
20 uncut plasmid sample which consisted of 15/liI of PJC-20 plasmid,
2ill lOx react buffer, 3ill of ddH20 and 5ill of loading buffer; b) BRL 
Supercoiled DNA sample which consisted of 4ill of supercoiled DNA 
molecular weight ladder (94ng//il) , 2iil 10X react buffer, 14 ill T.E. 
buffer, 1^1 ddH20 and 5 ill loading buffer; c)Digoxigenin Labelled 
Lambda Hind III Fragments Sample which consisted of 15^1 
Digoxigenin Labelled Hind III Fragments (10ng//il) , 2/xl TE buffer,
5/xl loading buffer. The samples were loaded into wells (0.8mm x 
5.3cm) in 0.8% agarose gel. The agarose gel was 4mm thick, 
contained 0.5Mg/ml ethidium bromide, and was 5.7 x 8.3 cm. The 
electrophoretic run was performed in a BRL Horizon 58 baby gel 
electrophoretic tank using IX TAE buffer as electrophoretic buffer. 
The electrophoresis was run at 100 volts for a period of 43 min 
using a BRL Model 200 power supply. The resulting electrophoretic 
run was viewed on a 254nm UV transilluminator. A photographic 
record was made by the use of a Polaroid Quick Shooter Camera using 
Polaroid 667 film.
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6.8b pLR-20 Plasmid Prep from PJC-70
Fifteen microliters of Qiagen Maxi Prep eluate PJC-70 
plasmid digested with 2 /xl Eco R1 (Boehringer Mannheim; 12 
units/ml) restriction enzyme in a total volume of 20 /xl for 60 
minutes at 37° C. Five microliters of loading buffer was added to 
the 20 ill of digest and the resulting 25 ill were loaded onto the 
same agarose gel configuration as cited for pLR-7. The 
electrophoresis was run at 100 volts for a period of 45 min.
6.8c Gene Clean Protocol
Either a Hind III(pLR-7) or EcoRl (pLR-20) fragment 
obtained from the preceding protocols was excised from an ethidium 
bromide stained gel. The excised gel slice was added to a (Pre­
weighed) eppendorf tube(Bio 101). This tube which contained the 
gel slice was weighed in order to determine the approximate volume 
of the gel slice by weight (lgm agarose gel equals approximately 
lml (Bio 101)) . To the eppendorf tube containing the agarose slice
was added two to three volumes of Nal stock solution (Bio 101 Gene
Clean kit stock solution). This tube was then placed into a 55° C 
waterbath for a period of 5 min until all the gel had melted. To a 
5fil aliquot (5/xl of GLASSMILK solution added to 5/xg or less of DNA) 
of GLASSMILK solution( silica matrix: Bio 101 Gene Clean kit stock 
solution) was added to the DNA solution, which was then mixed by 
pipetting and incubated for 5 min in an ice bath (at 2 min
intervals the GLASSMILK suspension was mixed to ensure that it
remained in suspension). The GLASSMILK was pelleted in an 
eppendorf centrifuge for 5 secs at 23,420 xg. The Nal stock 
solution supernate was carefully removed so as not to disturb the 
GLASSMILK pellet. The GLASSMILK was resuspended in an additional 
wash with Nal (400 /xl) and incubated for 3-5 min in a waterbath at
55° C. The GLASSMILK was pelleted for 5 secs at 23,420 x g in an 
eppendorf microcentrifuge. The Nal supernate was again removed 
from the GLASSMILK pellet. An aliquot of 700/xl of ice cold NEW 
solution (Bio 101 Gene Clean kit stock preparation) was added to 
the pellet which was resuspended by pipetting back and forth. The 
GLASSMILK pellet was pelleted by centrifugation at 23,420 x g in an 
eppendorf microcentrifuge for 5 sec. The supernate was then 
discarded. The wash procedure with NEW solution was repeated two 
more times. After the supernate from the third and final NEW wash 
was removed, the eppendorf tube was spun for a few additional 
seconds to the last bit of New supernate. The GLASSMILK pellet was 
resuspended in 10 /xl of TE buffer and incubated for 3 minutes in a 
55° C waterbath. The suspension was pelleted at 23,420 x g in an 
eppendorf microcentrifuge. The supernate was transferred to a 
sterile 1.5 ml eppendorf tube. The GLASSMILK pellet was 
resuspended for a second time in 10/xl of TE buffer and incubated 
for 3 minutes in a 55° C waterbath. The suspension was pelleted 
again at 23,420 x g in an eppendorf microcentrifuge. The supernate 
was pooled with the supernate obtained in the preceding step. The 
resulting 20ul aliquot of either the pLR-7 or pLR-20 plasmid was 
then ready to be labelled and utilized as a probe.
6.8d Random Primer Labeling of DNA with diaoxigenin-ll-dUTP
The GENE CLEAN plasmid prep(s) derived in the preceding 
section served as the purified DNA for digoxigenin labeling in a 
scaled up labeling reaction(Boehringer Mannheim). The amount of 
DNA utilized in the labeling reaction varied from 200 ng to 500 ng 
(DNA concentration was estimated based upon the intensity of 
ethidium bromide staining of a molecular weight standard on known 
concentration as seen on a 254nm UV Transilluminator) . The 20 /xl
aliquot of DNA was added to a sterile eppendorf tube and boiled in 
a waterbath for a period of 10 min to achieve denaturation. The 
denatured DNA was then placed in an ice bath for 3 min. To the DNA 
aliquot were added 5/xl of Hexanucleotide mixture (Boehringer 
Mannheim Genius Digoxigenin Labeling and Detection Kit) , 5/xl dNTP 
(Boehringer Mannheim Genius Digoxigenin Labeling and Detection 
Kit) , 17/xl of dd H20 and 3/xl of Klenow enzyme (DNA Polymerase, Large 
Fragment, 2 Units//xl) . The total volume of the reaction was 50/xl. 
The labeling aliquot was briefly spun down in a microcentrifuge and 
then incubated in a 37° C incubator overnight. The labeling 
reaction was stopped by adding 4/xl of a 0.2M EDTA solution (pH 8.0) 
and it was precipitated with 5/xl of 4M LiCl and 150 /xl of 
prechilled (-20° C) ethanol. The eppendorf tube which contained the 
labelling mixture was mixed by inversion of the tube. The 
eppendorf tube was then placed in a -70° C freezer for 30 minutes. 
The tube was then centrifuged at 12,000 x g for 30 min. The 
resulting supernate was removed gently so as not to disturb the 
pellet. The pellet was washed with 40 /xl of cold (-20° C) ethanol 
(70% v/v) and centrifuged again for 10 min at 12,000 x g for 30 
min. The supernate was again carefully removed so as not to 
disturb the pellet. The pellet was dried under vacuum for 1-2 min. 
The pellet was re-suspended in 50 /xl of TE/SDS buffer (See Appendix 
II). The labelled probe was stored at -20° C until needed.
6.8e Checking the Specificity of the Labelled Probe VIA Southern 
Blotting
The original pBR322 plasmid vector which contained the 
pLR-7 plasmid inserted at the Hind III site or the pUC-18 plasmid 
which contained the pLR-20 plasmid inserted at the Eco RI site were 
first digested with the appropriate restriction enzyme. The
restriction digest was the same as previously cited for pLR7 or 
pLR20 Plasmid Preps. The plasmid digests were electrophoretically 
analyzed against the appropriate uncut plasmid vector, BRL 
Supercoiled DNA and Digoxigenin Labelled Lambda Hind III Fragments 
under the same conditions as previously cited for pLR-7 or pLR-20 
Plasmid Preps. The gel was further exposed to Ultraviolet light 
(254nm) for a period of 5 min to induce photonicking thus 
facilitating the transfer of plasmid or supercoiled DNA ( Crawford 
and Bates, 1986).
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6.8f Transfer of DNA from Agarose Gels to Nvlon Membranes
The DNA within the agarose gel was denatured by exposure 
to several volumes of 1.5 M NaCl and 0.5M NaOH for 1 hr at room 
temperature with constant shaking and was followed by a subsequent 
neutralization step. During neutralization, the gel was exposed to
1.0 M Tris-HCl buffer (pH 8.0) + 1.5M NaCl for a period of 1 hr at 
room temperature under constant shaking. The gel was then 
inverted. A piece of Whatman 3MM paper was then wrapped around a 
BRL plexiglass gel support and placed in a BRL plexiglass reservoir 
which was filled with 10 X SSC (See Appendices I and II). This 
Whatman 3MM paper served as a wick. The wick and supporting BRL 
plexiglass were then set up with the wick resting upon the 
plexiglass and its ends immersed in the reservoir. Two additional 
pieces of Whatman 3mm paper were cut to the same size as the gel (6 
x 8 cm) and soaked in 2x SSC (See Appendix II) for 2-3 min. A 
nylon membrane (Biodyne A, Pall Corp. U.S.A.) was cut to the same 
dimensions as the gel ( 6 x 8  cm) and immersed in 2xSSC for 2-3 min. 
One of the pieces of Whatman 3MM paper was placed atop the wick.
The inverted gel was placed upon the Whatman 3MM paper and it was
smoothed down with a glass rod to remove air bubbles. A Pall 
Biodyne A nylon transfer membrane was placed upon the upper surface 
of the inverted gel and was also smoothed down to remove air
bubbles. The second Whatman 3MM paper was placed upon the nylon
transfer membrane and was then smoothed down to remove air bubbles. 
Finally, atop the Whatman 3MM paper a stack of 7 BRL blotting pads 
were added. A second plexiglass plate was placed atop the blotting 
pads. On this plexiglass plate was placed a 200 gm weight. The 
weighted blotting stack or transfer assembly was not disturbed for 
12-24 hours in order to facilitate the transfer of DNA from the 
agarose gel to the nylon transfer membrane by capillary action.
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The transfer assembly was subsequently taken apart and the side of 
the nylon membrane in contact with the gel surface was marked with 
soft pencil. The nylon membrane (marked surface up) was placed 
into a baking dish containing 6xSSC and placed upon a rotatory 
shaker for 5 min at room temperature. The- nylon membrane was 
placed upon a dry piece of Whatman 3MM paper and allowed to air 
dry. The air dried nylon membrane was then placed between two 
sheets of Whatman 3MM paper and baked for 2 hours at 80° C in order 
to bind the DNA to the nylon membrane. The membrane was then ready 
for Prehybridization and hybrization.
6.8g Hybridizing Diaoxiaenin-ll-dUTP Labelled pLR-7 or p LR-20 
Probes to Immobilized target DNA
The nylon membrane was then placed within a BRL heat 
sealable hybridization bag (7 X 10 cm) , which was then filled with 
25ml of hybridization fluid (See Appendix II) which had been 
prewarmed (70°C ) for 1 hr. prior to its use in prehybridization.
The hybridization bag was then heat sealed and placed upon a 
rotator in a 68° C incubator for 3-4 hrs. The microtube which 
contained the labelled probe DNA (pLR-7 or pLR-20) was boiled for 
10 min to denature the probe DNA. The denatured labelled probe DNA 
was cooled for 3 min in an ice bath. The heat sealed bag was 
opened and the Pre-hybridization fluid was removed and replaced 
with 3.99 ml of prewarmed hybridization fluid (prewarmed for 1 hour 
at 70° C) plus 10/Ltl of denatured labelled probe DNA (pLR-7 or pLR- 
20) . The bag was again heat sealed and was again placed upon a 
rotating platform in a 68° C incubator. After overnight incubation, 
the bag was opened and the hybridization fluid was discarded. The 
nylon membrane was washed twice for 5 min at room temperature in 50 
ml solution of 2x SSC, 0.1% (w/v) SDS. The washings were carried
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out on a shaking platform. The nylon membrane was then washed an 
additional two times, 15 min each in 50 ml of O.lx SSC, 0.1% SDS on 
a shaking platform at 68° C. The membrane was now ready for the 
detection of probe DNA-target DNA hybrids.
6.8h Detecting Probe DNA - Target DNA Hybrids.
The nylon membrane was washed in Buffer #1 (See Appendix 
II) for 1 min under constant shaking at room temperature. This 
washing was followed by a 30 min incubation in 100 ml of prewarmed 
(prewarmed for 1 hour at 70° C) Buffer #2 (See Appendix II) under 
constant shaking at room temperature. The nylon membrane was then 
briefly washed on a shaking platform for 1 min.in Buffer #1 at room 
temperature. The nylon membrane was subsequently exposed to a 
diluted anti-digoxigenin antibody conjugated with alkaline 
phosphatase diluted 1:5000 in Buffer #1 thus yielding a final 
activity of 150mU/ml for a period of 60 min at room temperature on 
a shaking platform. Enhanced sensitivity of detection was achieved 
with a 1:500 dilution of anti-digoxigenin antibody (final activity 
of 1500 mU/ml). The unbound antibody-conjugate was removed by two 
15 min washings at room temperature in 100 ml of Buffer #1 (under 
constant shaking). The nylon membrane was equilibrated with Buffer 
#3 (See Appendix II) for 2 min at room temperature on a shaking 
platform. The nylon membrane was placed into a BRL heat sealable 
bag, and a freshly prepared Colorimetric detecting solution 
consisting of 9.920 ml of Buffer #3 plus 45/xl of NBT solution 
(Boehringer Mannheim) and 35/xl of X-phosphate-solution was added. 
The bag was heat sealed and placed in a darkened desk drawer for a 
period of 2-3 hours at room temperature. The nylon membrane was 
removed from the bag and the color reaction was stopped by washing 
the nylon membrane for 5 min in 50 ml of Buffer #4 (See Appendix
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II) under constant shaking (at room temperature). The detected 
bands were documented by either photocopying or photographing the 
wet nylon membrane.
6.9 Southern Transfer of MAI Plasmid DNA
Aliquots of MAI plasmid sample and BRL Supercoiled DNA 
ladder were loaded onto an 11 X 14 cm agarose gel in a BRL H5 
Electrophoretic Tank and run under the same conditions as cited for 
electrophoresis of MAI plasmid DNA. The gel was prepared for 
southern blotting in the same manner as cited above but, in the 
actual southern blotting procedure for MAI plasmids, I utilized a 
larger nylon membrane (11 x 14 cm) and a blotting stack of 12 BRL 
pads (11 x 14 cm) and a heavier weight 500 gm weight. The Southern 
blot protocol, hybridization procedures and non-radioactive 
detection procedures utilized for the MAI plasmid DNA preps were 
identical to that cited above.
RESULTS AND DISCUSSION
6.10 Qiagen Midi (30-150ml Plasmid Prep and Electrophoresis for the 
isolation of j_
6.10a E_t. coli plasmid pJC-20
The use of 150 ml Qiagen Midi preps did indeed yield 
(pJC-20= pBR322 : pLR-7 Hind III insert) plasmid DNA devoid of 
contaminating chromosomal DNA. Figure 13a showed that the intact 
plasmid was >16kb, and was composed of two Hind III fragments: 
pBR322 (4.3kb) and pLR7 (15.7kb) (See Figure 13a).
6.10b Ei coli pJC-70
The Qiagen syringe pressure operated Midi column was 
replaced by the newer Qiagen gravity operated Maxi column which had 
a higher DNA capacity (150-500ml) than the midi column. The Qiagen 
Maxi prep (150ml) gave a (pJC-70=pUC-18 : pLR20 Eco RI insert) 
plasmid DNA devoid of contaminating genomic DNA (See Figure 13b). 
The uncut pJC-70 plasmid was >16 kb when measured against a 
supercoiled DNA (See Figure 13b). The Eco RI digest of pJC-70 
produced two fragments of 13 kb (pLR-20 Eco RI insert) and 2.7 kb 
(pUC-18 plasmid vector)(See Figure 13b).
6.10c Checking the Specificity of Labelled Probes Via Southern 
Blotting
When the previously purified (via Gene Clean) and 
digoxigenin labelled Hind III fragment (pLR-7) probe was tested for 
specificity, it revealed a strong homology with pLR-7 at a 1:500 
conjugate (alkaline phosphate conjugated to anti-digoxigenin Fab 
fragments) dilution (See Figure 14) . This check of specificity 
also revealed some hybridization with the parent pBR322 plasmid
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vector segment of pJC-20. This result indicates some degree of 
carryover of the parent plasmid vector (pBR322) (Figure 14).
Similarly the probe pLR-20 (Eco RI fragment of pJC-70) 
showed very strong homology with the heavier fragment (pLR-20) at 
1:500 conjugate dilution (alkaline phosphate conjugated to anti- 
digoxigenin Fab fragments) (See Figure 15). This specificity 
check also displayed a very faint band of hybridization with the 
parent pUC-18 plasmid vector segment of the Eco RI digest of pJC- 
70. This second faint band of homology would, therefore, be 
indicative of a slight degree of carryover of the parent plasmid 
vector (pUC-18) (See Figure 15).
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i
Figure 13a: Electrophoresis of plasmid pJC-20. Agarose Gel
Electrophoresis
Lane 1: Lambda Hind III digest, Lane 2: BRL Supercoiled DNA Ladder, 
Lane 3: pJC-20 Hind III Cut Plasmid, Lane 4: pJC-20 Uncut Plasmid
Figure 13b : Electrophoresis of plasmid pJC-70. Agarose Gel 
Electrophoresis
Lane is Lambda Hind III digest, Lane 2: Supercoiled DNA Ladder, 
Lane 3: pJC-70 Eco RI Cut Plasmid, Lane 4: pJC-70 Uncut Plasmid
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Figure 14: Specificity Check of probe, pLR-7.
L: Agarose Gel Electrophoresis
R: Southern Blot of Agarose Gel Electrophoresis 
Probe Conditions : pLR-7 (10 /il pLR-7 probe/ 4.0 ml 
hybrid, fluid)
Detection: 1:500 dilution Anti-digoxigenin Fab
Colorimetric Visualization Interval: 2 hrs
Lane 1(L&R): Lambda Hind III fragments, Lane 2(L&R): pJC-20 Hind 
III Cut Plasmid
132
Figure 15: Specificity check of probe p LR-20.
L: Agarose Gel Electrophoresis
R: Southern Blot of Agarose Gel Electrophoresis
Probe Conditions : pLR-20 (10 /xl pLR-20 probe/ 4.0 ml 
hybrid, fluid)
Detection: 1:500 dilution Anti-digoxigenin Fab
Colorimetric Visualization Interval: 2 hrs
Lane 1 (L&R): Lambda Hind III fragments, Lane 2(L&R): pJC-70 Eco RI 
Cut Plasmid
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6.11 Electrophoresis of MAI Plasmid DNA for the Presence of PLR-7 
and
PLR-20 Type Plasmids
6.11a PLR-7 Type Plasmids
The majority (85% or 17/20) of MAI strains isolated from 
AIDS patients at St. Vincent's Hospital and Memorial Sloan- 
Kettering Cancer Center, and analyzed via Southern Transfer for 
homology with Digoxigenin-Labelled pLR-7 probe, were shown to 
possess pLR-7 type plasmids (See Figure 16; Table 11). The AIDS 
related strains in this study that showed homology with the probe 
(pLR-7=15.7kb) displayed pLR-7 type plasmid bands varying from 14- 
18kb when measured against BRL supercoiled molecular weight 
markers.
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Figure 16: Detecting the presence of pLR-7 type plasmids.
L: Agarose Gel Electrophoresis
Gel Specifics: (11 x 14 cm gel, 0.6% Agarose, 9.68mm
in Thickness )
Voltage: 104 volts 
Duration of run : 2hrs 35 min
R: Southern Blot of Agarose Gel Electrophoresis
Probe Conditions : pLR-7 (10 /xl pLR-7 probe/ 4.0 ml 
hybrid, fluid)
Detection: 1:5000 dilution Anti-digoxigenin Fab
Colorimetric Visualization Interval: 2 hrs 3 5min
Lane 1 (L&R): BRL Supercoiled DNA Ladder, Lane 2 (L&R): LR25,
Lane 3 (L&R): 10,000, Lane 4 (L&R): 10,001, Lane 5 (L&R): 10,002, 
Lane 6 (L&R): 10,011
6.11b PLR-20 Type Plasmids
By contrast to the results obtained with the pLR-7 probe, 
those for the pLR-20 were quite different. When the same 20 
strains derived from St. Vincent*s Hospital and Memorial Sloan- 
Kettering Cancer Center were analyzed via Southern Transfer for 
homology with Digoxigenin-Labelled pLR-20 probes, only 20% (4/20) 
of the isolates (See Table 11) showed homology with the pLR-20 
probe (See Figure 17). The plasmid bands which displayed homology 
with the pLR-20 probe were 13 kb (pLR-20)=+ 13 kb). The pLR-20 
probe was derived from a pUC-18 parent plasmid vector. This pUC-18 
plasmid vector contained a pBR322 ampicillin resistence gene 
sequence (Davis et al., 1986). The presence of this pBR322 
ampicillin resistance gene sequence in the pUC-18 parent plasmid 
vector enabled pLR-20 probe homology with the BRL supercoiled DNA 
ladder to occur, therefore permitting visualization of the 
supercoiled DNA ladder on the nylon transfer membrane. This 
visualization of the BRL supercoiled DNA molecular weight marker 
permitted a direct molecular weight determination of the plasmid 
DNA. A summary of the pLR-20 type plasmid bearing strains can be 
seen in Table 11.
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Figure 17: Detecting the presence of p LR-20 type plasmids.
L: Agarose Gel Electrophoresis
Gel Specifics: (11 x 14 cm gel, 0.6% Agarose, 9.68mm 
in Thickness )
Voltage: 106 volts 
Duration of run : 2hrs 35 min
R: Southern Blot of Agarose Gel Electrophoresis
Duration of run : 2hrs 35 min 
Probe Conditions : pLR-20 (10 /il pLR-20 probe/ 4.0 ml 
hybrid, fluid)
Detection: 1:500 dilution Anti-digoxigenin Fab
Colorimetric Visualization Interval: 2 hrs 53min
Lane 1 (L&R): BRL Supercoiled DNA Ladder, Lane 2 (L&R): MDX 
Lane 3 (L&R): 10,002, Lane 4 (L&R): 10,0010 
Lane 5 (L&R): 10,010 IV, Lane 6 (L&R): 10,011,
Lane 7 (L&R): 10,011 IV, Lane 8 (L&R): 10,015
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6.12 Cross Hybridization of p LR-7 and p LR-20 probes with 
chromosomal DNA
When we sought to increase the sensitivity of the non­
radioactive digoxigenin colorimetric detection by utilizing a more 
concentrated anti-digoxigenin conjugate (1:500) rather than the 
dilution recommended by the manufacturer (1:5000), there occurred 
cross hybridization of the pLR-7 probe with chromosomal DNA. Cross 
hybridization of the pLR-20 probe with chromosomal DNA, however, 
was not encountered at the more concentrated 1:500 dilution of the 
anti-digoxigenin conjugate.
6.13 Conservation of Plasmids
Two of the four corded MAI isolates derived from patient 
blood revealed the presence of plasmids (See Table 11). Two of 
these corded MAI isolates (10,010, 10,011) carried pLR-7 type 
plasmids, while the two remaining corded strains (10,002, 10,015) 
carried neither the pLR-7 nor the pLR-20 type plasmids. The pLR20 
type plasmids were not seen in any of the original four corded 
isolates. When corded strains 10,010 and 10,011 were passed 
through 4 subculturings, cording was lost by the fourth subculture 
but, the presence of the pLR7 plasmid still remained (See Table
12). Crawford and Falkinham have stated that plasmid carriage in 
many plasmid bearing strains of MAI remained despite the fact that 
these strains had been maintained in laboratory culture media for 
many years (Crawford and Falkinham, 1990) . This continued 
conservation of MAI plasmids, was found also by J.J. McFadden and 
his Co-workers (J.J. McFadden, Personal Communication).
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6.14 Presence of Mixed Cultures
Initially corded strains 10,002, 10,010 and 10,015 were 
isolated and subcultured with the Para SL/C cited in Section IV.
The results as concerns the plasmid profile for strains 10,002,
10,010 and 10,015 and their respective fourth subcultured strains 
(10,002-IV, 10,010-IV, 10,015-IV) show that these strains are 
basically the same (See Tables 11 & 12).
When corded strain 10,011 was subcultured 4 times, it 
lost cording but, its fourth subcultured strain 10,0il-IV, had 
present both pLR7 and pLR20 type plasmids (See Table 12) . The 
plasmid profile seen on the ethidium bromide stained agarose gel in 
Figure 17 (See lanes 6L,7L) shows plasmids of differing sizes in 
the fourth subcultured strain 10,011-IV when run alongside the 
original corded strain 10,011 (See Figure 17: lanes 6L&7L). This 
result clearly shows these two strains are different.
The original corded strain 10,011, and the fourth 
subcultured strain 10,011-IV, were subcultured in the same manner 
as that cited above for the other corded strains (10,002, 10,010, 
10,015). This manipulation with Para SL/C would rule out the 
presence of a non-acid-alcohol fast, non-paraffinophilic and 
nonmycobacterial contaminant. However, the application of Para 
SL/C does not rule out the possibility of the existence of mixed 
cultures of MAI within the initial AIDS patient blood isolate. 
Arbeit and his co-investigators have noted that it is not uncommon 
for AIDS patients to suffer from bacteremia due to more than one 
strain of MAI occurring simultaneously (Arbeit et al., 1992).
The initial presence of two distinct strains of MAI 
isolate 10,011 does provide a plausable explanation for the 
differing plasmid profiles obtained for 10,011 and 10,011-IV in
Section VI and the differing R.F.L.P profiles obtained for these 
organisms in Section VII.
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Table 11: PLR-7 and PLR-20 Plasmid Type Presence In H&l lgolate.fi
Strain Hospital Where 
Isolated
PLR-7 Type
Plasmid
Presence
PLR-20 Type
Plasmid
Presence
953 St. Vincent*s 
Hospital
+ —
1516 St. Vincent*s 
Hospital
+ +
1762 St. Vincent's 
Hospital
— •
4861 St. Vincent's 
Hospital
+ •
6475 St. Vincent's 
Hospital
+ +
8197 St. Vincent's 
Hospital
+ •
8515 St. Vincent's 
Hospital
+
15113 St. Vincent's 
Hospital
+ •*
10,000 St. Vincent's 
Hospital
■ + +
10,001 St. Vincent's 
Hospital
+ ND*
10,002 St. Vincent's
Hospital
(corded)
10,010 St. Vincent's
Hospital
(corded)
+
10,011 St. Vincent's
Hospital
(corded)
+
10,015 St. Vincent's
Hospital
(corded)
SK015 Sloan-
Kettering
+ •
SK016 Sloan-
Kettering
+ •
SK024 Sloan-
Kettering
+ •
SK037 Sloan-
Kettering
+ +
SK060 Sloan-
Kettering
+ -
SK069 Sloan-
Kettering
— -
SK095 
ot done
Sloan-
Kettering
+ *

Table 12: Conservation of Plasmids in 4x Subcultured MAI
Strains that have lost Cording
Strain of MAI Hospital where PLR-7 Type PLR-20 Type
Isolated Plasmid Plasmid
10,002 IV St. Vincent's +
Hospital
10.010 IV St. Vincent's + -
Hospital
10.011 IV St. Vincent's + +
Hospital
10,015 IV St. Vincent's
Hospital
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6.15 General Plasmid Carriage
The plasmid profile of St. Vincent's blood derived MAI 
isolates showed that the predominant plasmid type was the pLR-7. 
This finding is in complete agreement with the findings of several 
other groups of investigators (Crawford and Bates, 1986; Jucker and 
Falkinham, 1990; Hellyer et al., 1991). Hellyer et al. examined a 
small collection of our St. Vincent's blood isolates (953, 1516, 
1762, 4861, 6475, 8197, 8515, 15113, 10,000) and found that the 
pLR-7 type plasmid was present in 89% of these isolates whereas, 
the pLR-20 type plasmid was present in 33%. In addition, this 
investigation again substantiated the earlier findings of Hellyer 
et al. that reported pLR-20 related plasmids were almost always 
found in those strains that also carried a plasmid related to pLR- 
7. The pLR-20 plasmid was only seen in the presence of the pLR-7 
plasmid in our investigation.
The findings of Hellyer et al. served as a check on our 
plasmid isolation protocols since when we repeated their analysis 
of the above strains, we obtained the same results (Hellyer et al., 
1991) . PLR-7 type plasmids were found in 85% of the MAI isolates 
obtained from St. Vincent's Hospital and Memorial Sloan-Kettering 
Cancer Center. By contrast, only 20% of the aforementioned 
isolates showed the presence of pLR-20 type plasmids. The study of 
pLR-7 and pLR-20 type plasmid carriage in MAI performed by Hellyer 
and co-workers included British AIDS-related isolates, U.S. AIDS- 
related isolates, British non-AIDS isolates and British veterinary 
isolates. Hellyer found that 62% of his isolates carried pLR-7 
type plasmids but only 17% carried pLR-20 type isolates. A chi- 
square analysis of the distribution of plasmids among pLR-7 and 
pLR-20 types which compared the data from Hellyer's investigation 
with this investigation failed to show any statistically
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significant difference in (P>0.05) plasmid carriage. The study of 
Hellyer and co-workers noted the presence of plasmids of >150 kb in 
St. Vincent's strains 953, 1516, 1762, 4861, 6475, 8515, 10,000 and 
15113 but, I was never able to find these plasmids of >150 kb in 
the aforementioned strains.
6.16 Hybridization and Variation in p LR-7 and p LR-20 Plasmid Size 
The pLR-7 and pLR-20 plasmid types were found not to 
cross hybridize with each other as had been noted by Hellyer et al. 
(1991). It was noted in our investigation that those pLR-7 type 
plasmids which showed homology with the pLR-7 probe varied from 14 
kb to >16.2kb. An accurate measurement of supercoiled DNA was only 
possible up to the upper limit of the BRL Supercoiled DNA Ladder 
(16.2 kb) which served as the Supercoiled molecular weight 
standard. The study of Hellyer et al. found a greater variation in 
size in those plasmids showing homology with pLR-7 probe (15-30 
kb). The pLR-20 type plasmids which showed homology with the pLR- 
20 probe were found to be 13 kb which was a bit smaller than the 
14-16 kb ranged noted by Hellyer et al. Our pLR-20 plasmid, 
however, did fit within the range of 12.8 kb -15.3 kb cited for 
pVT2 type plasmids by Jucker and Falkinham (Hellyer et al., 1991; 
Jucker and Falkinham, 1990). The pLR-20 plasmid of Crawford and 
the pVT2 plasmid of Jucker and Falkinham may be closely related to 
each other (Crawford and Falkinham, 1990; Crawford, Personal 
Communication).
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6.17 Differences in pLR-7 Plasmid Carriage between U.K. and U.S.A. 
MAI Blood Isolates
There did occur major differences in the percentage of 
AIDS-derived MAI carrying pLR-7 type plasmids between the British 
blood isolates (29%) and our total St. Vincent's blood-derived 
isolates (79%) (Hellyer et al., 1991). In the British alimentary 
tract and respiratory tract, the percentage of isolates carrying 
pLR-7 type plasmids were 25% and 28% respectively. The higher 
carriage of pLR-7 type plasmids in the American isolates was also 
noted by Crawford et al. (100%) and Morris et al. (75%) (Crawford 
and Bates, 1986; Morris et al., 1990).
6.18 AIDS-related Plasmid Presence and Virulence
The literature has shown that members of the M_j_ avium. M. 
intracellulare. and M^ . scrofulaceum group or MAC organisms have 
been shown to encode functions that are involved in restriction and 
modification and mercury and copper resistance (Jucker and 
Falkinham, 1990) . For the most part, the studies that have focused 
upon the functions of plasmids such as the pLR-7 and pLR-20 type 
plasmids isolated from M^ . avium still are inconclusive at best.
The current state of knowledge concerning the presence of plasmids 
in most MAC complex organisms and their relationship to MAC 
virulence is still not clearly understood.
Section VII
The Application of Restriction Fragment Length Polymorphism
(R.F.L.P)
To
AIDS- related Mvcobacterium avium Isolates
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INTRODUCTION
7.0 Restriction Fragment Length Polymorphism Analysis
The restriction fragment length polymorphism (RFLP) 
analysis and its application to MAI complex organisms has been 
previously discussed in Section I (See paragraphs 1.6-1.8).
This section will focus upon the application of 
restriction fragment length polymorphism analysis to AIDS-related 
M. avium complex strains isolated at St. Vincent's Hospital and 
Memorial Sloan-Kettering Cancer Center.
METHODS AND MATERIALS
7.1 Isolation of Genomic DNA
A 7 day old 5ml starter culture (7H9 broth supplemented 
with 1% glycerol and 4% O.A.D.C) inoculated with IL avium cells 
grown at 37° C served as inoculum for an erlenmeyer flask containing 
20 ml of the 7H9 broth. The 20 ml aliquot of M^ _ avium cells were 
incubated at 37° C for a period of 2-3 weeks. The cells were 
exposed to 2% (w/v) glycine for a period of 48 hours prior to their 
being harvested. The cells contained within the erlenmeyer were 
pelleted by centrifugation at 11,950 x g in a Sorvall SS-34 rotor 
at 4° C for 20 min. The pellet was washed in TEN buffer (See 
Appendix I) and re-suspended into 5.0 ml TEN (McFadden et al.,
1990; Van Soolingen et al., 1991). The 5.0ml of re-suspended 
pellet was then digested with lOmg/ml of subtilisin (Sigma) for 3 
hours at 37° C which was then followed by exposure to lysozyme 
(lmg/ml; Boehringer Mannheim) for an additional 3 hours at 50° C.
SDS was then added to 1% and pronase (Calbiochem) added to 3mg/ml 
and incubated at 37° C for 24 hours, with a further addition of 
pronase (to a total of 6mg/ml) after 18 hours. The DNA was then 
extracted by multiple phenol/chloroform extraction, Ribonuclease A 
digestion and ethanol precipitation. The sample was spun down at
15,000 x g for 30 min at 4° C in a Sorvall SS-34 rotor and the 
supernate was gently removed and discarded. The resulting pellet 
was washed in 70% (v/v) ethanol and was spun in a Sorvall SS-34 
rotor at 15,000 xg for 15 min at 4° C. The supernate was gently 
removed and discarded. The remaining pellet was air dried at room 
temperature for 10 minutes. The pellet was re-suspended in 300 /Ltl 
of TE buffer and stored at -20° C.
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7.2 Boehrinaer Mannheim Column Chromatography Protocol for MAI 
Genomic DNA Isolation
The Mj. avium cells were grown and harvested in the same 
manner as cited above. The pellet was gently re-suspended in 2ml 
of the Boehringer Mannheim Solution #1 (lysis buffer) (Boehringer 
Mannheim Biochemicals , Indianapolis, Indiana, U.S.A.). An aliquot 
of 60 ill heat treated (boiled in 100° C water bath for 15 minutes) 
RNase A (See Appendix I) solution and 160 /zl of a Lysozyme (See 
Appendix I) solution was added to the tube. The tube was mixed by 
gentle inversion and incubated at 37° C for a of period 3 0 min. An 
aliquot of 100 /xl of Proteinase K solution (See Appendix I) was 
then added to the tube which was gently mixed by inversion and 
incubated for a period of 30 min at 55° C. During the proteinase K . 
incubation, a Boehringer Mannheim Column was equilibrated with 6 ml 
of Boehringer Mannheim Kit Solution #2 (Column Wash Buffer). The 
column eluate port was capped when the level of the Solution #2 or 
Column Wash Buffer was 0.5 cm above the surface of the column gel 
matrix. The Proteinase K digest or sample was then prepared.
Column was further equilibrated with 4 ml of Boehringer Mannheim 
kit Solution #2.
The 6 ml sample was added to the column with eluate port 
still capped. The sample was then pipetted back and forth through 
the column so as to cause a re-suspension of the column matrix and 
sample. The column bed was then allowed to settle for a period of 
10 min at room temperature. The column eluate port cap was then 
removed and the column flow was allowed to proceed via gravity 
flow. When the wash buffer level was 0.5 cm above the gel matrix, 
an additional aliquot of 3 ml of wash buffer was carefully layered 
onto the column so as not to disturb the gel matrix. A 10ml 
syringe was added to the top of the column and slight pressure was
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applied. When the residual of the wash buffer reach 0.5 cm above 
the gel matrix, the syringe was removed and the column was then 
primed with 0.5ml of Boehringer Mannheim Solution #3 (Column 
Elution Buffer) under gravity flow. When the primer aliquot of 
elution buffer reached 0.5 cm above the gel matrix, 2 additional 
milliliters of elution buffer were added and a 10 ml syringe was 
connected to the column. A slight pressure was applied to the 
syringe. The eluate resulting from the treatment with the elution 
buffer contained the purified Genomic DNA. The column was then 
discarded.
The column eluate (2ml) was treated with 0.5 volumes of 
isopropanol, then placed in a Sorvall SS-34 rotor and spun at 
17,200 x g for 20 min at 4° C. The supernate was carefully removed 
with a sterile pipette so as to not disturb the DNA pellet. The 
DNA pellet was then washed by adding 1.0 volume of 70% (v/v) 
ethanol and further centrifuged at 17,200 x g for a period of 20 
min at 4° C. The supernate was carefully removed so as not to 
disturb the DNA pellet. The Genomic DNA pellet was air dried for 
10 min. The Genomic DNA pellet was resuspended in 300 ill of TE 
buffer and stored at -20° C.
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7.3 Modified Oiaaen Prep For The Isolation of Genomic DNA From MAI
7.3a Mini Prep Protocol
The basic inoculum was the same as that cited in the 
preceding genomic protocols but an aliquot of 40ml aliquot of M^ _ 
avium cells were utilized rather than the 20ml previously cited for 
genomic DNA preps. The cells were then grown and harvested in the 
same manner as cited above for genomic DNA (Qiagen Inc.,
Chatsworth, California, U.S.A.).
The cells were then ready for the Qiagen procedure for 
genomic DNA isolation which differs from that utilized for plasmid 
DNA isolation. The pellet was resuspended in 1ml of Qiagen PI 
buffer (See Appendix III; Qiagen Genomic DNA Prep). The 
composition of this PI buffer utilized for genomic DNA preps 
differed from that used for plasmid DNA preps. A 1ml aliquot of 
aqueous solution of lysozyme (20mg/ml) was then added to the 
solution to give a total volume of 2 ml and a final lysozyme 
concentration of lOmg/ml. The solution was then vortexed and 
incubated at 37° C for 20 minutes. One ml of Qiagen P2 buffer (See 
Appendix III; Qiagen Genomic DNA Prep) was added to the solution 
which was then incubated for 20 min in an ice bath. The P2 buffer 
utilized in Qiagen Genomic DNA preps also differed from that 
utilized in Qiagen plasmid DNA preps. A 1ml aliquot of an aqueous 
solution of Proteinase K (40mg/ml) was added to the solution to 
give a total volume of 4ml and a final Proteinase K concentration 
of lOmg/ml. The solution was then vortexed and incubated at 50° C 
for 2 hrs. The incubation was followed by a centrifugation at
20,000 x g in a Sorvall SS-34 rotor for 15 min at 4° C. The 
supernate (lysate) was then carefully removed and saved. The 
buffers utilized for the remainder of the Qiagen Genomic DNA prep
were the standard Qiagen buffers which were routinely utilized for 
plasmid DNA preps. A Qiagen Maxi Column was equilibrated with 10 
ml of QBT buffer (See Appendix III; Qiagen Plasmid DNA Prep) . The 
lysate was loaded onto the Qiagen Maxi Column and when the lysate 
was almost absorbed into the gel matrix (0.5 cm above column gel 
matrix) the column was washed with 2 x 30ml of QC buffer (See 
Appendix III; Qiagen Plasmid DNA Prep). The column was eluted with 
15ml of QF buffer (See Appendix III; Qiagen Plasmid DNA Prep). The 
eluate was aliquoted in lOOOjttl amounts into microcentrifuge tubes 
and 500/xl of isopropanol was added per lOOO/ul aliquot of eluate.
The microcentrifuge tubes were placed into an eppendorf 
microcentrifuge (microcentrifuge held within a 4° C refrigerated 
chamber) and spun at 16,000 x g for 30 min. The supernate derived 
from the centrifugation was carefully removed and discarded. The 
genomic DNA pellets were washed in 1000/xl of 70% (v/v) ethanol by 
being spun for 30 min at 16,000 x g in an eppendorf microcentrifuge 
kept at 4° C. A single volume of 300 /xl of TE buffer was pipetted 
through all the microcentrifuge tubes that contained dried Genomic 
DNA pellet. The resuspended pooled Genomic DNA pellet was stored 
at -20° C.
7.3b Maxi Prep Protocol
The basic inoculum was the same as that cited in the 
preceding genomic protocols but an erlenmeyer flask containing 150 
ml of the 7H9 broth rather than the smaller volumes previously 
cited. In addition, the avium cells were incubated at 37° C for 
a period of 4-6 weeks under constant shaking conditions.
The cells were then grown and harvested in the same 
manner as cited previously for genomic DNA. The pellet was
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resuspended in 3ml of PI which was 1/50 volume (manufacturer's 
recommendation) of the initial 150ml culture. Lysozyme was added 
dry to the solution rather than as an aqueous concentrate. The 
final concentration of lysozyme, however, was the same as that 
cited for the Mini Prep (lOmg/ml). The solution was then treated 
in the same manner as cited for the Mini prep. Proteinase K was 
added dry to the solution rather than as an aqueous concentrate.
The final concentration of Proteinase K, however, was the same as 
that cited for the Mini Prep (lOmg/ml) . The protocol from this 
point on was the same as that cited for the Mini prep.
7.4 Check of Quality of DNA
Samples of 650-1500 ng of genomic DNA preparation 
were applied to 11 x 14 cm 0.8% agarose gels which contained 
0.5/xg/ml of ethidium bromide and were 9.68 cm in thickness.
Samples of 1320ng (66ng/jzl) Lambda Hind III fragments served as 
both molecular weight markers and an ethidium bromide intensity 
standard to be utilized to estimate the DNA concentrations of the 
genomic DNA samples in the gel. The gels were placed within a BRL 
Model H5 Horizontal Electrophoretic Tank containing IX TAE buffer 
and l.Oug/ml ethidium bromide. Electrophoretic runs were carried 
out using a BRL Model 250 Power Unit set at 50-60 Volts and run for 
3-4 hours. The gel was viewed on a 254nm transilluminator and the 
electrophoretic run photographed. Those aliquots of genomic DNA 
found displaying a band of >20 kb in size were utilized in the 
subsequent restriction digests and RFLP analyses.
7.5 pMB-22 Plasmid Prep
The pMB22 recombinant plasmid is composed of a pGEM- 
1 plasmid vector which is 3.0 kb and has a 5.4kb insert at the
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Bam HI site. The insert in pMB22 contains IS900 + flanking DNA (M^ . 
paratuberculosis) . A 4mm loopful of EL*, coli containing the pMB22 
recombinant was inoculated into 4 ml of LB broth (See Appendix IV) 
containing 25 /xg/ml of ampicillin to select for plasmid bearing 
strains and incubated overnight at 37° C. This overnight growth 
served as inocula for a 150 ml (in a 500 ml erlenmyer flask) LB 
broth batch culture (containing 25 fig/ml ampicillin) which was 
placed into a 37° C shaker bath. The A650nm reading was taken at 30 
min intervals. When the A650nin reading reached 0.9 O.D. units, 
spectinomycin was added to a final concentration of 150/xg/ml, and 
the culture was returned to the shaker bath and incubated overnight 
at 37° C. The cells were harvested in the same manner as that 
previously cited (See Section VI; 6.4). The Qiagen Maxi Plasmid 
protocol utilized for the isolation of pMB-22 remained the same as 
that cited for pJC-20 (See Section VI; 6.6, 6.6a, 6.6b).
Fifteen microliters of Qiagen Maxi Prep eluate 
PMB22 plasmid clone was digested with 2 /xl of BamHI (Boehringer 
Mannheim) and was subjected to agarose gel electrophoresis. The
5.4 kb fragment was excised from the gel and recovered by the Gene 
Clean Protocol (Section VI; 6.8c). The 5.4kb fragment was labelled 
by digoxigenin (See Section VI; 6.8d).
7.6 Specificity of the Labelled PMB-22 Probe
Fifteen microliters of Qiagen Maxi Prep eluate 
pMB22 plasmid was digested with 2 /xl of BamHI (Boehringer Mannheim; 
11 units/ml) restriction enzyme in a total volume of 20 /xl for 60 
minutes at 37° C. Five microliters of loading buffer were added to 
the 20 /xl of digest. A 25/xl aliquot of the pMB22 digest and 
several additional samples were subsequently analyzed 
electrophoretically. The additional samples analyzed were:
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a) pMB22 uncut plasmid sample which consisted of 15/xl of pMB22 
plasmid, 2/xl lOx react buffer, 3/xl of ddH20 and 5/xl of loading 
buffer; b) BRL Supercoiled DNA sample which consisted of 4/xl of 
supercoiled DNA molecular weight ladder (94ng//xl) , 2/xl 10X react 
buffer, 14 /xl T.E. buffer, 1/xl ddH20 and 5/xl loading buffer; 
c)Digoxigenin Labelled Lambda Hind III Fragments Sample which 
consisted of 15/xl Digoxigenin Labelled Hind III Fragments 
(10ng//xl) , 2/xl TE buffer, 5/xl loading buffer. The samples were 
electrophoresed and photographed in the same manner as that cited 
for pLR-7 (See Section VI; 6.8a). Southern blotting and 
hybridization were carried out using the same methodologies cited 
above (See Section VI; 6.8f, 6.8g). Non-radioactive colorimetric 
detection was carried at the enhanced detection (1:500 dilution) 
level previously cited (See Section VI; 6.8h).
7.7 Restriction Digests Of Genomic DNA
Genomic DNA (650-1500ng/130/xl) were totally digested with 
72 Units Pvu II (Boehringer Mannheim 12 Units//xl) restriction 
endonuclease and 15/xl of 10X React Buffer in a total volume of 
151/xl for a period of 3 hours at 37° C. The digests were stored 
overnight at -20° C.
7.8 Agarose Gel Electrophoresis of Genomic DNA Digests
An aliquot of 37/xl of loading buffer was added to the 
restriction digests of the Genomic DNA samples cited above. These 
samples of genomic digest were loaded onto a 1% agarose gel which 
was 11 x 14 cm, 9.68mm in thickness and contained 0.5/xg/ml ethidium 
bromide. A sample of 1250 ng/lane of digoxigenin labelled Lambda 
Hind III (10ng//xl) served as a linear molecular weight standard.
156
The gel was placed in a BRL H5 electrophoretic tank containing IX 
TAE Buffer and run at 60 Volts for 4 hours using a BRL Model 250 
Power Unit. The electrophoretic gel was viewed on a 254nm 
Transilluminator to determine the completeness of the Pvu II 
restriction digestion per genomic prep. Adequately digested 
genomic preps were seen as even smears down the gel. A 
photographic record of the agarose gel was then made.
7.9 Southern Transfer of Genomic DNA Digest
The gel was prepared for southern blotting in the same 
manner as cited above but, in the actual southern blotting 
procedure for cited MAI plasmids, I utilized a larger nylon 
membrane (11 x 14 cm) and a blotting stack of 12 BRL pads (11 x 14 
cm) and a heavier weight 500 gm weight. The Southern blot protocol 
and hybridization procedures utilized for the pMB-22 probe 
specificity check MAI Genomic DNA preps were identical to that 
cited above. The duration of the period required for non- 
radioactive/colorimetric detection of R.F.L.P. bands was slightly 
longer (3-3.5 hrs.) than that cited for the pMB-22 specificity 
check.
7.10 Restriction Fragment Length Polymorphisms R.F.L.P. Analysis
The R.F.L.P banding patterns obtained in the present 
investigation were classified according to R.F.L.P. designations 
established by McFadden and co-workers for AIDS-related M;_ avium 
complex organisms (McFadden et al., 1990).
RESULTS AND DISCUSSION
7.11 Isolation of Genomic DNA
The basic protocol as cited by McFadden et al. and Van 
Soolingen et al. did yield sufficient quantities of MAI genomic DNA 
for R.F.L.P. assays but, necessitated the use of toxic reagents 
such as phenol and chloroform as well as, generated toxic organic 
wastes that posed a. problem as concerns compliance with the new 
safety guidelines for proper handling and disposal of these 
reagents (McFadden et al., 1990; Van Soolingen et al., 1991). The 
red tape created by these new regulations, forced us to abandon 
these Chloroform/phenol based extractions in favor of genomic DNA 
isolation alternatives that did not require an organic phase 
(chloroform/phenol). These non-organic phase genomic DNA 
isolations alternatives were based upon column chromatographic 
protocols.
7.12 Boehringer Mannheim Column for Purification of Genomic DNA
The Boehringer Mannheim Column chromatographic protocol 
which was adapted to MAI complex organisms did yield pure 
restriction endonuclease grade samples of genomic DNA that were 
able to be analyzed in R.F.L.P. analyses and did show that it was 
possible to eliminate the need to utilize organic phase 
(chloroform/ phenol extraction) for genomic DNA isolation. The 
column, however, suffered from an important drawback as concerns 
its application in MAI genomic DNA isolations, namely, with the 
crude sample lysate derived from 15-20ml of 7-14 day old cultures 
of MAI, the column (syringe pressure operated) often became clogged 
producing an eluate that either showed lower yields of genomic DNA 
or a complete absence of genomic DNA. When increased operating 
pressure was applied to the syringe to overcome the effects of
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column clogging, a blowback in the column occurred. The blowback 
produced a corresponding destruction of the column gel bed.
The column clogging and the associated reductions in 
genomic DNA yields limited the usefulness of the Boehringer 
Mannheim column protocol for MAI genomic DNA isolation. The larger 
amounts of MAI genomic DNA that were needed (1250-2000ng/lane) for 
successful R.F.L.P. analysis via Southern Transfer and non­
radiometric digoxigenin /colorimetric detection could not always be 
obtained via the Boehringer Mannheim protocol. Therefore, the 
Boehringer Mannheim column system was abandoned.
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7.13 Oiaaen Column Protocol For Genomic DNA Isolation
7.13a Mini Prep Protocol
The Mini prep protocol was only utilized on a trial basis 
to determine the feasibility of Qiagen Maxi Columns for isolation 
of M_s_ avium genomic DNA (See Figure 18) . The presence of intact 
genomic DNA >20 KB seen on gel electrophoresis proved that Qiagen 
Maxi columns offered an additional column based method capable of 
isolating M^ Avium genomic DNA without the need for an organic 
phase (chloroform/phenol). In addition, the Qiagen Maxi column 
which was gravity operated, did not become clogged and had a very 
large capacity for crude DNA lysates (150-500 ml). From the 
initial success of the pilot mini prep series, it was decided that 
the Qiagen Maxi Column be utilized in all subsequent MAI genomic 
DNA isolations. It was also decided that all future Batch Culture 
Preps be 150ml aliquots (Maxi Preps) of MAI strain grown up at 4-6 
week intervals to take advantage of the greater DNA binding 
capacity of the Qiagen Maxi Column.
160
Figure 18 : Qiagen Genomic DNA Preparation.
Agarose Gel Electrophoresis (Qiagen Mini Prep)
Gel Specifics: (11 x 14 cm gel, 1.0% Agarose, 9.68mm
in Thickness )
Voltage: 60 volts 
Duration of run : 4 hrs.
Lanes 2-5 each contained 100/zl of DNA preparation. 
Lane 1: Lambda DNA Hind III markers, Lane 2: 10,002, 
Lane 3: 10,010, Lane 4: 10,011, Lane 5: 10,015,
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7.13b Maxi Prep Protocol
The Mini prep protocol demonstrated that the large 
capacity of the Qiagen Maxi Column could be utilized for MAI 
genomic DNA isolation derived from a larger biomass generated 
during the longer period of growth (4-6 weeks) thus providing 
isolations yielding higher concentrations of genomic DNA. The 
larger yields of MAI genomic DNA are extremely important especially 
when performing R.F.L.P. with the non-radioactive 
Digoxigenin/colorimetric detection which required slightly larger 
sample sizes (650-1500ng sample mycobacterial genomic DNA /lane) 
to be added to the gel than do radioactive based detection systems 
(300-1000ng sample mycobacterial genomic DNA/lane; Hampson et al.,
1989).
7.14 Quality of MAI Genomic DNA Preps
M. avium genomic DNA preparations were run 
electrophoretically on agarose gel. Those preparations found to be 
intact and >20 kb as determined against Lambda Hind III markers, 
were utilized in the subsequent restriction digests and RFLP 
analyses.
7.15 Check of the Labelled PMB-22 Probe
Specificity of the labelled probe Via Southern Blotting 
revealed a strong homology with the heavier fragment (5.4kb) at an 
anti-digoxigenin conjugate dilution of 1:500 (See Figure 19). This 
check of specificity also revealed that there did occur lesser 
homology with the parent pGEM-1 plasmid vector segment (3.0kb) of 
the Bam HI digest of plasmid clone pMB-22. This result therefore 
indicates that there did occur some degree of carryover of the 
parent plasmid vector (See Figure 19).
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Figure 19: Specificity of Labelled PMB-22 Probe.
L: • Agarose Gel Electrophoresis
Gel Specifics: (5.7 x 8.3 cm gel, 0.6% Agarose, 
4.0mm in Thickness )
Voltage:100 volts 
Duration of run : 45 min.
R: Southern Blot
Probe Conditions : pMB-22 (10 /xl probe/ 4.0 ml 
hybrid. fluid)
Detection: 1:500 dilution Anti-digoxigenin Fab
Colorimetric Visualization Interval: 2hr
R
Lane 1 (L&R): Digoxigenin-labelled Lambda DNA Hind III markers, 
Lane 2 (L&R): pMB-22 plasmid clone Bam HI digest
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Figure 20: R.F.L.P. Banding Patterns
L: . Agarose Gel Electrophoresis (Qiagen Columns)
Gel Specifics (11 x 14 cm gel, 1.0% Agarose, 9.68 mm 
in thickness)
Voltage: 60 volts.
Duration of run: 4 hrs.
R: Southern Blot
Probe Conditions: pMB-22 (10 til probe/ 4.0 ml 
hybrid, fluid)
Detection: 1:500 dilution Anti-digoxigenin Fab
Colorimetric Visualization Interval: 3 hr.
7 6 5 4 3 2 1 11
Kb
£*23 -6-6
Mf2<3
-*0.56
R
Lanes 2-7 contain 130 til of Pvu II digested genomic DNA.
Lane 1 (L&R) : Digoxigenin-labelled Lambda DNA Hind III markers,
Lane 2 (L&R): 10,002-IV, Lane 3 (L&R): 10,011,
Lane 4 (L&R): 10,011-IV, Lane 5 (L&R): 10,010,
Lane 6 (L&R): 10,010-IV, Lane 7 (L&R): 10,015-IV
7.16 Non-radioactive Detection System For R.F.L.P.
The non-radioactive digoxigenin-labelled probed linked to 
a colorimetric detecting system was sensitive enough to yield 
discernible R.F.L.P. banding patterns (See Figure 20). It was 
however necessary to add slightly larger amounts of sample genomic 
DNA digest (650-1500ng/lane) to achieve results comparable to that 
obtained by Hampson and co-workers via a 32 P radiolabelled probe 
(300-1000ng/lane)linked to an autoradiographic detection system 
(Hampson et al., 1989). Other investigators have also found that 
the non-radioactive-digoxigenin labelled probe could serve as an 
adequate substitute of radiolabelled probes in R.F.L.P analyses 
(McFadden et al., 1990). Recent refinements in the non-radioactive 
detecting systems such as chemiluminescent labelling and 
autoradiographic detection have now improved these systems to 
levels of sensitivity that are comparable to that obtained via 
radiolabelled systems.
7.17 R.F.L.P. Patterns
The data cited in Table 13 reveals that the AIDS-related 
MAI isolates from patients at St. Vincent's Hospital and Memorial- 
Sloan Kettering Cancer Center consisted of the currently known M. 
avium R.F.L.P. banding patterns.
This investigation has observed that the R.F.L.P. pattern 
most closely resembling Al occurred in 50% of the MAI isolates 
successfully analyzed. R.F.L.P. patterns A2, A3 and A/I occurred 
respectively at 25%, 12.5% and 12.5% (See Table 14).
The A/I banding pattern has been previously reported to 
occur particularly in animal derived MAI isolates and not occur in 
AIDS related MAI isolates (Kunze et al., 1991). Therefore, the 
presence of an AIDS blood isolate of MAI (SK060) having an A/1
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banding pattern is a rare and significant finding (Dr. Sheldon 
Brown, Personal Communication).
The occurrence of the Al pattern in our R.F.L.P. analyzed 
strains appeared to be seen at a lower frequency than the >70% 
occurrence seen by other investigators (Hampson et al., 1989; 
McFadden et al., 1990). Our finding is based upon a very limited 
sample derived from only two medical centers in the city of New 
York and is therefore too small to provide a reliable quantitative 
result.
Corded strain 10,011 contained numerous bands that did 
not resemble any of the known banding patterns. The 4x subcultured 
derivative 10,011-IV contained fewer bands than the original corded 
strain but, still did not resemble any of the known banding 
pattern. Given the shared number of bands between the original 
corded strain 10,011 and the 4x subcultured strain 10,011-IV as 
well as, the loss of bands seen in the subcultured variant, the 
presence of a mixed culture in the original strain would appear to 
be a viable possibility.
Table 13: R.F.L.P. Types in AIDS-Related MAI
M. avium Strain
10,002
10,010
10,011
10,015
SK015
SK016
SK024
SK037
SK060
SK069
SK095
Hospital where 
isolated
St. Vincent's 
Hospital
St. Vincent's 
Hospital
St. Vincent's 
Hospital
St. Vincent's 
Hospital
Memorial Sloan- 
Kettering Cancer 
Center
Memorial Sloan- 
Kettering Cancer 
Center*
Memorial Sloan- 
Kettering Cancer 
Center
Memorial Sloan- 
Kettering Cancer 
Center
Memorial Sloan- 
Kettering Cancer 
Center
Memorial Sloan- 
Kettering Cancer 
Center
R.F.L.P.
Type
NS*
Al
MC-
A3
Al
Al
A2
Al
A/1
ND+
A2Memorial Sloan- 
Kettering Cancer 
Center
*NS= Not successful, DNA degradation after several attempts 
+ND= not done 
"MC= mixed culture
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Table
Types
R.F.
14: Frequency of Occurrence (%) of Particular R.F.L.P.
(St. Vincent1s Hospital/ Memorial Sloan Kettering) 
L.P. Type
A6
A/1 
A2 
A3
Strains displaying 
Specific R.F.L.P. 
Type
SK015, SK016 , 
SK037,10,010
SK060
SK02 4, SK095
10,015
Frequency of 
Occurrence of 
Specific R.F.L.P. 
Type (%) Among MAI 
Strains 
Successfully 
Analyzed
50%
12.5  ^
25% 
12.5!
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7.18 R.F.L.P. Types Among Corded and Non-Corded AIDS-related MAI 
Strains
The R.F.L.P. analyses of corded strains 10,010 and 10,015 
from AIDS patients at St. Vincent*s Hospital, as well as, their 
variants that had lost cording revealed that there was conservation 
of R.F.L.P. type despite a loss in cording (See Table 15; See 
Figure 20).
The plasmid analysis of corded strain 10,011 and its lost 
cording subculture 10,011-IV had revealed differing plasmid 
profiles when reviewed in Section VI. This finding was further 
substantiated by the distinctly differing R.F.L.P. banding patterns 
for these strains seen in Figure 20. The parental strain 10,011 
contained bands both similar and also distinct from that of the 
10,011-IV subculture. In addition, there were more bands seen in 
the initial isolate and fewer in the 4x subcultured variant (See 
Figure 20) . This isolate was originally derived from an AIDS 
bacteremia, isolated on Para SL/C, and speciated biochemically and 
via GEN PROBE as M^ . avium. The presence of distinctly different 
R.F.L.P. banding patterns would support the notion of a polyclonal 
M. avium bacteremia as has been cited in the literature by Arbeit 
et al.(1992).
The experimental results obtained in this section would 
therefore indicate that the loss of MAI cording is a complex 
multifactorial mechanism which cannot be easily explained in terms 
of a simple alteration of the MAI Genomic R.F.L.P. pattern 
generated via the pMB-22 probe in a Southern DNA Fingerprinting 
motif. The significance, however, of a particular R.F.L.P. pattern 
type with respect to corded and related lost corded derivatives 
still remain unclear.
Table 15: R.F.L.P. Types in Parent and
4x Subcultured AIDS-Related MAI
M. avium Strain Hospital where R.F.L.P.
isolated Type
10,002, 10,002-IV St. Vincent1s NS*
10.010, 10,010-IV St. Vincent's Al
10.011, 10,011-IV St. Vincent's MC+
10,015, 10,015-IV St. Vincent's A3
*NS= Not successful, DNA degradation after several attempts 
+MC= mixed culture
Section VIII 
Invasion 
of HeLa Cells By 
Strains of MAI
INTRODUCTION
8.0 Bacterial Adhesion
Pathogenicity has been defined as the ability of 
microorganisms to cause disease (Arbuthnott and Smyth, 1979). With 
few exceptions, pathogenicity is rarely the property of a single 
determinant of the pathogen but rather, it is multifactorial. In 
flowing systems, such as the gastrointestinal tract, a successful 
pathogen must be able to colonise and/or penetrate the body 
surfaces, namely, the skin or mucosal epithelia of the respiratory 
tract, oropharynx, urogenital tract or conjunctiva and it must be 
capable of multiplying on or in the tissues of the host (Arbuthnott 
and Smyth, 1979; Marshall and Bitton, 1980). Thus, the outcome of 
the interaction between host and the invading microbe depends both 
on a combination of virulence factors produced by the pathogen and 
the susceptibility of the host (Arbuthnott and Smyth, 1979).
8.1 The Colonization Of The Gastrointestinal Tract By Atypical 
Mycobacteria And AIDS-related MAI
In mouse tissue, most environmental mycobacteria are of 
low pathogenicity requiring the introduction of very large numbers 
of organisms (Collins, 1988) . Of the 31 serovars making up the MAI 
complex group of organisms, less than 12 serovars are capable of 
causing progressive disease following an intragastric challenge.
A large number of the serovars making up the MAI complex, however, 
are able to colonize both nasopharyngeal and intestinal mucosa. In 
normal patient populations, as many as 30% of the patients fecal 
samples have atypical mycobacteria. In geographic areas where 
soil and water are contaminated with atypical mycobacteria, 
individuals may be repeatedly colonized by many different MAI 
serovars. Those MAI strains which do colonize the
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gastrointestinal tract could in theory be expected to infect the 
submucosal tissues and its draining lymph nodes when the normal 
host cellular defenses are depressed.
The clinical picture of AIDS-related MAI infection is one 
associated with anorexia, abdominal pain, diarrhea and 
malabsorption (Hoyt et al., 1992; Hellyer et al., 1991: Stacey,
1986). These clinical findings are thus suggestive of a disease in 
which the infection occurs by way of the gastrointestinal tract 
(Hellyer et al., 1991; Hoyt et al., 1992). In the AIDS-patient, 
colonization by a food or water borne virulent serovar MAI complex 
organisms would initiate the chain of events leading to the 
terminal form of MAI infection (Collins, 1988; Okello et al.,
1990). The main evidence for this hypothesis is that there occurs 
extensive infection of the lower gastrointestinal tract in some 
patients with AIDS and the concurrent isolation of IL avium complex 
organisms from stool and blood in many other AIDS patients (Okello 
et al., 1990). The role of JL avium-intracellulare complex 
organisms in causing diarrhea has still not been established but, a 
causative or contributory role for producing the diarrhea has been 
suspected because of the presence in some AIDS patients, of large 
numbers of mycobacteria in stool and mucosal samples from the small 
intestine (Smith et al, 1992). Positive MAI isolates from stool 
are thought to reflect either MAI colonization or gastrointestinal 
disease (Hoyt et al., 1992). Stacey noted that in 3 of 5 AIDS 
patients, the presence of disseminated MAI was first seen by the 
presence of acid-alcohol fast bacteria in fecal smears (Stacey, 
1986). In 6 additional AIDS patients, however, Stacey noted that 
no clinical or pathological evidence of dissemination was found and 
he thus proposed this as evidence in support of the theory that the
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gastrointestinal tract is a portal of entry for MAI (Stacey, 1986).
8.2 In Vitro Models for Determining MAI Uptake
8.2a Macrophage and Monocvte Models
Crowle and co-workers cultured normal human macrophages 
in the presence of M_s_ avium and found that the uptake and 
replication of a variety of Mj. avium strains could be measured by 
colony forming unit (C.F.U.) counts of the mycobacteria resulting 
from lysis of the M^ avium infected macrophages exposed to 
sonication (Crowle et al., 1986). In addition, Crowle and 
associates noted that the microscopic counts of acid-alcohol fast 
bacilli were not useful because the organisms which multiplied 
inside the macrophages were usually not acid-alcohol fast. When 
Crowle et al. utilized electron microscopy, however, the 
intracellular bacilli were observed to be undergoing transverse 
fission and were surrounded in individual vacuoles by a broad 
electronlucent zone and possessed cell walls which were thinner 
than extracellular cultivated Mj. avium. In the Crowle 
investigation, 15 strains of M^ . avium (serovars: 1, 2, 3, 4, 8 and 
9) examined were derived from patients with nontuberculous 
granulomatous infection, HIV, unrelated problems, or laboratory 
reference isolates. Phagocytosis of the mycobacteria by the 
macrophages did not differ between lab strains and patient strains 
but, there did occur a difference in the ability of strains to 
replicate within the macrophage. The laboratory derived strains of 
MAI were termed virulent because they were able to replicate within 
the macrophage. The laboratory strains of MAI were termed 
avirulent because they did not replicate within the macrophage.
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The virulent patient isolates could be compared with other patient 
isolates by intracellular replication rates.
The intracellular replication of MAI was further 
investigated by Stokes and Collins using mouse macrophages (Stokes 
and Collins, 1988). Macrophages were derived from MAI susceptible 
but, BCG infected mouse strain C57BL/6, and inbred MAI resistant 
mouse strain A/J which was not BCG infected. The BCG infected MAI 
susceptible macrophage strain C57BL/6 strains was better able to 
control the intracellular MAI replication than was the MAI 
resistant BCG uninfected inbred strain A/J. This investigation 
revealed that resistance to intracellular growth of MAI could be 
acquired.
An in vitro model for MAI pathogenicity which utilized 
normal human peripheral blood monocytes was employed by Toba et 
al.(1989). In Toba's investigation twelve strains of MAI complex 
organisms ( 7 non-AIDS isolates and 5 AIDS-related isolates) were 
used to obtain an in vitro infection of the monocytes. The 
monocyte model measured mycobacterial uptake and intracellular 
replication via a microscopic count of the alcohol-acid fast 
bacilli and the C.F.U. of mycobacteria, respectively, in lysed 
monocytes. The CFU count obtained from the 5 AIDS-related MAI 
strains revealed that only in one of the AIDS-associated strains of 
MAI had intracellular mycobacterial replication occurred. Among 
the non-AIDS-derived MAI strains, intracellular replication had 
occurred in 2 of the 7 strains. Further investigations with the 
monocyte model by Toba and co-workers revealed that pre-treatment 
of the monocytes with gamma interferon prior to infection with MAI 
(AIDS and Non-AIDS strains) brought about a decrease in 
phagocytosis but, had no effect on intracellular replication of M. 
avium organisms. From this investigation with gamma interferon
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pre-treatment, it was concluded that most strains of MAI do not 
multiply within monocytes from healthy individuals and that gamma 
interferon pretreatment does not have macrophage activating factor 
activity for MAI infection in human monocytes.
Shiratsuchi et al. (1990) carried out in vitro studies 
with normal human peripheral blood monocytes which were precultured 
for 2 days before MAI infection. The 13 MAI strains which were 
utilized to infect the monocytes were derived from AIDS and Non- 
AIDS strains (six AIDS-related MAI strains, 3 Non-AIDS-related MAI 
strains and 4 MAI strains selected on the basis of colonial 
morphology). The MAI uptake by the monocytes detected by counting 
intracellular acid-fast bacilli was found to differ according to 
colonial morphology. The MAI strains displaying round and opaque 
colonies were found to be phagocytosed more readily than those MAI 
strains with flat colonies. Shiratsuchi et al. noted that virulence 
defined as intracellular growth was also partly associated with 
colonial morphology. There did, however, occur exceptions in which 
some strains with flat colonial morphology did possess the capacity 
to multiply within normal human monocytes but, some round opaque 
strain did not possess the capacity to multiply within normal human 
monocytes.
The effects of gamma interferon and alpha/2A interferon 
upon monocytes and macrophages were further investigated by 
Blanchard and co-workers (Blanchard et al., 1991). This new 
investigation utilized a rapid radiolabel assay ([2-3H] glycerol) 
with monocytes obtained from normal human peripheral blood, 4- day 
cultured derived and matched monocyte cultures. The application of 
the radiolabel assay to normal fresh human peripheral blood 
monocytes resulted in the finding that these cells were able to 
kill 40-92% of inoculated MAI (laboratory strains; serovar 8). The
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bactericidal activity was however, found to be significantly lower 
in 4-day old culture-derived macrophages which were compared with 
matched monocyte cultures. When gamma interferon was added to the 
fresh monocytes, there was a corresponding inhibition of 
bactericidal activity. The experiments with culture-derived 
macrophages found that pretreatment of culture-derived macrophages 
with gamma-interferon did not enhance either MAI intracellular 
survival or growth. Results similar to that obtained with gamma- 
interferon for monocytes and cultured macrophages were obtained 
with alpha/A2 interferon. From these studies, Blanchard and co­
workers concluded that the innate efficiency of mycobacterial 
killing by monocytes can be down-regulated by interferon but, 
macrophages are not significantly affected.
Meylan and co-workers tested whether in vitro infection 
of macrophages with either HIV or mycobacteria would influence the 
replication of the other pathogen (Meylan et al.,1992). In this 
protocol, the macrophages were infected sequentially with the 
macrophage-tropic isolate HTLV-IIIBa_L/85 and HU. tuberculosis H37Rv 
or M. avium. The intracellular growth of mycobacteria was measured 
by colony counting and radiometric assay of macrophage lysates and 
the replication of HIV by the release of p24 antigen into the 
culture supernates. The phagocytosis and intracellular growth of 
the mycobacteria was similar in HIV-infected macrophages and 
controls. Mycobacteria were found not to affect the replication of 
HIV in macrophages. The ultimate result of these studies was the 
failure to find any direct intracellular interaction between HIV 
and mycobacteria in cultured macrophages that would explain the 
increased rate of mycobacterial diseases in patients infected with 
HIV or that would support a hypothesis that mycobacterial infection
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of macrophages can intrinsically enhance HIV replication in these 
cells.
In an effort to improve the efficacy of the macrophage 
model systems vis a vis their application to macrophage virulent 
strains of MAI, Straub and co-workers have developed a 
miniaturization of the conventional macrophage system (Straub et 
al. ,1990). The standard conventional macrophage assay required 106- 
107 cells/ well (each well required 1-1.5ml of media) and needed 
numerous 35 or 100ml petri dishes which in turn required 60-70 
mice. The miniaturized system by contrast, utilized microtiter 
plates into which were placed 105 macrophages/we11 (each well 
contained 200 /xl volume of media) and permitted an entire assay to 
be performed within a 96 well plate and in turn required only 10 
mice. This has proved to be a useful means of selecting human 
derived isolates of MAI in patients with pulmonary MAI disease 
based upon the ability of the MAI to infect and multiply within 
cultured mouse pulmonary alveolar macrophages.
8.2b Human Intestinal Epithelial Model
When the focus of AIDS-related MAI occurs within the 
gastrointestinal tract, there is colonization of the columnar 
epithelial layer with subsequent invasion of the layer and 
underlying tissue (Arbuthnott and Smyth, 1979; Marshall and Bitton, 
1980). To study the invasion of gastrointestinal epithelial cells, 
models relying on epithelial or epithelial-like tissue culture 
systems rather than macrophage or monocyte tissue culture systems 
would provide a more relevant model.
Mapother and Songer (1984) examined the interaction of 
the pathogen M^ . avium and the saprophytes M^ _ phlei and Mj_ smeomatis 
with human intestinal epithelial cells in vitro to determine the
invasiveness of these mycobacteria. The human intestinal 
epithelial cell monolayers were inoculated with cultures of M. 
avium (serovars 2, 8, 10) that were viable, autoclaved, formalin 
killed, exposed to UV light or suspended in anti-M. avium serovar 2 
serum. A parallel series of human intestinal cell monolayers were 
exposed to the aforementioned mycobacterial saprophytes. In 
addition, the effects of four reagents known to block phagocytosis 
or endocytosis (cytochalasin B, dibutyryl cyclic adenosine 
monophosphate, iodoacetate, and 2,4-dinitrophenol) on the 
mycobacterial -intestinal epithelial interaction were also studied.
A maximal uptake of avium pathogenic mycobacteria by the human 
intestinal epithelial cell monolayer was achieved after 2- 3 hours 
of incubation at 37° C. The M^ _ avium cells belonging to serovar 2 
were found to be taken up in greater quantity than either serovar 8 
or 10. Neither of the saprophytes examined (i.e. IL phlei, M. 
smegmatis) were found to attach or penetrate the human intestinal 
epithelial cell monolayers. Only viable M^ _ avium mycobacterial 
cells were ingested by the intestinal monolayer whereas, non-viable 
M. avium cells were not. The pre-treatment of the human intestinal 
epithelial monolayer by the phagocytotic or endocytotic reagents 
cited above did indeed bring about a diminished uptake of the M. 
avium cells thus suggesting that the apparatus of uptake is an 
endocytic process which is induced by virulent mycobacteria.
8.2c HeLa Cell Model
The use of macrophage, monocyte and human intestinal 
epithelial monolayer tissue culture systems all suffer from three 
basic shortcomings, namely, availability, cost and viability of the 
cell line in vitro. Therefore, a cell culture system which is less 
costly, more readily obtainable (i.e. commercially available) and
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are easily maintained in vitro would be more advantageous to use 
than those cell culture systems cited above.
Riley has successfully utilized a HeLa Cell Model to 
study patterns of attachment of EU. coli (Riley, 1988). The Riley 
model for E_s_ coli attachment required HeLa Cells to be suspended 
and diluted to 1-2 x 105 cells/ml in growth medium, and 1.5ml of the 
suspension be added per well of a 24 polystyrene culture plate.
The cells were incubated at 37° C in an atmosphere of C02 until the 
HeLa Cells covered 50% of the bottom of each well. The media per 
well was then replaced with 0.5% mannose (without antibiotics) as 
means to prevent nonspecific binding by E_s_ coli. Finally, each of 
the wells was exposed to 0.1ml of overnight growth of coli and 
incubated for 3 hr at 37° C. The media was then removed and the 
infected cells of the monolayer were washed 6X with P.B.S. (pH 7.4) 
and fixed with methanol for 5 min. The monolayer was subsequently 
stained with Giemsa stain, washed with distilled H20 and dried. The 
wells containing the infected monolayers were then viewed under an 
inverted light microscope for patterns of bacterial attachment.
The application of a HeLa Cell model for mycobacterial 
virulence was cited in the investigations conducted by Clark and 
Forrest in the 1950's (Clark and Forrest, 1959). Cultivation of 
tuberculous and non-tuberculous strains in vitro using the HeLa 
Cell model permitted Clark and Forrest to observe differences vis a 
vis the ability of tuberculous and non-tuberculous strains to grow 
within the HeLa cells. The non-tuberculous or atypical strains 
grew rapidly enough within the HeLa cells to permit cultures to be 
read in three days.
Given the fact that AIDS-related M;. avium infection is 
found in a diversity of organs, it is reasonable to state that 
these organisms first associate and subsequently penetrate an
epithelial layer of cells before reaching the internal regions of 
the target organ. HeLa Cells have epithelial cell characteristics 
and could be used to indicate virulence as a function of 
invasiveness.
MATERIALS AND METHODS
8.3 MAI Strains
The MAI strains utilized for the HeLa Cell Invasion study 
were noncorded strains (SK015, SK016, SK024, SK037, SK060, SK069, 
SK090, SK095), corded strains (10,002, 10,010, 10,011, 10,015) and 
the lost cording strains (10,002-IV, 10,010-IV, 10,011-IV, 10,015- 
IV) .
8.4 MAI Cultivation
A 4mm loopful of MAI strain was inoculated into a 5.0 ml 
tube of Middlebrook 7H9 broth supplemented with 2% glycerol and 4% 
O.A.D.C and incubated for 7 days at 37° C. This growth served as 
inoculum for infected HeLa Cells (cited below).
8.5 HeLa Model for Determining M. avium complex Invasion
8.5a Light Microscopy
Sterile tissue culture media (Eagles Minimum Essential 
Medium (MEM); without antibiotics) and 10% Fetal Calf Serum 
(F.C.S.) was added to tissue culture wells (24 well polystyrene 
culture plate) in aliquots of 1.0 ml. To these wells were added 
HeLa Cells ( final concentration: 1-2 x 105 cells/ml/) followed by 
cover slips. One control well contained MEM plus F.C.S. without 
HeLa Cells. The cells were incubated at 37° C in an atmosphere of 
C02 until the HeLa Cells covered 50% of the bottom of each well.
The MEM media per well was then replaced with fresh sterile MEM 
media (without antibiotics). Finally, each of the wells were 
exposed to 0.1ml of 7 day old Middlebrook 7H9 broth culture which 
contained MAI growth (cited above) of IL avium (a ratio of 100 MAI 
Colony forming units/ HeLa Cell) for 24, 48, 72 and 96 hours at
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37° C. The media was then removed, and the infected cells of the 
monolayers were washed 3X with sterile P.B.S. (pH 7.4). The cover 
slips containing the infected monolayers were removed and fixed in 
concentrated methanol for 20 min. The cover slips containing the 
infected monolayers were subsequently stained via the Kinyoun Acid 
Alcohol Fast stain procedure (Modified from; Riley, 1988). The 
aforementioned cover slips were then viewed via light microscopy 
at 400X and 1000X Oil Immersion. The degree of invasion or 
association of MAI to the HeLa Cell was quantified by a number 
ranging from 0-3 (0= 0 organisms/1000 cells; 1= <1 organism/oil 
immersion field (5-10 cells) (non-invasive)): 2= 1 or more 
organism/ oil immersion field (5-10 cells) (invasive); 3= 1 or more 
organism/cell (invasive)).
8.5b Electron Microscopy
Sterile tissue culture media (Eagles Minimum Essential 
Medium (MEM); without antibiotics) and 10% Fetal Calf Serum 
(F.C.S.) was added to tissue culture wells (24 well polystyrene 
culture plate) in aliquots of 1.0 ml. To these wells were added 
HeLa Cells ( final concentration: 1-2 x 105 cells/ml/). One control 
well contained MEM plus F.C.S. without HeLa Cells. The cells were 
incubated at 37° C in an atmosphere of C02 until the HeLa Cells 
covered 50% of the bottom of each well. The MEM media per well was 
then replaced with fresh sterile MEM media (without antibiotics). 
Finally, each of the wells were exposed to 0.1ml of 7 day old 
Middlebrook 7H9 broth culture which contained MAI growth (cited 
above) of avium (a ratio of 100 MAI Colony forming units/ HeLa 
Cell) for 48 hours at 37° C. The media was then removed, and the 
infected cells of the monolayers were washed 3X with sterile P.B.S. 
(pH 7.4). The MAI infected monolayers from each were aseptically
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pipetted into separate microcentrifuge tubes. The microcentrifuge 
tubes were spun at 11,950 xg at a temperature of 4° C in a Sorvall 
RC-2B High Speed Centrifuge using an SS-34 Sorvall rotor fitted 
with microtube adaptors for 15 min. The resulting supernates 
generated from centrifugation were carefully removed and discarded. 
The resulting pellet was fixed 2x in 2.5% (v/v) buffered ( in 0.2M 
Phosphate Buffer pH=7.3) glutaraldehyde (2 hours required for each 
fixation). The cells were again spun at 11,950 xg for 10 min and 
the resulting supernates carefully removed and discarded. The 
monolayer pellet was then washed IX in PBS and spun at 11,950 xg 
for 10 min and the supernates were carefully aspirated off and 
discarded. The monolayer pellet was then treated with 4% buffered 
( 0.2M Phosphate buffer pH=7.3) Osmium tetroxide for 30 min at room 
temperature. The monolayer was again spun at 11,950 xg for 10 min 
and supernates carefully withdrawn and discarded. The pellets were 
passed through increasing concentrations of ethanol (30%, 50%, 75%, 
95%, 95%, 100%, 100%) at intervals of 10 mins per specified 
concentration of ethanol to achieve dehydration of the pellet. The 
final supernates of 100% ethanol were carefully aspirated off, and 
the pellets were first transferred to electron microscopic 
embedding capsules. The pellets were then exposed to concentrated 
propylene oxide (at room temperature) for a period of 30 min. The 
propylene oxide was carefully aspirated off and the pellets were 
then infiltrated with a 60% : 40% ratio of propylene oxide : spur 
(embedding plastic) for 30 min. The infiltrating fluid (60:40) was 
aspirated off and replaced with a second infiltrating fluid 
consisting of 30% (propylene oxide) : 70% (spur) for an additional 
time interval of 30 mins. Finally, the latter infiltrating fluid 
was aspirated and replaced by 100% spur. The 100% spur was placed 
within a 60-70° C oven overnight to achieve polymerization of the
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spur embedding plastic. The polymerized plastics were then 
sectioned on an LKB ultromicrotome at a thickness of 700-900 
Angstroms (silver/gold interface). The sections were mounted on 
copper grids and first stained for 10 mins. in uranyl acetate 
followed by 3 mins lead nitrate. The sections were viewed on a 
Zeiss Model E.M. 9S2 Electron Microscope at a magnification of 
4,500x (Modified from; Mokotoff, 1978).
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RESULTS AND DISCUSSION
8.6 HeLa Model for Determining M. avium complex Invasion
8.6a Light Microscopy
Figure 21 shows a light microscopic view of a HeLa Cell 
monolayer displaying non-invasion by fL avium SK037 as seen by the 
absence of intracellular acid-alcohol fast bacilli. By contrast, 
figure 22 shows a light microscopic view of a HeLa monolayer 
showing invasion by M^ . intracellulare SK069 as seen by the 
abundance of intracellular acid-alcohol fast bacilli. The presence 
of intracellular forms in figure 22 was confirmed by electron 
microscopy (See Figure 23). Other strains of MAI were also 
analyzed via light microscopy using the HeLa Cell protocol. These 
subsequent analyses yielded results that indicated a variety of 
indices of invasiveness (See Table 16). Initial studies indicated 
that an incubation period of 48 hours provided an adequate 
incubation time for the invasion of HeLa Cells by M_j_ avium bacilli.
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Figure 21: Hela cell monolayer flight microscopy).
A Light Microscopic View of a HeLa cell Monolayer 
showing Non-Invasion by M_j_ avium strain SK037 as seen by 
an absence of intracellular acid-alcohol fast 
mycobacteria. Magnification: 400x (Microscopic 
Magnif ication)
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Figure 22: Hela cell monolaver flight microscopy).
A Light Microscopic View of a HeLa Cell Monolayer 
showing invasion by M;. intracellulare strain SK069 as 
seen by an abundance of intracellular acid-alcohol fast 
mycobacteria. Magnification: 400x (Microscopic 
Magnification).
Table 16: Association of MAI Organisms to HeLa Cells
Strain Invasion
Index
pLR-7
plasmid
Present
pLR-20
plasmid
Present
R.F.L.P
Type
10,002
(c)a
3 — — NS*
10,002IV 
(lc)b
3 — — NS
10,010
(c)
1 + — A1
10,010IV
(lc)
3 + ■ — A1
10,011
(c)
3 + — +MC
10,011IV
(lc)
3 + + MC
10,015
(c)
2 — — A3
10,015IV 
(lc)
3 — — A3
SK015 
(nc)c
1 + — A1
SK016
(nc)
2 + — A1
SK024
(nc)
3 + — A2
SK037
(nc)
1 + + A1
SK060
(nc)
3 + — A/1
SK069
(nc)
2 + — ND**
SK090
(nc)
0 + — ND
SK095
(nc)
2 + — A2
(c)a= corded; (lc)b= lost cording : (nc)c= non-corded
NS*= Not successful, DNA degradation after several attempts
ND**=not done ; MC+=Mixed culture
Invasion index number: 0= 0 organisms/1000 cells; 1= <1
organism/oil immersion field (5-10 cells) (non-invasive):
2= 1 or more organisms/oil immersion field (in 5-10 cells) 
(invasive); 3= 1 or more organisms/cell (invasive).
8.6b Electron Microscopy
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8.6b Electron Microscopy
Electron microscopy of these HeLa Cell infected by 
M. intracellulare strain SK069 revealed that these bacterial cells 
were intracellular and were surrounded by an electron-transparent 
zone (See Figure: 23) . The presence of this electron-transparent 
zone surrounding a mycobacteria located inside a phagocytic vacuole 
has been observed by other investigators (Draper and Rees, 1970). 
Draper and Rees suggested that the production of this inert and 
mechanically protective zone could perhaps explain why many 
mycobacterial pathogens are resistant to killing by phagocytic 
cells.
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Figure 23: Hela cell monolayer (electron microscopy).
An Electron Microscopic View of HeLa Cell 
showing invasion of cell by M^ . intracellulare strain 
SK069. Magnification: 4,500x (Microscopic 
Magnification).
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8.7 HeLa Invasiveness Vis a Vis Cording. Loss of Cording. Non- 
Cording. Plasmids and R F L P Type
The loss of MAI cording did not correspond with a 
diminished index of invasiveness. In one case the parental corded 
strain (10,002) and subcultured derivative(10,002-IV) had the same 
index of invasiveness. In another case the corded parental strains 
(10,010, 10,015) had lower indices of invasiveness than the 
subcultured derivatives (10,010-IV, 10,015-IV). The total absence 
(strain 10,015), unique presence of pLR-7 (strain SK090) or the 
presence of both the pLR-7 and pLR-20 types of plasmids (strain 
SK037) appeared not to be indicative of a heightened index or 
invasiveness as can be seen in Table 16. The small sampling of 
R.F.L.P. types analyzed and cited in Table 16 does not permit a 
direct correlation between R.F.L.P. type and a heightened index of 
invasiveness. There were numerous examples, of strains differing 
in one or more of the variables cited above which were either 
hyperinvasive, hypoinvasive or noninvasive.
From the results obtained it would appear that virulence 
as measured by the ability of a particular strain of MAI to invade 
HeLa Cells involved much more intricate genetic machinery than 
variations with respect to cording, plasmids and R.F.L.P type.
8.8 Invasion Of The Gastrointestinal Epithelium by MAI And The HeLa 
Cell Model
The incidence of disseminated MAI infection among AIDS 
patient is high with antemortem rates varying between 17%-30% 
(Hopewell et al., 1992). Due to the wide variety of manifestations 
of the HIV viral infection, the simultaneous presence of 
opportunistic infections, neoplasms, and the toxicities and adverse 
reactions from numerous medications utilized for treatment, it is
difficult to assess the impact of MAI disease on the clinical 
status, survival or longevity of patients suffering from the AIDS 
Syndrome. What is, however, quite clear from a 1989 Centers for 
Disease Control study is that those patients with MAI appeared to 
have a significantly shortened life expectancy. The present 
situation as concerns AIDS-related MAI is made even gloomier by the 
fact that no large-scale studies have yet proven that chemotherapy 
for MAI infection reduces morbidity or mortality (Hopewell et al., 
1992). Recent clinical data cited by several groups of 
investigators (Hoyt et al., 1992; Hellyer, et al., 1991; Okello et 
al., 1990; Collins, 1988; Stacey, 1986) would support the theory 
that the gastrointestinal tract is the portal of entry of MAI.
Thus, when speaking of an infection of the gastrointestinal tract 
wherein M^ _ avium complex infection involves the colonisation and 
subsequent invasion of columnar epithelial tissue, an in vitro 
model system focusing upon an association and invasion of an 
intestinal epithelial monolayer or epithelial-like monolayer would 
be a relevant model as relates to gastrointestinal tract virulence.
The application of HeLa cells which are well 
characterized, have epithelial characteristics and are readily 
available, to study the invasive capacity of MAI strains derived 
from AIDS patient isolates of M;. avium complex has demonstrated 
that all strains are not equal with respect to their invasive 
capacity (See Table: 23). The finding of inequality as it relates 
to AIDS-related M_j_ avium complex invasiveness of HeLa Cells in this 
investigation with AIDS-related Mj. avium complex organisms echoes 
those results obtained by Clark and Forrest 33 years ago with Non- 
AIDS-related tuberculous and nontuberculous strains. Thus, the 
HeLa Cell Model is a useful model which can be applied to study
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invasiveness and related virulence factors (Clark and Forrest,
1959).
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APPENDIX I: General Stock Solutions
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General Stock Solutions:
0.5M EDTA (pH 8.0)
Add 93.05 g of disodium ethylene tetraacetate 2H20 to 400 ml of
ddH20. Stir on a magnetic stirrer. Adjust the pH to 8.0 with NaOH.
Autoclave for 15min at 1.0kg/cm2.
Ethidium bromide (50/ig/ml)
Add 5mg of ethidium bromide to 100 ml of ddH20. Store within a dark 
bottle at 4° C.
Glycine 20% (w/v)
Add 20 g of glycine to 50 ml of ddH20 and bring volume up to 100ml.
Autoclave for 15min at 1.0kg/cm2.
10% (w/v) N-Lauroylsarcosine
Add 20 g of N-Lauroylsarcosine to a final volume of 200ml of ddH20. 
Autoclave for 15min at 1.0kg/cm2.
Lysozyme
Add 50mg/ml of ddH20. Filter sterilize on a 0.22um Corning filter. 
Dispense into aliquots and store at -20° C.
1 M MgCl2
Add 20.3g of MaCl2.6H20 to a final volume of 100ml ddH20. Autoclave 
for 15min at 1.0kg/cm2.
5 N NaCl
Add 292.2g of NaCl in a final volume of 1.0 liter of ddH20.
10 N NaOH
Add 200 g of NaOH in 450ml of ddH20. Adjust the volume to 500ml 
with ddH20.
Proteinase K
Add 20mg/ml of ddH20. Filter sterilize on a 0.22/m Corning filter. 
Dispense into aliquots and store at -20° C.
RNase Free of DNase
Dissolve pancreatic RNase (RNase A) at a concentration of lOmg/ml 
in TE buffer and heating for 10 min at 70° C inactive DNase, 
followed by slow cooling to room temperature. Dispense in aliquots 
and store at -20° C.
Sample loading buffer 
Glycerol 5ml
Na2EDTA. 2H20 0.37g
SDS O.lg
Bromophenol 0.0lg
blue
Adjust the volume to 10ml with ddH20.
10% (w/v) SDS (Sodium dodecyl sulphate).
Dissolve lOOg of SDS in 900ml of ddH20. Heat to 68° C to facilitate
dissolution. Adjust the pH to 7.2 by adding a few drops of conc.
HC1. Adjust the volume to a liter.
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2OX SSC
Dissolve 87•65g of NaCl and 44.lg sodium citrate in 400ml of ddH20. 
Adjust pH to 7.0 with a few drops of ION NaOH. Adjust the volume 
to 500 ml. Autoclave for 15min at 1.0kg/cm2.
5OX TAE 
To make 500ml:
Tris base 242g 
glacial 57.1ml 
acetic 
acid
0.5M EDTA 100ml 
(PH 8.)
Autoclave for 15 min at 1.0kg/cm2.
Tris 1M, pH 7.5:
To make 500ml: 
dd H20 400ml v
Tris base 60.55g 
HCl(conc) 32.5ml
Ajust the pH with additional concentrated HC1 until pH 7.5 is 
reached. Bring the volume to 500ml with ddH20. Autoclave for 15 
min at 1.0 kg/cm2.
Tris 1M, pH 8.0:
To make 500ml: 
ddH20 400ml
Tris base 60.55g 
HCl(conc) 21ml
Adjust the pH with additional concentrated HC1 until pH 7.5 is 
obtained.
Bring the volume to 500ml with ddH20. Autoclave for 15 min at 1.0 
kg/cm2.
Tris 2M, pH 8.0:
To make 500ml: 
ddH20 400ml
Tris base 121.lg 
HCl(conc) 21ml
Adjust the pH with additioanl concentrated HCl until pH 8.0 is 
obtained. Bring the volume to 500ml with ddH20. Autoclave for 15 
min at 1.0 kg/cm2.
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Tris 1M, pH 9.5:
To make 500ml: 
ddH20 400ml
Tris base 60.55g 
HCl(conc) 10ml
Adjust the pH with additional concentrated HC1 until pH 9.5 is 
obtained. Bring the volume to 50ml with ddH20. Autoclave for 15 
min at 1.0 kg/cm2.
TE (pH 8.0)
To make 250ml:
lOmM Tris-HCl (pH 8.0) 2.5ml of 1.0M Tris-HCl (pH8)
lmM EDTA (pH 8.0) 0.5ml of 0.5M EDTA (pH8)
Bring volume up to 250ml with ddH20. Sterilize by filtration 
through a Corning 0.22 /ra pore size filter membrane.
TEN (pH 8.0)
To make 250ml:
50mM Tris-HCl (pH 8.0) 12.5ml of 1.0M Tris-HCl (pH8)
150mM NaCl 7.5ml of 5.0M NaCl
lOOmM EDTA (pH 8.0) 50.0ml of 0.5M EDTA (pH8)
Bring volume up to 250ml with ddH20. Sterilize by filtration 
through a Corning 0.22 /tm pore size filter membrane.
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Solutions for Boehringer Mannheim Genius Kit
Labeling solutions
0.2M EDTA (pH 8.0)
To make 250ml:
0.2M EDTA (pH8.0) 100 ml of 0.5M EDTA Stock
ddH20 150ml
Sterilize on a Corning 0.22 /zm pore size filter membrane. 
4M LiCl
Add 84.78 g of LiCl to a final volume of 500ml of ddH20. 
for 15 min at 1.0kg/cm2.
lOmM Tris-HCl, ImM EDTA, 0.1% SDS 
To make 250ml:
lOmM Tris-HCl (pH 8.0) 2.5ml of 1.0M Tris-HCl(pH8)
ImM EDTA (pH 8.0) 0.5ml of 0.5M EDTA (pH8)
0.1% SDS 2.5ml of 10% SDS
Bring volume up to 250ml with dd H20.
Sterilize on a Corning 0.22/zm pore size filter membrane.
Denaturation Solution 
1.5M NaCl and 0.5M NaOH 
To make 200ml:
1.5M NaCl 60ml of 5.ON NaCl
0.5M NaOH 10ml of 10N NaOH
Bring volume up to 200ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane.
Neutralization buffer 
1M Tris-HCl (pH8.0) and 1.5MNaCl.
To make 200ml:
1.0M Tris-HCl (pH8.0) 100ml of 2M Tris-HCl (pH8.0)
1.5M NaCl 60ml of 5.0NNaCl.
Bring volume up to 200ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane.
DNA Transfer Solutions 
2X SSC
To make 200ml:
2X SSC 20ml of 20X SSC
Bring up volume to 200ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane. 
6X SSC
To make 200ml
6X SSC 60ml of 20X SSC
Bring up volume to 200ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane.
10X SSC 
To make 200ml:
10X SSC 100ml of 20X SSC
Bring up volume to 200ml with ddH20.
Autoclave
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Sterilize on a Corning 0.22/zm pore size filter membrane.
Hybridization Solution:
To make 100ml:
5X SSC 25ml of 20X SSC
0.1% N-lauroylsarcosine 1ml of 10% N-lauroylsarcosine 
0.02% SDS 0.2ml 10% SDS
Bring up volume to 100ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane.
Heat to 50-70°C for 1 hr prior to use and add l%(w/v) of Boehringer 
Mannheim Blocking Reagent (Vial 11).
Solutions for Stringency Washes:
2X SSC, 0.1% SDS
To make 100ml
2X SSC 10ml of 2OX SSC
0.1%SDS 1ml of 10% SDS
Bring volume up to 100ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane.
Solutions for probe DNA Detection:
(Buffer #1)
lOOmM Tris-HCl; 150mM NaCl; pH 7.5 
To make 250ml
lOOmM Tris-HCl (pH7.5) 25ml of 1.0M Tris-HCl (pH7.5)
150mM NaCl 7.5ml of 5.0M NaCl
Bring volume up to 250ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane.
(Buffer #2)
lOOmM Tris-HCl; 150mM NaCl; pH 7.5; 0.5% (w/v) Blocking Reagent.
To make 250ml
lOOmM Tris-HCl (pH7.5) 25ml of 1.0M Tris-HCl (pH7.5)
150mM NaCl 7.5ml of 5.0M NaCl
Bring volume up to 250ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane.
Heat to 50-70°C for 1 hr prior to use and add 0.5%(w/v) of 
Boehringer Mannheim Blocking Reagent (Vial 11).
(Buffer #3)
lOOmM Tris-HCl; lOOmM NaCl; 50mM MgCl2; pH 9.5.
To make 250ml:
lOOmM Tris-HCl(pH9.5) 25ml of 1.0M Tris-HCl pH 9.5
lOOmM NaCl 5ml of of 5.0M NaCl
50mM MgCl2 12.5ml of MgCl2
Bring volume up to 250ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane.
Detect Color Solution (freshly prepared)
45 /zl Boehringer Mannheim NBT solution (vial 9)
35 /zl Boehringer Mannheim X-phosphate solution (vial 10) 
10ml Buffer #3
(Buffer #4)
lOmM Tris-HCl; ImM EDTA; pH 8.0 
To make 250ml:
lOmM Tris-HCl (pH8.0) 2.5ml of 1.0M Tris-HCl (pH 8.
ImM EDTA 0.5ml of 0.5M EDTA
Bring volume up to 250ml with ddH20.
Sterilize on a Corning 0.22/zm pore size filter membrane
APPENDIX III: Solutions for Qiagen Column Kits
Solutions for Qiagen Column Kits
Solutions for Qiagen Genomic DNA Prep
PI Buffer
lOmM Tris-HCl
lOOmM NaCl
5mMEDTA
pH 7.0
P2 Buffer 
lOmM Tris-HCl 
250mM NaCl 
1.2% Triton X-100 
lOOug/ml RNase A 
12mM EDTA 
0.5M Guanidine-HCl 
pH 8.0
QBT Buffer (Equilibration Buffer)
750mM NaCl
50mM MOPS
15% Ethanol
0.15% Triton X-100
pH 7.0
QC Buffer (Wash Buffer) 
lOOOmM NaCl 
50mM MOPS 
15% Ethanol 
pH 7.0
QF Buffer (Elution Buffer)
1250mM NaCl 
50mM Tris-HCl 
15% Ethanol 
pH 8.5
Solutions for Qiagen Plasmid DNA Prep
PI Buffer
50mM Tris-HCl
lOmM EDTA
lOOug/ml RNase A
pH 8.0 (store at 4° C) .
P2 Buffer 
0.2 M NaOH 
1% SDS
P3 Buffer
3.0 M Potassium Acetate 
pH 5.5
QBT Buffer (Equilibration Buffer)
750mM NaCl
50mM MOPS
15% Ethanol
0.15% Triton X-100
pH 7.0
QC Buffer (Wash Buffer) 
lOOOmM NaCl 
50mM MOPS 
15% Ethanol 
pH 7.0
QF Buffer (Elution Buffer)
1250mM NaCl 
50mM Tris-HCl 
15% Ethanol 
pH 8.5
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Media:
Czapek Broth
NaN03 3.0 g
K2HP04 1.0 g
MgS04.7H20 0.5 g
KC1 0.5 g
FeS04 O.Olg
Bring volume up to 900 ml with ddH20, and adjust the pH to 7.5 with 
IN HCL and IN NaOH. The volume is then brought to 1 liter by the 
further addition of ddH20. The broth is autoclaved for 15 min at 
lkg/cm2.
LB Broth
Tryptone 10 g
Yeast Extract 5 g
NaCl 10 g
Bring volume to 900ml with ddH20, and adjust the pH to 7.2 with IN 
NaOH. The volume is then brought to 1 liter by the further 
addition of ddH20. The broth is autoclaved for 15 min at lkg/cm2.
L Agar
Tryptone 10 g
Yeast Extract 5 g
NaCl 10 g
Difco Agar 20 g
Bring volume to 900ml with ddH20, and adjust the pH to 7.2 with IN 
NaOH. The volume is then brought to 1 liter by the further 
addition of ddH20. The broth is autoclaved for 15 min at lkg/cm2.
1.0 g 
2.5 g 
0.5 g 
0.1 g 
0.5 g 
0.001 g 
0.04 g 
0.05 g 
0.001 g 
0.001 g 
0.5 mg 
0.5 g 
10 ml
Bring volume to 900ml with ddH20. The volume is then brought to 1 
liter by the further addition of ddH20. The broth is autoclaved for 
15 min at lkg/cm2. A supplement of BBL O.A.D.C. (final 
concentration 4% (v/v)) is added to the 7H9 broth just prior to 
inoculation witH MAI complex organisms.
Middlebrook 7H9 Broth
Monopotassium Phosphate 
Disodium Phosphate 
Monosodium Glutamate 
Sodium Citrate 
Ammonium Sulphate 
Pyridoxine
Ferric Ammonium Citrate 
Magnesium Sulphate 
Zinc Sulphate 
Copper Sulphate 
Biotin
Calcium Chloride 
Glycerol
Tissue Culture Media
Eagle's Minimum Essential Medium
L-Amino Acids
Arginine
Cystine
Glutamine
Histidine
Isoleucine
Leucine
Methionine
Phenylalanine
Threonine
Tryptophan
Tyrosine
Valine
Vitamines
Choline
Folic Acid
Inositol
Nicotinamide
Pantothenic acid
Pyridoxal HC1
Riboflavin
Thiamine HC1
Inorganic Salts
NaCl
KC1
NaH2P04. 2H20 
MgCl2. 6H20 
CaCl2 
NaHC03
Other Components 
Glucose 
Phenol Red 
Fetal Calf Serum
(MEM)
mg/liter
105.0
24.0
292.0
31.0
52.0
52.0
15.0
32.0
48.0
10.0
36.0
46.0
1.0
1.0
2.0
1.0
1.0
1.0
0.10
1.0
6800.0
400.0
150.0
200.0
200.0 
2000.0
1000.0
10.0 
10%
Filter sterilize with 0.22/zm pore size filter membrane.
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Tryptone Broth
Bacto Yeast Extract 3 g
Bacto Tryptone 5 g
Bacto Dextrose 1 g
Bring volume to 900ml with ddH20. The volume is then brought to 1 
liter by the further addition of ddH20. The broth is autoclaved for 
15 min at lkg/cm2.
APPENDIX V: Stains
Stains:
Kinyoun Acid-Fast Stain (Luna, 1968)
Kinyoun Carbol Fuchsin Solution
Basic fuchsin 4.0 g
Phenol crystals 8.0ml
(melted)
Alcohol, 95% 20.0ml
distilled water 100.0ml
Acid-Alcohol
Absolute Ethanol 97.0ml
HC1 (cone.) 3.0ml
Methylene Blue Solution (Stock)
Methylene Blue 1.4 g
Alcohol, 95% 100.0 ml
Methylene Blue Solution (Working)
Methylene blue solution (stock) 10.0ml
distilled water 90.0ml
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